<html>
<head>
<meta charset="utf-8" />
<title>Early treatment with hydroxychloroquine: a country-randomized controlled trial</title>
<meta name="keywords" content="COVID, COVID-19, country analysis">
<meta name="viewport" content="width=device-width,initial-scale=1.0,minimum-scale=1.0,viewport-fit=cover">
<link href="https://fonts.googleapis.com/css2?family=Open+Sans:wght@300;400;600;700&display=swap" rel="stylesheet">
<link href="https://fonts.googleapis.com/css?family=Roboto+Condensed:300,300i,400,400i,500,500i,700,700i,900,900i|Roboto:300,300i,400,400i,500,700,900&display=swap" rel="stylesheet">
<link rel="apple-touch-icon" sizes="180x180" href="/apple-touch-icon.png">
<link rel="icon" type="image/png" sizes="32x32" href="/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="16x16" href="/favicon-16x16.png">
<link rel="manifest" href="/site.webmanifest">
<link rel="mask-icon" href="/safari-pinned-tab.svg" color="#5bbad5">
<meta name="msapplication-TileColor" content="#da532c">
<meta name="theme-color" content="#ffffff">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@CovidAnalysis">
<meta name="twitter:title" content="Early treatment with hydroxychloroquine: a country-randomized controlled trial">
<meta name="twitter:description" content="A country-based analysis of HCQ use">
<meta name="twitter:image" content="https://hcqtrial.com/ogimg200807/rctc.png">
<meta property="og:type" content="article">
<meta property="og:title" content="Early treatment with hydroxychloroquine: a country-randomized controlled trial">
<meta property="og:description" content="A country-based analysis of HCQ use">
<meta property="og:image" content="https://hcqtrial.com/ogimg200807/rctc.png">
<style>
* {
 margin:0;
 padding:0;
}
body {
 font-family:'Roboto',sans-serif;
 /* font-family:'Roboto Condensed',sans-serif; */
 /* font-family: system-ui, -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Ubuntu, "Helvetica Neue", sans-serif; */
 /* font-family:'Open Sans',sans-serif; */
 /* -webkit-font-smoothing:antialiased; */
 line-height:1.45;
 color:rgb(0,0,0);
 font-weight:300;
 font-size:12pt;
 margin-top:20px;
 margin-bottom:60px;
 margin-left:50px;
 margin-right:50px;
}
* {
 outline:none;
}
.center {
 margin:auto;
 max-width:800px;
 position:relative;
}
.mobile {
 display:none;
}
.desktop {
 display:inline-block;
}
a {
 text-decoration:none;
 color:#000000;
}
.underu a:hover {
 text-decoration:underline;
}
.footer {
 margin-left:0px;
 text-align:left;
 margin-top:34px;
 color:#aaa;
}
.footer a {
 color:#aaa;
}
.topt {
 font-size:16px;
 position:absolute;
 top:0;
 right:0;
 margin-left:10px;
 text-align:right;
 margin-top:0px;
 color:#aaa;
}
.topt a {
 color:#aaa;
}
.mtopt {
 font-size:10pt;
 margin:auto;
 display:block;
 /* position:absolute; */
 /* top:50px; */
 /* left:0; */
 /* width:100%; */
 text-align:center;
 margin-top:0px;
 color:#222;
}
.mtopt a {
 color:#222;
}
.social {
 display:inline-block;
}
.toptl {
 margin-bottom:2px;
}
.socialimg {
 height:20px;
}
.socialimg:hover {
 filter:brightness(80%);
}
.msocialimg {
 margin-top:3px;
 height:12px;
}
.tsocialimg {
 margin-top:7px;
 height:40px;
}
.tsocialimg:hover {
 filter:brightness(80%);
}
.item {
 margin-bottom:20px;
 margin-left:0px;
}
.dot {
}
.item:first-letter {
}
.head {
 font-size:22px;
 font-weight:400;
 text-align:center;
 margin:auto;
 margin-bottom:6px;
}
.save {
 font-weight:500;
 color:#000;
}
.change {
 color:#00f;
}
.em {
 font-weight:500;
}
.chartdiv {
 position:relative;
 margin-top:40px;
 width:100%;
 text-align:center;
 margin-bottom:30px;
}
.mchartdiv {
 margin-top:-20px;
 width:100%;
 text-align:center;
 margin-bottom:25px;
}
.tablediv {
 margin-top:30px;
 width:100%;
 text-align:center;
 margin-bottom:25px;
}
.chart {
 border-radius:10px;
 width:100%;
 max-width:700px;
}
.chart2 {
 width:90%;
 max-width:600px;
}
.chart3 {
 width:80%;
 max-width:500px;
}
.dimg {
 position:absolute;
 color:#aaa;
 font-weight:700;
 width:160px;
 margin-left:-80px;
 left:50%;
 padding:3px 10px 3px 10px;
 background-color:#f8f8f8;
 /* border:1px solid #ccc; */
 border-radius:5px;
 display:none;
}
.dimg:hover {
 text-decoration:underline;
}
.hidden {
 display:none;
}
.at:hover {
 text-decoration:underline;
}
.ct:hover {
 /* text-decoration:underline; */
}
.ar:hover {
 text-decoration:underline;
}
.tt:hover {
 text-decoration:underline;
}
.tr:hover {
 text-decoration:underline;
}
.ft:hover {
 text-decoration:underline;
}
.fr:hover {
 text-decoration:underline;
}
.rt:hover {
 text-decoration:underline;
}
.rr:hover {
 text-decoration:underline;
}
.toc {
 position:fixed;
 bottom:0px;
 left:0px;
 width:100%;
 background-color:#f8f8f8;
 opacity:0.97;
 font-size:13.5pt;
 font-family:'Roboto Condensed',sans-serif;
 font-weight:500;
 text-align:center;
 color:#888;
}
.toc2 {
 margin:auto;
 text-align:center;
 position:relative;
 padding-top:2px;
 padding-bottom:1px;
 border-top:1px solid #ccc;
}
.toc2 a {
 color:#888;
}
.draft {
 display:none;
 position:absolute;
 color:#808080;
 top:270px;
 opacity:0.3;
 font-size:90pt;
 font-family:'Roboto Condensed',sans-serif;
 font-weight:900;
 transform:translateX(0%) translateY(0%) rotate(-45deg);
 text-align:center;
 line-height:1.02;
 width:100%;
}
.draft1 {
 margin:auto;
 text-align:center;
}
.draft2 {
 font-size:30pt;
 text-align:center;
}
.odometer.odometer-auto-theme, .odometer.odometer-theme-minimal {
 display: inline-block;
 vertical-align: bottom;
 position: relative;
}
.odometer.odometer-auto-theme .odometer-digit, .odometer.odometer-theme-minimal .odometer-digit {
 display: inline-block;
 vertical-align: bottom;
 position: relative;
}
.odometer.odometer-auto-theme .odometer-digit .odometer-digit-spacer, .odometer.odometer-theme-minimal .odometer-digit .odometer-digit-spacer {
 display: inline-block;
 vertical-align: bottom;
 visibility: hidden;
}
.odometer.odometer-auto-theme .odometer-digit .odometer-digit-inner, .odometer.odometer-theme-minimal .odometer-digit .odometer-digit-inner {
 text-align: left;
 display: block;
 position: absolute;
 top: 0;
 left: 0;
 right: 0;
 bottom: 0;
 overflow: hidden;
}
.subbtn {
 outline:none;
 background-color:#7080ff;
 color:#FFF;
 padding:10px 18px;
 border:0;
 border-radius:4px;
 font-size:13pt;
 margin:10px 0px;
 cursor:pointer;
}
.subblock {
 margin-top:40px;
}
.subdiv {
 width:95%;
 max-width:600px;
 margin:30px auto 30px 0px;
}
.subresp {
 padding-top:15px;
 padding-bottom:5px;
}
.subtext {
 resize:none;
 font-family:'Open Sans',sans-serif;
 -webkit-box-sizing:border-box;
 -moz-box-sizing:border-box;
 box-sizing:border-box;
 color:#000;
 display:inline-block;
 overflow:hidden;
 padding:10px;
 width:100%;
 border-radius:0px;
 box-shadow:0;
 -webkit-box-shadow:0;
 -webkit-appearance:none;
 border:1;
 border-color:#ccc;
 font-size:16px;
}
.subtext::placeholder {
 color:#aaa;
}
.odometer.odometer-auto-theme .odometer-digit .odometer-ribbon, .odometer.odometer-theme-minimal .odometer-digit .odometer-ribbon {
 display: block;
}
.odometer.odometer-auto-theme .odometer-digit .odometer-ribbon-inner, .odometer.odometer-theme-minimal .odometer-digit .odometer-ribbon-inner {
 display: block;
 -webkit-backface-visibility: hidden;
}
.odometer.odometer-auto-theme .odometer-digit .odometer-value, .odometer.odometer-theme-minimal .odometer-digit .odometer-value {
 display: block;
 -webkit-transform: translateZ(0);
}
.odometer.odometer-auto-theme .odometer-digit .odometer-value.odometer-last-value, .odometer.odometer-theme-minimal .odometer-digit .odometer-value.odometer-last-value {
 position: absolute;
}
.odometer.odometer-auto-theme.odometer-animating-up .odometer-ribbon-inner, .odometer.odometer-theme-minimal.odometer-animating-up .odometer-ribbon-inner {
 -webkit-transition: -webkit-transform 5s;
 -moz-transition: -moz-transform 5s;
 -ms-transition: -ms-transform 5s;
 -o-transition: -o-transform 5s;
 transition: transform 5s;
}
.odometer.odometer-auto-theme.odometer-animating-up.odometer-animating .odometer-ribbon-inner, .odometer.odometer-theme-minimal.odometer-animating-up.odometer-animating .odometer-ribbon-inner {
 -webkit-transform: translateY(-100%);
 -moz-transform: translateY(-100%);
 -ms-transform: translateY(-100%);
 -o-transform: translateY(-100%);
 transform: translateY(-100%);
}
.odometer.odometer-auto-theme.odometer-animating-down .odometer-ribbon-inner, .odometer.odometer-theme-minimal.odometer-animating-down .odometer-ribbon-inner {
 -webkit-transform: translateY(-100%);
 -moz-transform: translateY(-100%);
 -ms-transform: translateY(-100%);
 -o-transform: translateY(-100%);
 transform: translateY(-100%);
}
.odometer.odometer-auto-theme.odometer-animating-down.odometer-animating .odometer-ribbon-inner, .odometer.odometer-theme-minimal.odometer-animating-down.odometer-animating .odometer-ribbon-inner {
 -webkit-transition: -webkit-transform 5s;
 -moz-transition: -moz-transform 5s;
 -ms-transition: -ms-transform 5s;
 -o-transition: -o-transform 5s;
 transition: transform 5s;
 -webkit-transform: translateY(0);
 -moz-transform: translateY(0);
 -ms-transform: translateY(0);
 -o-transform: translateY(0);
 transform: translateY(0);
}
@media (max-width:667px) {
 .topt {
  display:none;
 }
}
@media only screen and (min-device-width:10px) and (max-device-width:667px) and (orientation:portrait) {
 .mtopt {
  /* display:block; */
 }
 .topt {
  display:none;
 }
 body {
  font-size:16px;
  margin:10px;
  margin-bottom:30px;
  overflow-x:hidden;
  max-width:100vw;
 }
 html {
  overflow-x:hidden;
  max-width:100vw;
 }
 .item {
  /* padding-left:20px; */
  margin-left:9px;
 }
 .subblock {
  margin-left:10px;
 }
 .footer {
  margin-left:10px;
 }
 .dot {
  display:inline-block;
  margin-left:-9px;
  text-align:left;
  width:9px;
 }
 .head {
  font-size:18px;
  margin-bottom:6px;
 }
 .mobile {
  display:inline-block;
 }
 .desktop {
  display:none;
 }
}
/* ------------------------- */
sup, sub {
 vertical-align: baseline;
 position: relative;
 top: -0.4em;
}
sub {
 top: 0.4em;
}
.nobreak {
}
.mtopt {
 /* display:inline; */
 color:#444;
 /* top:65px; */
 font-size:12pt;
}
.mtopt a {
 color:#444;
}
.msocialimg {
 margin-top:3px;
 margin-right:2px;
 height:16px;
 filter:brightness(80%);
}
.msocialimg:hover {
 filter:brightness(60%);
}
.fdiv {
 display:inline-block;
 vertical-align:top;
 color:#777;
}
.fdiv a {
 color:#777;
}
.topt {
 display:none;
}
b {
 font-weight:400;
}
.em {
 font-weight:400;
}
.ref {
 font-size:16px;
 margin-bottom:10px;
}
.refn {
 font-style:italic;
 font-weight:500;
 color:rgb(121,121,121);
}
.refyes {
 /* color:#098003; */
}
.refno {
 /* color:#db2e02; */
}
.refmixed {
 /* color:#d6790f; */
}
.refunclear {
 /* color:#d6790f; */
}
.reflate {
 /* color:#d6790f; */
}
.refsum {
 margin-bottom:25px;
}
.refl {
 color:rgb(121,121,121);
 font-family:'Roboto Condensed',sans-serif;
 font-size:15.5px;
 font-weight:300;
 margin-bottom:9px;
 margin-left:30px;
 text-indent:0px;
}
.refl a {
 color:rgb(121,121,121);
}
.refln {
 margin-left:-30px;
 display:inline-block;
 width:30px;
}
.reft {
 font-style:italic;
}
.refu:hover {
 text-decoration:underline;
}
.refa {
 font-weight:700;
}
.refcomment {
 font-style:italic;
}
.refcountry {
 font-family:'Roboto Condensed',sans-serif;
 font-size:13pt;
 font-weight:700;
}
.refstatus {
 font-weight:400;
 /* font-size:20px; */
}
.refspace {
 margin-bottom:40px;
}
.refcountryc {
 margin-top:20px;
 color:#555;
}
.refsrc {
 font-style:italic;
}
.ctable {
 margin:auto;
 font-size:11pt;
 color:rgb(71,71,71);
 border-collapse:collapse;
 border:1px solid #aaa;
}
.ctable td {
 border:1px solid #bbb;
 padding:7px 5px 7px 5px;
 text-align:center;
}
.ctable2 {
 margin:auto;
 font-size:11pt;
 color:rgb(71,71,71);
 border-collapse:collapse;
 border:1px solid #aaa;
 table-layout:fixed;
}
.ctable2 td {
 border:1px solid #bbb;
 padding:9px 9px 9px 9px;
 text-align:center;
}
.ct2c {
 width:160px;
}
.ctcd {
 width:60px;
}
.ctr {
}
.ctr2 {
}
.studydist {
 margin:auto;
 font-weight:300;
 border-collapse:collapse;
 border:1px solid #aaa;
}
.studydist td {
 border:1px solid #bbb;
 padding:7px 7px 7px 7px;
 text-align:center;
}
.marseillet {
 margin:auto;
 font-weight:300;
 border-collapse:collapse;
 border:0px;
}
.marseillet td {
 border:0px;
 padding:7px 7px 7px 7px;
 text-align:center;
}
.tcaption {
 font-family:'Roboto Condensed',sans-serif;
 margin-top:15px;
 margin-bottom:25px;
 margin-left:auto;
 margin-right:auto;
 font-style:italic;
 text-align:center;
}
.fcaption {
 font-family:'Roboto Condensed',sans-serif;
 max-width:700px;
 margin-left:auto;
 margin-right:auto;
 margin-top:15px;
 margin-bottom:25px;
 font-style:italic;
}
.tnum {
 font-weight:700;
 font-style:italic;
}
.section {
 margin-bottom:40px;
}
.par {
 margin-bottom:15px;
}
.head {
 color:rgb(81,81,81);
 font-weight:700;
}
.au {
 color:#333;
 margin-bottom:3px;
 /* font-family:'Roboto Condensed',sans-serif; */
}
.head1 {
 font-family:'Roboto Condensed',sans-serif;
 font-size:18pt;
 font-weight:700;
 margin-bottom:17px;
 /* color:rgb(81,81,81); */
 color:#116399;
}
.head1 a {
 color:#116399;
}
.head2 {
 display:inline;
 font-family:'Roboto Condensed',sans-serif;
 /* font-size:16px; */
 font-weight:700;
 /* color:rgb(81,81,81); */
 color:#116399;
}
.head2 a {
 color:#116399;
}
.abstract {
 padding:20px;
 font-family:'Roboto Condensed',sans-serif;
 font-size:14pt;
 font-weight:500;
 background-color:#9fc8e3;
}
.abstract b {
 font-family:'Roboto Condensed',sans-serif;
 font-weight:900;
}
.refurl:hover {
 text-decoration:underline;
}
.tsum {
 position:relative;
 padding:25px 50px 20px 50px;
 /* background-color:#9fc8e3; */
 background-color:#1c4991;
 color:#fff;
 /* color:#222; */
 width:700px;
 height:355px;
 font-family:'Roboto',sans-serif;
 font-size:22.2pt;
 line-height:1.3;
 font-weight:300;
}
.ti2a {
 position:absolute;
 margin-top:-95px;
 margin-left:-80px;
 opacity:0.2;
}
.ti2b {
 width:360px;
}
.thea {
 font-family:'Roboto Condensed',sans-serif;
 font-size:30pt;
 margin-bottom:17px;
 line-height:1.15;
 font-weight:900;
}
.timg {
 /* margin-top:7.5px; */
 float:right;
 width:320px;
 height:350px;
 padding-left:2px;
}
.tpar {
 font-family:'Roboto Condensed',sans-serif;
 margin-bottom:12px;
 font-weight:500;
}
.tres {
 font-family:'Roboto Condensed',sans-serif;
 font-weight:700;
}
.tbld {
 font-weight:900;
}
.ibg {
 display:none;
 position:absolute;
 top:-50px;
 right:0px;
 opacity:0.15;
}
.ibg2 {
 transform:translateX(0%) translateY(0%) rotate(90deg);
 width:360px;
}
@media only screen and (min-device-width:10px) and (max-device-width:667px) and (orientation:portrait) {
 body {
  font-size:11pt;
  margin-bottom:20px;
 }
 .subblock {
  margin-left:0px;
 }
 .toc {
  font-size:9pt;
  padding-bottom:constant(safe-area-inset-bottom);
  padding-bottom:env(safe-area-inset-bottom);
 }
 .footer {
  margin-left:0px;
 }
 .draft {
  top:150px;
 }
 .head {
  line-height:1.3;
  font-size:17px;
  margin-bottom:6px;
 }
 .head1 {
  font-size:16pt;
 }
 .abstract {
  padding:10px;
  font-size:11pt;
 }
 .chartdiv {
  margin-top:20px;
  margin-bottom:20px;
 }
 .mtopt {
  top:75px;
  font-size:10pt;
 }
 .msocialimg {
  margin-top:1px;
  margin-right:2px;
  height:16px;
 }
 .ref {
  /* font-family:'Roboto Condensed',sans-serif; */
  font-size:10pt;
  /*
  display:inline-block;
  vertical-align:middle;
  */
 }
 .refurl {
  /*
  vertical-align:middle;
  display:inline-block;
  white-space:nowrap;
  overflow:hidden;
  text-overflow:ellipsis;
  max-width:200px;
  */
 }
 .refsum {
  margin-bottom:20px;
 }
 .refl {
  font-size:9pt;
  margin-left:25px;
 }
 .refln {
  margin-left:-25px;
  display:inline-block;
  width:25px;
 }
 .refcountry {
  font-size:12pt;
 }
 .refspace {
  margin-bottom:25px;
 }
 .ctable {
  font-size:7pt;
 }
 .ctable td {
  padding:5px 1px 5px 1px;
 }
 .ctable2 {
  font-size:8pt;
 }
 .ctable2 td {
  padding:5px 5px 5px 5px;
 }
 .ct2c {
  width:125px;
 }
 .ctcd {
  width:60px;
 }
 .studydist {
  font-size:9pt;
 }
 .studydist td {
  padding:6px 6px 6px 6px;
 }
 .marseillet {
  font-size:9pt;
 }
 .marseillet td {
  padding:6px 6px 6px 6px;
 }
 .ref {
  /*
  display:inline-block;
  vertical-align:text-bottom;
  */
 }
 .refu {
  /*
  vertical-align:text-bottom;
  display:inline-block;
  white-space:nowrap;
  overflow:hidden;
  text-overflow:ellipsis;
  max-width:200px;
  */
 }
}
@media only screen and (min-device-width:10px) and (max-device-width:400px) and (orientation:portrait) {
 .toc {
  font-size:8pt;
 }
}
@media only screen and (min-device-width:10px) and (max-device-width:350px) and (orientation:portrait) {
 .toc {
  font-size:7pt;
 }
}
.print {
 display:none;
}
@media print {
 @page {
  size:letter portrait;
  margin:2.5cm
 }
 @page :first {
  /* margin-top:10cm */
 }
 .toc {
  display:none;
 }
 .print {
  display:block;
 }
 .draft {
  top:190px;
 }
 .mtopt {
 }
 body {
  margin:0px;
  /* margin:25mm 25mm 25mm 25mm; */
  /* margin:20px; */
  line-height:1.5;
  color:rgb(0,0,0);
  font-weight:200;
  font-size:9.5pt;
  widows:3;
  orphans:3;
 }
 .center {
  margin:auto;
  max-width:550px;
  position:relative;
 }
 .abstract {
  padding:10px;
  font-size:10pt;
 }
 .par {
  text-align:justify;
  text-justify:auto;
 }
 .ref {
  font-size:9pt;
  text-align:left;
 }
 .studydist {
  font-size:9pt;
 }
 .marseillet {
  font-size:9pt;
 }
 .nobreak {
  page-break-inside:avoid;
 }
 .ctable {
  font-size:9pt;
  page-break-inside:avoid;
 }
 .ctable td {
  border:1px solid #bbb;
  padding:4px 2px 4px 2px;
 }
 .ctable2 {
  font-size:8pt;
  page-break-inside:avoid;
 }
 .ctable2 td {
  border:1px solid #bbb;
  padding:4px 2px 4px 2px;
 }
 .ct2c {
  width:100px;
 }
 .ctcd {
  width:50px;
 }
 .refl {
  text-align:left;
  color:rgb(0,0,0);
  font-size:9pt;
 }
 .refl a {
  color:rgb(0,0,0);
 }
 .refn a {
  color:rgb(0,0,0);
 }
 .refcountryc {
  margin-top:20px;
  color:#000;
 }
 .head {
  color:#000;
  font-size:14pt;
 }
 .head1 {
  color:#000;
  page-break-after:avoid;
  page-break-inside:avoid;
  font-size:12pt;
 }
 .head1::after {
  content:"";
  display:block;
  height:100px;
  margin-bottom:-100px;
 }
 .head2 {
  font-size:9.5pt;
  color:#000;
 }
 .par {
  widows:3;
  orphans:3;
 }
 .chart {
  width:90%;
 }
 .chart2 {
  width:80%;
 }
 .chart3 {
  width:70%;
 }
 .chartdiv {
  page-break-inside:avoid;
 }
 .tablediv {
  page-break-inside:avoid;
 }
 .social {
  display:none;
 }
 .subblock {
  display:none;
 }
 .footer {
  display:none;
 }
}
</style>
</head>
<body>
<div class=center>


























<div class='tsum hidden' id=tsum><img class=timg src=plot/plot1ac.svg>
<div class=thea>Country-based analysis of early HCQ treatment</div>
<div class=ti2a><img id=ti2b class=ti2b data-src=rctbg.png></div>
<div class=tpar>Countries adopted or declined early treatment, forming a
2.7B person country-randomized trial</div>
<!-- <span class=tbld> -->
<div class=tpar>As of Aug 7, treatment countries have a
79.1% lower death rate after adjustments
<!-- </span> -->
</div></div>





<div id=draft class=draft>
<span class=draft1>DRAFT&nbsp;4</span><br>
<span class=draft2>DO NOT SHARE</span>
</div>



<div class=head><a class=head id=top href='/'>Early treatment with hydroxychloroquine: a country-randomized controlled trial</a></div>

<div class=mtopt>
<div class="au underu"><a href="/faq.html">Covid Analysis</a>, August 5, 2020 (updated August 7, 2020)</div>
<div class=fdiv>
<span class=underu><a href="https://twitter.com/CovidAnalysis">@CovidAnalysis</a></span>&nbsp;&nbsp;</div>
<div class=social>
<div class=fdiv><a target="_blank" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fhcqtrial.com%2F"><img class=msocialimg src='fb.svg'></a></div>
<div class=fdiv><span class=underu><a target="_blank" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fhcqtrial.com%2F">Share</a></span>&nbsp;&nbsp;</div>
<div class=fdiv><a href="https://twitter.com/intent/tweet?text=Early%20treatment%20with%20hydroxychloroquine%3A%20a%20country-randomized%20controlled%20trial&url=https%3A%2F%2Fhcqtrial.com%2F&hashtags=hcqtrial&via=CovidAnalysis"><img class=msocialimg src='twitter.svg'></a></div>
<div class=fdiv><span class=underu><a href="https://twitter.com/intent/tweet?text=Early%20treatment%20with%20hydroxychloroquine%3A%20a%20country-randomized%20controlled%20trial&url=https%3A%2F%2Fhcqtrial.com%2F&hashtags=hcqtrial&via=CovidAnalysis">Tweet</a></span></div>
</div>
</div>





<div id='fig_mainplot' class=chartdiv onmouseover='download("m",0)' onmouseout='download2("m")'> <a href="plot/plot1ax.png" download><div id=dlm class=dimg>Download
Image</div></a><img class=chart src=plot/plot1ax.svg>
</div>





<div class=section><div class=abstract>

Many countries either adopted or declined early treatment with HCQ, forming a
large country-randomized controlled trial with 2.0 billion people in the
treatment group and 663 million to the control group. As of August 7, 2020, an
average of 38.5/million in the treatment group have died,
and 440.2/million in the control group, relative risk
0.087. After adjustments, treatment and control deaths become
79.6/million and 630.0/million,
relative risk 0.13. Confounding factors affect this
estimate, including varying degrees of spread between countries. Accounting
for predicted changes in spread, we estimate a relative risk of
0.21. <b>The treatment group has
79.1% lower chance of death</b>. We examined
diabetes, obesity, hypertension, life expectancy, population density,
urbanization, testing level, and intervention level, which do not account for
the effect observed.</div></div>






<!-- Based on these interim results, we recommend dramatically reducing the
size of the control group, and allowing people to voluntarily leave the
control group. -->

<a class=st id="setup" href="#setup"><div class=head1>Trial Setup</div></a>



<div class=section>

<div class=par><a class=st id="treatment" href="#treatment"><div class=head2>Treatment.</div></a>  We investigate early or
prophylactic treatment for COVID-19 with hydroxychloroquine (HCQ), which has
been adopted or declined in different countries. Since the severity of
COVID-19 varies widely based on age and comorbidities, treatment was generally
only initiated in higher risk individuals. The primary endpoint was
death.</div>



<div class=par><a class=st id="groups" href="#groups"><div class=head2>Treatment groups.</div></a>  Entire countries made
different decisions regarding treatment with HCQ, essentially assigning
themself to the treatment or control group. For the purposes of this study,
selection into the treatment or control group was based on the same
information and is essentially random.</div>




<div class=par>We focus here on countries that chose and maintained a clear
assignment to one of the groups for a majority of the duration of their
outbreak, either adopting widespread use, or highly limiting use. Some
countries have very mixed usage, and some countries have joined or left the
treatment group during their outbreak. We searched government web sites,
Twitter, and Google, with the assistance of several experts in HCQ usage, to
confirm assignment to the treatment or control group, locating a total of
193 relevant references, shown in <a class=ar id="acite_countryhcq" href="#appendix_countryhcq">Appendix 12</a>. We
excluded countries with <1M population, and countries with <0.5% of people
over the age of 80. COVID-19 disproportionately affects older people and the
age based adjustments are less reliable when there are very few people in the
high-risk age groups. We also excluded countries that adopted early widespread
use of masks because these countries tend to have significantly lower spread,
which we discuss in detail below.</div>




<div class=par>Collectively the countries we identified with stable and
relatively clear assignments account for 34.7% of the
world population (2.7B of 7.8B). Details
of the groups and evidence, including countries identified as having mixed use
of HCQ, can be found in <a class=ar id="acite_countryhcq" href="#appendix_countryhcq">Appendix 12</a>.
</div>






<div class=par><a class=st id="analysis" href="#analysis"><div class=head2>Analysis.</div></a>  We analyze deaths per capita
with data from <span class=refn>[<a class=rr id="cite_ourworldindata" href="#ref_ourworldindata">Our World in Data</a>]</span>. To determine the effectiveness of
treatment we could compare the death rates for the entire populations in the
treatment and control groups, however we use the average of the individual
country rates in each group in order to minimize effects due to differences
between countries.</div>



<div class=par>Since randomization was done at a coarse country level, we
adjust for differences between countries and analyze confounding factors. <a
id='cases' href='#cases'>We</a> analyze deaths rather than cases because case
numbers are highly dependent on the degree of testing effort, criteria for
testing, the accuracy and availability of tests, accuracy of reporting, and
because there is very high variability in case severity, including a high
percentage of asymptomatic cases.</div>


<a class=st id="results" href="#results"><div class=head1>Results</div></a>


<div class=section>

<div class=par>
Many countries either adopted or declined early treatment with HCQ, forming a
large country-randomized controlled trial with 2.0 billion people in the
treatment group and 663 million to the control group. As of August 7, 2020, an
average of 38.5/million in the treatment group have died,
and 440.2/million in the control group, relative risk
0.087. After adjustments, treatment and control deaths become
79.6/million and 630.0/million,
relative risk 0.13. Confounding factors affect this
estimate, including varying degrees of spread between countries. Accounting
for predicted changes in spread, we estimate a relative risk of
0.21. <b>The treatment group has
79.1% lower chance of death</b>. We examined
diabetes, obesity, hypertension, life expectancy, population density,
urbanization, testing level, and intervention level, which do not account for
the effect observed. <a class=fr id="fcite_mainplot" href="#fig_mainplot">Figure 1</a> shows cumulative
demographic adjusted death rates by country and trial group. Adjustments are
detailed in the next section. Some analyses adjust graphs for the date since a
specific milestone was reached, such as 0.1 deaths per million. We do not do
this because an effective treatment will alter the time that such a
milestone is reached. </div>

<div class=par>For comparison, if we use the median of country death rates in
each group rather than the mean, the relative risk is 0.12
(before prediction of future spread). If we combine all countries into single
treatment and control groups, the relative risk is 0.13. Since
the sample sizes are very large, <i>p</i> < 0.0001, however it is more important to
analyze confounding factors. </div>

<div id='fig_mainplot' class=chartdiv onmouseover='download("m",0)' onmouseout='download2("m")'> <a href="plot/plot1ax.png" download><div id=dlm class=dimg>Download
Image</div></a><img class=chart src=plot/plot1ax.svg>
<div class=fcaption><a class=ft href="#fcite_mainplot"><span class=tnum>Figure 1.</span></a> Adjusted deaths per million for countries
using widespread early HCQ versus those that do not, with a prediction
for the following 90 days. As of August 7, 2020, countries using early HCQ are predicted to have a 79.1% lower death rate after adjustments.</div>
</div>

</div>

<a class=st id="confounding" href="#confounding"><div class=head1>Confounding Factors</div></a>


<div class=section>

<div class=par>A number of confounding factors affect the results, which we
investigate here. For reference, the results before adjustments are shown in
<a class=fr id="fcite_unadjusted" href="#fig_unadjusted">Figure 2</a>.</div>


<div class=section>
<div id='fig_unadjusted' class=chartdiv><img class=chart src=plot/plot2.svg>
<div class=fcaption><a class=ft href="#fcite_unadjusted"><span class=tnum>Figure 2.</span></a> Deaths per million for countries using widespread early
HCQ versus those that do not, <b>before adjustments</b>.</div>
</div>
</div>



<div class=par><a class=st id="age" href="#age"><div class=head2>Age.</div></a>  The COVID-19 IFR varies around four
orders of magnitude depending on age. Since the proportion of older adults
varies significantly between countries, this is likely to have a significant
effect on the results <span class=refn>[<a class=rr id="cite_leffler" href="#ref_leffler">Leffler</a>]</span>. We approximate the relative risk
based on age using the infection fatality rates provided in <span class=refn>[<a class=rr id="cite_verity" href="#ref_verity">Verity</a>]</span>,
and shown in <a class=fr id="fcite_ifr" href="#fig_ifr">Figure 3</a>. Due to the distribution, simple adjustment based
on the median age, the proportion of people over 65, or similar may not be
very accurate. We obtained age demographics from <span class=refn>[<a class=rr id="cite_unage" href="#ref_unage">United Nations</a>]</span> which
provides a breakdown within 5 year age groups. Using the 9 age groups provided
by <span class=refn>[<a class=rr id="cite_verity" href="#ref_verity">Verity</a>]</span>, we computed an age adjustment factor for each country to
normalize the observed deaths to the predicted number of deaths if the
country's age distribution matched that of the country with the oldest
population. The age distributions and computed age factors are provided in
<a class=ar id="acite_countrystats" href="#appendix_countrystats">Appendix 1</a>. These adjustments are relatively significant as in
<span class=refn>[<a class=rr id="cite_leffler" href="#ref_leffler">Leffler</a>]</span>.</div>





<div id='fig_ifr' class=chartdiv><img class=chart2 src=img/ifr.svg>
<div class=fcaption><a class=ft href="#fcite_ifr"><span class=tnum>Figure 3.</span></a> Infection fatality rates from <span class=refn>[<a class=rr id="cite_verity" href="#ref_verity">Verity</a>]</span>.</div>
</div>


<div class=par><a class=st id="gender" href="#gender"><div class=head2>Gender.</div></a>  Risk differs significantly based
on gender <span class=refn>[<a class=rr id="cite_gebhard" href="#ref_gebhard">Gebhard</a>]</span>, so we also normalized for this in a similar
fashion. Data is from <span class=refn>[<a class=rr id="cite_unage" href="#ref_unage">United Nations</a>]</span>, and using the hazard ratio of 1.78 from
<span class=refn>[<a class=rr id="cite_williamson" href="#ref_williamson">Williamson</a>]</span> the resulting adjustment factors are shown in
<a class=ar id="acite_countrystats" href="#appendix_countrystats">Appendix 1</a>. These adjustments are relatively minor as in
<span class=refn>[<a class=rr id="cite_leffler" href="#ref_leffler">Leffler</a>]</span>. After adjusting for age and gender we obtain the results in
<a class=fr id="fcite_adjusted" href="#fig_adjusted">Figure 4</a>. Adusted mean treatment and control deaths become
79.6/million and 630.0/million,
relative risk 0.13.
</div>

<div id='fig_adjusted' class=chartdiv><img class=chart src=plot/plot1a.svg>
<div class=fcaption><a class=ft href="#fcite_adjusted"><span class=tnum>Figure 4.</span></a> Deaths per million for countries with widespread early
HCQ versus those that do not, after adjustment for differences in
demographics.</div>
</div>







<div class=par><a class=st id="masks" href="#masks"><div class=head2>Masks.</div></a>  Masks are used in a majority of
countries <span class=refn>[<a class=rr id="cite_wikimasks" href="#ref_wikimasks">Wikipedia</a>]</span>, however use varies between countries, and
research shows it may significantly affect the rate at which the virus spreads
<span class=refn>[<a class=rr id="cite_howard" href="#ref_howard">Howard</a>, <a class=rr id="cite_stutt" href="#ref_stutt">Stutt</a>]</span>. Mask usage was analyzed in <span class=refn>[<a class=rr id="cite_leffler" href="#ref_leffler">Leffler</a>]</span>, which
studied countries that widely and quickly adopted masks, as shown in
<a class=ar id="acite_masks" href="#appendix_masks">Appendix 11</a>. These countries generally have much lower death rates and
may have significantly lower spread of the virus to date. We excluded
countries on this list. This excluded South Korea, Czech Republic, and
Venezuela, which were provisionally identified as countries using early HCQ.
This favors the control group. If we do not exclude these countries, the
treatment group adjusted mean deaths is
67.5/million, and the relative risk decreases to
0.11.</div>






<div class=par><a class=st id="health" href="#health"><div class=head2>Population health.</div></a>  Health conditions
such as diabetes, obesity, and hypertension significantly increase the risk of
death with COVID-19 <span class=refn>[<a class=rr id="cite_gaohyper" href="#ref_gaohyper">Gao</a>, <a class=rr id="cite_williamson" href="#ref_williamson">Williamson</a>]</span>. This could affect the
results because the prevalence of these conditions differs between countries.
These conditions often occur together, for example <span class=refn>[<a class=rr id="cite_iglay" href="#ref_iglay">Iglay</a>]</span> found the
most common comorbid conditions for diabetes were hypertension (82%) and
obesity (78%), which makes combined country-level adjustment difficult,
however we can first analyze the conditions individually. We examined the
relationship of the diabetes, obesity, and hypertension levels with the
adjusted deaths per million for the countries in our study, with data from
<span class=refn>[<a class=rr id="cite_wbdiabetes" href="#ref_wbdiabetes">International Diabetes Federation</a>]</span>, <span class=refn>[<a class=rr id="cite_ciaobesity" href="#ref_ciaobesity">CIA</a>]</span>, and
<span class=refn>[<a class=rr id="cite_mills" href="#ref_mills">Mills</a>]</span> respectively. <a class=ar id="acite_diabetes" href="#appendix_diabetes">Appendix 2</a>, <a class=ar id="acite_obesity" href="#appendix_obesity">Appendix 3</a>, and
<a class=ar id="acite_hypertension" href="#appendix_hypertension">Appendix 4</a> show scatter plots, and the data can be found in
<a class=ar id="acite_countrystats" href="#appendix_countrystats">Appendix 1</a>. There was no significant correlation for diabetes,
<i>r<sup>2</sup></i> = 0.00. There is a small
correlation with obesity, <i>r<sup>2</sup></i> =
0.09. Excluding countries with an obesity prevalence
below 10% (2 countries) reduces the correlation,
<i>r<sup>2</sup></i> = 0.03. Re-running the
analysis in this case results in a relative risk of
0.13. The correlation for
hypertension, <i>r<sup>2</sup></i> = 0.01, is
very low. Based on this we do not expect adjustments to significantly affect
the results. We re-ran the analysis adjusting for each of these factors
individually (HR estimates: diabetes 1.63 <span class=refn>[<a class=rr id="cite_williamson" href="#ref_williamson">Williamson</a>]</span>,
obesity 1.4 <span class=refn>[<a class=rr id="cite_williamson" href="#ref_williamson">Williamson</a>]</span>, hypertension
2.12 <span class=refn>[<a class=rr id="cite_gao" href="#ref_gao">Gao (B)</a>]</span>), which resulted in a relative risk of
0.127, 0.125,
0.128 respectively for diabetes, obesity, and
hypertension. We also examined life expectancy with data from
<span class=refn>[<a class=rr id="cite_owidlife" href="#ref_owidlife">Our World in Data (B)</a>]</span>. <a class=ar id="acite_life_expectancy" href="#appendix_life_expectancy">Appendix 5</a> shows a
scatter plot and the data can be found in <a class=ar id="acite_countrystats" href="#appendix_countrystats">Appendix 1</a>. The
correlation, <i>r<sup>2</sup></i> = 0.09, is
relatively low, and is in the direction of higher life expectancy resulting in
higher deaths. Therefore we do not find evidence that country-level
differences in health have a significant effect on the results.</div>





<div class=par><a class=st id="testing" href="#testing"><div class=head2>Testing.</div></a>  Countries with more
widespread testing could potentially be more successful in minimizing  deaths.
We examined the relationship of testing per capita with adjusted deaths, with
data from <span class=refn>[<a class=rr id="cite_owidtests" href="#ref_owidtests">Our World in Data (C)</a>]</span>. <a class=ar id="acite_testing" href="#appendix_testing">Appendix 10</a>
shows a scatter plot, and the data can be found in <a class=ar id="acite_countrystats" href="#appendix_countrystats">Appendix 1</a>.
The correlation <i>r<sup>2</sup></i> =
0.04, is very low and is also in
the opposite direction of the expected potential correlation (we find that
more testing is correlated with higher deaths). Therefore differences in
testing do not appear to significantly affect the results.</div>






<div class=par><a class=st id="coadministered" href="#coadministered"><div class=head2>Co-administered treatments.</div></a>  Several
theories exist for why HCQ is effective <span class=refn>[<a class=rr id="cite_andreani" href="#ref_andreani">Andreani</a>, <a class=rr id="cite_brufsky" href="#ref_brufsky">Brufsky</a>, <a class=rr id="cite_clementi" href="#ref_clementi">Clementi</a>, <a class=rr id="cite_dewilde" href="#ref_dewilde">de Wilde</a>, <a class=rr id="cite_derendorf" href="#ref_derendorf">Derendorf</a>, <a class=rr id="cite_devaux" href="#ref_devaux">Devaux</a>, <a class=rr id="cite_hoffmann" href="#ref_hoffmann">Hoffmann</a>, <a class=rr id="cite_hunature" href="#ref_hunature">Hu</a>, <a class=rr id="cite_keyaerts" href="#ref_keyaerts">Keyaerts</a>, <a class=rr id="cite_kono" href="#ref_kono">Kono</a>, <a class=rr id="cite_liu" href="#ref_liu">Liu</a>, <a class=rr id="cite_pagliano" href="#ref_pagliano">Pagliano</a>, <a class=rr id="cite_savarino2" href="#ref_savarino2">Savarino</a>, <a class=rr id="cite_savarino" href="#ref_savarino">Savarino (B)</a>, <a class=rr id="cite_scherrmann" href="#ref_scherrmann">Scherrmann</a>, <a class=rr id="cite_sheaff" href="#ref_sheaff">Sheaff</a>, <a class=rr id="cite_vincent" href="#ref_vincent">Vincent</a>, <a class=rr id="cite_wang" href="#ref_wang">Wang</a>, <a class=rr id="cite_wangcell" href="#ref_wangcell">Wang (B)</a>]</span>,
some of which involve co-administration of other medication or suppplements.
Most commonly used are zinc <span class=refn>[<a class=rr id="cite_derwand" href="#ref_derwand">Derwand</a>, <a class=rr id="cite_shittu" href="#ref_shittu">Shittu</a>]</span> and Azithromycin (AZ) <span class=refn>[<a class=rr id="cite_guerin" href="#ref_guerin">Guérin</a>]</span>.
<i>In vitro</i> experiments report a synergistic effect of HCQ
and AZ on antiviral activity <span class=refn>[<a class=rr id="cite_andreani" href="#ref_andreani">Andreani</a>]</span> at concentrations obtained in
the human lung, and <i>in vivo</i> results are consistent with this
<span class=refn>[<a class=rr id="cite_gautretjaa" href="#ref_gautretjaa">Gautret</a>]</span>. Zinc reduces SARS-CoV RNA-dependent RNA polymerase
activity <i>in vitro</i> <span class=refn>[<a class=rr id="cite_te" href="#ref_te">te Velthuis</a>]</span>, however it is difficult to obtain
significant intracellular concentrations with zinc alone <span class=refn>[<a class=rr id="cite_maret" href="#ref_maret">Maret</a>]</span>.
Combining it with a zinc ionophore such as HCQ increases cellular uptake,
making it more likely to achieve effective intracellular concentrations
<span class=refn>[<a class=rr id="cite_xueplos" href="#ref_xueplos">Xue</a>]</span>. Zinc deficiency varies and inclusion of zinc may be more or
less important based on an individual's existing zinc level. Zinc consumption
varies widely based on diet <span class=refn>[<a class=rr id="cite_nihzinc" href="#ref_nihzinc">NIH</a>]</span>.
To the extent that the co-administration of zinc, Azithromycin,
or other medication or supplements is important, we may underestimate the
effectiveness of HCQ because not all countries and locations are using the
optimal combination.</div>










<div class=par><a class=st id="density" href="#density"><div class=head2>Population density and urbanization.</div></a> 
We tested the effect of population density <span class=refn>[<a class=rr id="cite_owiddensity" href="#ref_owiddensity">Our World in Data (D)</a>, <a class=rr id="cite_owiddata" href="#ref_owiddata">Our World in Data (E)</a>]</span> and
urbanization <span class=refn>[<a class=rr id="cite_wburban" href="#ref_wburban">World Bank</a>]</span>, with scatter plots shown in
<a class=ar id="acite_pop_density" href="#appendix_pop_density">Appendix 9</a> and <a class=ar id="acite_urban" href="#appendix_urban">Appendix 13</a>, and data shown in
<a class=ar id="acite_countrystats" href="#appendix_countrystats">Appendix 1</a>. The correlation for population density
<i>r<sup>2</sup></i> = 0.00. For
urbanization a small correlation was found, <i>r<sup>2</sup></i> =
0.13. Excluding countries with urbanization below 75%
(7 countries) reduces the correlation, <i>r<sup>2</sup></i>
= 0.03. Re-running the analysis in this case results
in a relative risk of 0.12. Therefore differences
in population density and urbanization do not appear to significantly affect
the results.</div>

















<div class=par><a class=st id="regimen" href="#regimen"><div class=head2>Treatment regimen.</div></a>  There are
differences in treatment regimens between and within countries. Details of
timing, determination of risk, and dosages differ. Because not all locations
are using the optimal regimen, this may reduce the effect observed.</div>

<div class=par><a class=st id="adherence" href="#adherence"><div class=head2>Adherence.</div></a>  Some people in the control
group obtained the treatment. This may reduce the effect observed.</div>



<div class=par><a class=st id="counterfeit" href="#counterfeit"><div class=head2>Counterfeit medication.</div></a>  Counterfeit
HCQ has been reported <span class=refn>[<a class=rr id="cite_fakehcq" href="#ref_fakehcq">Covid19Crusher</a>]</span>. This may reduce the effect
observed.</div>

<div class=par><a class=st id="seasonality" href="#seasonality"><div class=head2>Seasonality.</div></a>  Seasonality could affect
results, although <span class=refn>[<a class=rr id="cite_jamil" href="#ref_jamil">Jamil</a>]</span> show there is currently little evidence for
a large temperature dependence. We also note that the pandemic already covers
more than one season and over time is likely to cover all seasons.</div>


<div class=par><a class=st id="deathstatistics" href="#deathstatistics"><div class=head2>Accuracy of death statistics.</div></a>  The
accuracy of reported death statistics varies across and within countries.
Excess death statistics may be used in the future if they become available for
more countries, however it may be difficult to separate deaths due to COVID-19
and changes to other causes of death related to interventions.</div>



<div class=par><a class=st id="spread" href="#spread"><div class=head2>Degree of spread.</div></a>  The virus has spread
throughout countries at different rates, due to differences in the initial
number of infected persons arriving at the country, differences in treatments,
population dynamics, cultural differences, and interventions including masks,
social distancing, lockdowns, quarantine, and border restrictions. This factor
is likely to be significant but will decline over time. Since it is unlikely
that the virus will be eliminated soon, we expect that increasingly similar
percentages of people will have been exposed over time, and we will update
this analysis periodically to reflect the latest data. While interventions can
temporarily slow the spread of the virus, it is unlikely that high
intervention levels can be sustained indefinitely. Some countries, such as New
Zealand, have highly contained the virus to date, essentially by quickly
isolating themselves from the world with travel restrictions and strictly
enforced quarantine rules. These countries may avoid significant spread while
they remain isolated, however all of the countries in the treatment and
control groups here have experienced significant spread of the virus.</div>


<div class=par>We tested the effect of interventions using the average
intervention stringency index <span class=refn>[<a class=rr id="cite_stringency" href="#ref_stringency">University of Oxford</a>]</span> over the period analyzed,
as provided by <span class=refn>[<a class=rr id="cite_owiddata" href="#ref_owiddata">Our World in Data (E)</a>, <a class=rr id="cite_owidstringency" href="#ref_owidstringency">Our World in Data (F)</a>]</span>. <a class=ar id="acite_interventions" href="#appendix_interventions">Appendix 14</a>
shows a scatter plot, the correlation <i>r<sup>2</sup></i> =
0.12, suggesting a potential minor effect
whereby countries with higher interventions to date have lower deaths (note
that we excluded countries that quickly adopted masks, the effect may be
greater if they are included). Excluding the stringency outliers
(3 countries), results in a correlation
<i>r<sup>2</sup></i> = 0.01. Re-running the
analysis in this case results in a relative risk of
0.13, suggesting that the differences in
non-medical interventions have a relatively minor affect on the results at
present.</div>


<div class=par>The treatment group countries generally show significantly
slower growth in mortality which may be due to treatment, interventions,
differences in culture, or the initial degree of infections arriving into the
country. Over time we expect that increasingly similar percentages of people
will have been exposed, since it is unlikely that the virus will be eliminated
soon.</div>

<div class=par>To account for future spread, we created an estimate of the
future adjusted deaths per million for each country, 90 days
in the future, based on a second degree polynomial fit according to the most
recent 30 days, enforcing the requirement that deaths do not
decrease, and using an assumption of a progressively decreasing maximum
increase over time. <a class=fr id="fcite_extended" href="#fig_extended">Figure 5</a> shows the results, which predicts a
future relative risk of 0.21, i.e., the
treatment group has 79.1% lower chance of
death.</div>



<div id='fig_extended' class=chartdiv><img class=chart src=plot/plot1ax.svg>
<div class=fcaption><a class=ft href="#fcite_extended"><span class=tnum>Figure 5.</span></a> Demographic adjusted deaths per
million for countries using widespread early HCQ versus those that do not,
with an extended prediction for the following 90
days.</div></div>

</div>

<a class=st id="literature" href="#literature"><div class=head1>Literature Review</div></a>






<div class=section>

<div class=par><a class=st id="literatureintro" href="#literatureintro"><div class=head2>Introduction.</div></a>  CQ and HCQ are
4-aminoquinoline synthetic alternatives to quinine, a naturally occurring
compound found in cinchona bark, which has long been used for respiratory
infections and other conditions. The cost of HCQ is around 0.28 per dose
according to <span class=refn>[<a class=rr id="cite_hcqcost" href="#ref_hcqcost">Centers for Medicare and Medicaid Services</a>]</span>. CQ, HCQ, and quinine are on the World Health
Organization's list of essential medicines, the safest and most effective
medicines needed in a health system <span class=refn>[<a class=rr id="cite_whoessential" href="#ref_whoessential">World Health Organization</a>]</span>.</div>

<div class=par>HCQ is effective against
SARS-CoV-2 and related viruses <i>in vitro</i>
<span class=refn>[<a class=rr id="cite_keyaerts" href="#ref_keyaerts">Keyaerts</a>, <a class=rr id="cite_savarino2" href="#ref_savarino2">Savarino</a>, <a class=rr id="cite_savarino" href="#ref_savarino">Savarino (B)</a>, <a class=rr id="cite_vincent" href="#ref_vincent">Vincent</a>, <a class=rr id="cite_wang" href="#ref_wang">Wang</a>]</span>, plasma concentrations that
have been shown to be effective <i>in vitro</i> can be achieved safely
<span class=refn>[<a class=rr id="cite_keyaerts" href="#ref_keyaerts">Keyaerts</a>, <a class=rr id="cite_savarino2" href="#ref_savarino2">Savarino</a>, <a class=rr id="cite_vincent" href="#ref_vincent">Vincent</a>, <a class=rr id="cite_wang" href="#ref_wang">Wang</a>]</span>, and it has decades of use and a
very well established safety profile <span class=refn>[<a class=rr id="cite_cdchcq" href="#ref_cdchcq">CDC</a>]</span>.</div>



<div class=par><a class=st id="theoryinvitro" href="#theoryinvitro"><div class=head2>Theory and <i>in vitro</i> results.</div></a> 
Several <i>in vitro</i> studies <span class=refn>[<a class=rr id="cite_andreani" href="#ref_andreani">Andreani</a>, <a class=rr id="cite_clementi" href="#ref_clementi">Clementi</a>, <a class=rr id="cite_dewilde" href="#ref_dewilde">de Wilde</a>, <a class=rr id="cite_hoffmann" href="#ref_hoffmann">Hoffmann</a>, <a class=rr id="cite_keyaerts" href="#ref_keyaerts">Keyaerts</a>, <a class=rr id="cite_kono" href="#ref_kono">Kono</a>, <a class=rr id="cite_liu" href="#ref_liu">Liu</a>, <a class=rr id="cite_savarino2" href="#ref_savarino2">Savarino</a>, <a class=rr id="cite_sheaff" href="#ref_sheaff">Sheaff</a>, <a class=rr id="cite_vincent" href="#ref_vincent">Vincent</a>, <a class=rr id="cite_wang" href="#ref_wang">Wang</a>, <a class=rr id="cite_wangcell" href="#ref_wangcell">Wang (B)</a>]</span> show that CQ
inhibits related viruses and SARS-CoV-2, supported by several related theory
articles <span class=refn>[<a class=rr id="cite_brufsky" href="#ref_brufsky">Brufsky</a>, <a class=rr id="cite_derendorf" href="#ref_derendorf">Derendorf</a>, <a class=rr id="cite_devaux" href="#ref_devaux">Devaux</a>, <a class=rr id="cite_hunature" href="#ref_hunature">Hu</a>, <a class=rr id="cite_pagliano" href="#ref_pagliano">Pagliano</a>, <a class=rr id="cite_savarino" href="#ref_savarino">Savarino (B)</a>, <a class=rr id="cite_scherrmann" href="#ref_scherrmann">Scherrmann</a>]</span>. Theories for the mechanism of action
include HCQ/CQ protonation and accumulation in the endosome which prevents the
acidification required for genome release <span class=refn>[<a class=rr id="cite_fitch" href="#ref_fitch">Fitch</a>]</span>; acting as an
ionophoric agent that transports zinc ions into infected cells, where they
inhibit viral RNA replicase enzyme <span class=refn>[<a class=rr id="cite_xueplos" href="#ref_xueplos">Xue</a>]</span>; dampening excess immune
responses thereby mitigating the hyperactive immune response sometimes
associated with COVID-19 <span class=refn>[<a class=rr id="cite_schrezenmeier" href="#ref_schrezenmeier">Schrezenmeier</a>]</span>; and inhibiting oxidative
phosphorylation in mitochondria, likely by sequestering protons needed to
drive ATP synthase <span class=refn>[<a class=rr id="cite_sheaff" href="#ref_sheaff">Sheaff</a>]</span>.

<span class=refn>[<a class=rr id="cite_savarino" href="#ref_savarino">Savarino (B, 2003)</a>]</span> reviews the antiviral effects of CQ, noting that CQ inhibits the replication of several viruses including members of the flaviviruses, retroviruses, and coronaviruses. They note that CQ has immunomodulatory effects, suppressing the production/release of tumour necrosis factor α and interleukin 6, which mediate the inflammatory complications of several viral diseases; <span class=refn>[<a class=rr id="cite_keyaerts" href="#ref_keyaerts">Keyaerts (2004)</a>]</span> show that the IC50 of CQ for inhibition of SARS-CoV <i>in vitro</i> approximates the plasma concentrations of CQ reached during treatment of acute malaria, suggesting that CQ may be considered for immediate use in the prevention and treatment of SARS-CoV; <span class=refn>[<a class=rr id="cite_vincent" href="#ref_vincent">Vincent (2005)</a>]</span> show that CQ has strong antiviral effects on SARS CoV infection when cells are treated either before or after exposure, suggesting prophylactic and treatment use, and describing three mechanisms by which the drug could work; <span class=refn>[<a class=rr id="cite_savarino2" href="#ref_savarino2">Savarino (2006)</a>]</span> in an update to their 2003 paper discuss the <i>in vitro</i> confirmation of CQ inhibiting SARS replication via two studies, and note that CQ affects an early stage of SARS replication; <span class=refn>[<a class=rr id="cite_kono" href="#ref_kono">Kono (2008)</a>]</span> showed that CQ inhibits viral replication of HCoV-229E at concentrations lower than in clinical usage; <span class=refn>[<a class=rr id="cite_dewilde" href="#ref_dewilde">de Wilde (2014)</a>]</span> show that CQ inhibits SARS-CoV, MERS-CoV, and HCoV-229E-GFP replication in the low-micromolar range; <span class=refn>[<a class=rr id="cite_wangcell" href="#ref_wangcell">Wang (B, 2/4/20)</a>]</span> showed that CQ (EC50 = 1.13 μM; CC50 > 100 μM, SI > 88.50) potently blocked virus infection at low-micromolar concentration and showed high selectivity <i>in vitro</i>; <span class=refn>[<a class=rr id="cite_devaux" href="#ref_devaux">Devaux (3/12/20)</a>]</span> discusses mechanisms of CQ interference with the SARS-CoV-2 replication cycle; <span class=refn>[<a class=rr id="cite_liu" href="#ref_liu">Liu (3/18/20)</a>]</span> show that HCQ is effective <i>in vitro</i> and less toxic than CQ. They note that in addition to the direct antiviral activity, HCQ is a safe and successful anti-inflammatory agent that has been used extensively in autoimmune diseases and can significantly decrease the production of cytokines and, in particular, pro-inflammatory factors. Therefore, in COVID-19 patients, HCQ may also contribute to attenuating the inflammatory response. They note that based on the selectivity index, careful design of clinical trials is important to achieve efficient and safe control of the infection; <span class=refn>[<a class=rr id="cite_hunature" href="#ref_hunature">Hu (3/23/20)</a>]</span> note that CQ is known in nanomedicine research for the investigation of nanoparticle uptake in cells, and may have potential for the treatment of COVID-19; <span class=refn>[<a class=rr id="cite_pagliano" href="#ref_pagliano">Pagliano (3/24/20)</a>]</span> note that CQ and HCQ inhibit replication at early stages of infection, that no similar effect is reported for other drugs which are only able to interfere after cell infection, and that there is a large volume of existing data on safety; <span class=refn>[<a class=rr id="cite_clementi" href="#ref_clementi">Clementi (3/31/20)</a>]</span> show a greater inhibition for combined pre and post-exposure treatment with Vero E6 and Caco-2 cells; <span class=refn>[<a class=rr id="cite_brufsky" href="#ref_brufsky">Brufsky (4/15/20)</a>]</span> present a theory on HCQ effectiveness with COVID-19, wherein HCQ blocks the polarization of macrophages to an M1 inflammatory subtype and is predicted to interfere with glycosylation of a number of proteins involved in the humoral immune response, possibly including the macrophage FcR gamma IgG receptor and other immunomodulatory proteins, potentially through inhibition of UDP‐N‐acetylglucosamine 2‐epimerase. In combination with potential other immunomodulatory effects, this could blunt the progression of COVID‐19 pneumonia all to way up to ARDS; <span class=refn>[<a class=rr id="cite_andreani" href="#ref_andreani">Andreani (4/25/20)</a>]</span> show that HCQ and AZ have a synergistic effect <i>in vitro</i> on SARS-CoV-2 at concentrations compatible with that obtained in the human lung; <span class=refn>[<a class=rr id="cite_derendorf" href="#ref_derendorf">Derendorf (5/7/20)</a>]</span> discuss pharmacokinetic properties of HCQ+AZ as a potential underlying mechanism of the observed antiviral effects; <span class=refn>[<a class=rr id="cite_scherrmann" href="#ref_scherrmann">Scherrmann (6/12/20)</a>]</span> propose a new mechanism supporting the synergistic interaction between HCQ+AZ; <span class=refn>[<a class=rr id="cite_wang" href="#ref_wang">Wang (6/22/20)</a>]</span> show that CQ and HCQ inhibit the entry of COVID-19 spike pseudotype virus using ACE2 high expressed HEK293T cells; and <span class=refn>[<a class=rr id="cite_sheaff" href="#ref_sheaff">Sheaff (8/2/20)</a>]</span> present a new theory on SARS-CoV-2 infection and why HCQ/CQ provides benefits, which also potentially explains the observed relationships with smoking, diabetes, obesity, age, and treatment delay, and confirms the importance of accurate dosing. Metabolic analysis revealed HCQ/CQ inhibit oxidative phosphorylation in mitochondria (likely by sequestering protons needed to drive ATP synthase), inhibiting infection and/or slowing replication. </div>


<div class=par><span class=refn>[<a class=rr id="cite_hoffmann" href="#ref_hoffmann">Hoffmann</a>]</span> perform an <i>in vitro</i> study of CQ and
HCQ inhibition of SARS-CoV-2 into Vero (kidney), Vero-TMPRSS2, and Calu-3
(derived from human lung carcinoma) cells. They suggest a lack of
effectiveness, but there appears to be three unsupported steps made to reach
the conclusions in this paper. Firstly, authors conclude that CQ does not
block infection of Calu-3 when the results show statistically
significant inhibition at higher concentrations. Second, authors go from
analysis of one specific type of pulmonary adenocarcinoma cells that resemble
serous gland cells, <i>in vitro</i>, into a general claim of no inhibition in
lung cells. Thirdly, they disregard existing theories of CQ/HCQ effectiveness
to conclude a general lack of effectiveness.</div>

<div class=par>Calu-3 is one of many cell lines derived from human lung
carcinomas <span class=refn>[<a class=rr id="cite_shen" href="#ref_shen">Shen</a>]</span>. Calu-3 cells resemble serous gland cells (they do
not express 15-lipoxygenase, an enzyme specifically localized to the surface
epithelium, but they do express secretory component, secretory leukocyte
protease inhibitor, lysozyme, and lactoferrin, all markers of serous gland
cells). <span class=refn>[<a class=rr id="cite_shen" href="#ref_shen">Shen</a>]</span> note that the absence of systemic inflammation,
circulatory factors, and other paracrine systemic influences is a potential
limitation of the isolated cell system.</div>

<div class=par><span class=refn>[<a class=rr id="cite_hoffmann" href="#ref_hoffmann">Hoffmann</a>]</span> Fig. 1b @100uM shows CQ results in a ~4.5
fold decrease (note a log scale is used) in extracellular virus, p=0.05, after
24 hours (estimated from the graph). We note that the paper marks this as not
significant because the value is 0.517, however the p value is unlikely to be
accurate to this level. Additionally authors use Dunnett's test while other
tests may have higher power <span class=refn>[<a class=rr id="cite_sauder" href="#ref_sauder">Sauder</a>]</span>. We further note that the 95%
significance level is just a convention and results do not magically go from
non-significant at p=0.051 to significant at p=0.049. Results only apply to 24
hours later and we expect further decrease over time. Fig. 1a shows a ~45-50%
entry inhibition @100uM for HCQ/CQ (p=0.0005/0.0045), ~10-30% @10uM
(p=0.13/0.99). Inhibition is significantly better with Vero cells.</div>

<div class=par>There are several theories on how HCQ may help with COVID-19,
and we note that authors do not consider one of the most common theories where
HCQ functions as a zinc ionophore, facilitating significant intracellular
concentrations of zinc. Zinc is known to inhibit SARS-CoV RNA-dependent RNA
polymerase activity, and is widely thought to be important for effectiveness
with SARS-CoV-2 <span class=refn>[<a class=rr id="cite_shittu" href="#ref_shittu">Shittu</a>]</span>.</div>







<div class=par><a class=st id="animal" href="#animal"><div class=head2>Animal <i>in vivo</i> studies.</div></a> 
<span class=refn>[<a class=rr id="cite_keyaertsaac" href="#ref_keyaertsaac">Keyaerts (B, 2009)</a>]</span> showed that CQ inhibits HCoV-OC43 replication in HRT-18 cells in a mouse study. Lethal HCoV-OC43 infection in newborn C57BL/6 mice was treated with CQ acquired transplacentally or via maternal milk, with the highest survival rate (98.6%) found when mother mice were treated daily with a concentration of 15 mg of CQ per kg of body weight. Survival rates declined in a dose-dependent manner, with 88% survival when treated with 5 mg/kg CQ and 13% survival when treated with 1 mg/kg CQ. They conclude that CQ can be highly effective against HCoV-OC43 infection in newborn mice and may be considered as a future drug against HCoVs;
<span class=refn>[<a class=rr id="cite_yan" href="#ref_yan">Yan (2012)</a>]</span> show that CQ can efficiently ameliorate acute lung injury and dramatically improve the survival rate in mice infected with live avian influenza A H5N1 virus; and
<span class=refn>[<a class=rr id="cite_maisonnasse" href="#ref_maisonnasse">Maisonnasse (5/6/20)</a>]</span> study treatment in monkeys. They report no effect, however the data has several signs of effectiveness despite the very small sample sizes and 100% recovery of all treated and control monkeys. The final day lung lesion data shows 63% of control monkeys have lesions, while only 26% of treated monkeys do, p=0.095 (missing data for 7 monkeys is predicted based on the day 5 results and the trend of comparable monkeys). After one week, 74% of treated monkeys have recovered with <= 4 log10 copies/mL viral load, compared to 38% of control monkeys, p=0.095. 38% of control monkeys also have a higher peak viral load than 100% of the 23 treated monkeys post-treatment. The group with the lowest peak viral load is the PrEP group. All animals in this study were infected with the same initial viral load, whereas real-world infections vary in the initial viral load, and lower inital viral loads allow greater time to mount an immune response.</div>








<div class=par><a class=st id="human" href="#human"><div class=head2>Human <i>in vivo</i> studies.</div></a>  We found
66 studies related to the human <i>in vivo</i> use of HCQ
for treating COVID-19 <span class=refn>[<a class=rr id="cite_ahmad" href="#ref_ahmad">Ahmad</a>, <a class=rr id="cite_alberici" href="#ref_alberici">Alberici</a>, <a class=rr id="cite_an" href="#ref_an">An</a>, <a class=rr id="cite_arshad" href="#ref_arshad">Arshad</a>, <a class=rr id="cite_ashraf" href="#ref_ashraf">Ashraf</a>, <a class=rr id="cite_ayerbe" href="#ref_ayerbe">Ayerbe</a>, <a class=rr id="cite_barbosa" href="#ref_barbosa">Barbosa</a>, <a class=rr id="cite_bernaola" href="#ref_bernaola">Bernaola</a>, <a class=rr id="cite_bhattacharya" href="#ref_bhattacharya">Bhattacharya</a>, <a class=rr id="cite_borba" href="#ref_borba">Borba</a>, <a class=rr id="cite_boulwarepep" href="#ref_boulwarepep">Boulware</a>, <a class=rr id="cite_carlucci" href="#ref_carlucci">Carlucci</a>, <a class=rr id="cite_cavalcanti" href="#ref_cavalcanti">Cavalcanti</a>, <a class=rr id="cite_chamieh" href="#ref_chamieh">Chamieh</a>, <a class=rr id="cite_chatterjee" href="#ref_chatterjee">Chatterjee</a>, <a class=rr id="cite_chen" href="#ref_chen">Chen</a>, <a class=rr id="cite_chenrct" href="#ref_chenrct">Chen (B)</a>, <a class=rr id="cite_chenmedsci" href="#ref_chenmedsci">Chen (C)</a>, <a class=rr id="cite_colson" href="#ref_colson">Colson</a>, <a class=rr id="cite_darminiomonforte" href="#ref_darminiomonforte">D'Arminio Monforte</a>, <a class=rr id="cite_davido" href="#ref_davido">Davido</a>, <a class=rr id="cite_davidopp" href="#ref_davidopp">Davido (B)</a>, <a class=rr id="cite_esper" href="#ref_esper">Esper</a>, <a class=rr id="cite_ferreira" href="#ref_ferreira">Ferreira</a>, <a class=rr id="cite_gao" href="#ref_gao">Gao (B)</a>, <a class=rr id="cite_gao2" href="#ref_gao2">Gao (C)</a>, <a class=rr id="cite_gautretjaa" href="#ref_gautretjaa">Gautret</a>, <a class=rr id="cite_gautrettmaid" href="#ref_gautrettmaid">Gautret (B)</a>, <a class=rr id="cite_geleris" href="#ref_geleris">Geleris</a>, <a class=rr id="cite_gendelman" href="#ref_gendelman">Gendelman</a>, <a class=rr id="cite_giacomelli" href="#ref_giacomelli">Giacomelli</a>, <a class=rr id="cite_guerin" href="#ref_guerin">Guérin</a>, <a class=rr id="cite_recovery" href="#ref_recovery">Horby</a>, <a class=rr id="cite_huangnsr" href="#ref_huangnsr">Huang</a>, <a class=rr id="cite_huangjmcb" href="#ref_huangjmcb">Huang (B)</a>, <a class=rr id="cite_ip" href="#ref_ip">Ip</a>, <a class=rr id="cite_izoulet" href="#ref_izoulet">Izoulet</a>, <a class=rr id="cite_jiang" href="#ref_jiang">Jiang</a>, <a class=rr id="cite_kamran" href="#ref_kamran">Kamran</a>, <a class=rr id="cite_khurana" href="#ref_khurana">Khurana</a>, <a class=rr id="cite_kim" href="#ref_kim">Kim</a>, <a class=rr id="cite_lagier" href="#ref_lagier">Lagier</a>, <a class=rr id="cite_lee" href="#ref_lee">Lee</a>, <a class=rr id="cite_macias" href="#ref_macias">Macias</a>, <a class=rr id="cite_magagnoli" href="#ref_magagnoli">Magagnoli</a>, <a class=rr id="cite_mehevas" href="#ref_mehevas">Mahévas</a>, <a class=rr id="cite_mehra" href="#ref_mehra">Mehra</a>, <a class=rr id="cite_membrillo" href="#ref_membrillo">Membrillo de Novales</a>, <a class=rr id="cite_meo" href="#ref_meo">Meo</a>, <a class=rr id="cite_mikami" href="#ref_mikami">Mikami</a>, <a class=rr id="cite_million" href="#ref_million">Million</a>, <a class=rr id="cite_mitjapep" href="#ref_mitjapep">Mitjà</a>, <a class=rr id="cite_mitja" href="#ref_mitja">Mitjà (B)</a>, <a class=rr id="cite_molina" href="#ref_molina">Molina</a>, <a class=rr id="cite_otea" href="#ref_otea">Otea</a>, <a class=rr id="cite_paccoud" href="#ref_paccoud">Paccoud</a>, <a class=rr id="cite_pirnay" href="#ref_pirnay">Pirnay</a>, <a class=rr id="cite_rosenberg" href="#ref_rosenberg">Rosenberg</a>, <a class=rr id="cite_sbidian" href="#ref_sbidian">Sbidian</a>, <a class=rr id="cite_scholz" href="#ref_scholz">Scholz</a>, <a class=rr id="cite_singh" href="#ref_singh">Singh</a>, <a class=rr id="cite_skipper" href="#ref_skipper">Skipper</a>, <a class=rr id="cite_tang" href="#ref_tang">Tang</a>, <a class=rr id="cite_xue" href="#ref_xue">Xue (B)</a>, <a class=rr id="cite_yu" href="#ref_yu">Yu</a>, <a class=rr id="cite_zhong" href="#ref_zhong">Zhong</a>]</span>. 41
of these present positive results (of varying degrees and confidence)
<span class=refn>[<a class=rr id="cite_ahmad" href="#ref_ahmad">Ahmad</a>, <a class=rr id="cite_alberici" href="#ref_alberici">Alberici</a>, <a class=rr id="cite_arshad" href="#ref_arshad">Arshad</a>, <a class=rr id="cite_ayerbe" href="#ref_ayerbe">Ayerbe</a>, <a class=rr id="cite_bernaola" href="#ref_bernaola">Bernaola</a>, <a class=rr id="cite_bhattacharya" href="#ref_bhattacharya">Bhattacharya</a>, <a class=rr id="cite_boulwarepep" href="#ref_boulwarepep">Boulware</a>, <a class=rr id="cite_carlucci" href="#ref_carlucci">Carlucci</a>, <a class=rr id="cite_chamieh" href="#ref_chamieh">Chamieh</a>, <a class=rr id="cite_chatterjee" href="#ref_chatterjee">Chatterjee</a>, <a class=rr id="cite_chen" href="#ref_chen">Chen</a>, <a class=rr id="cite_chenrct" href="#ref_chenrct">Chen (B)</a>, <a class=rr id="cite_colson" href="#ref_colson">Colson</a>, <a class=rr id="cite_darminiomonforte" href="#ref_darminiomonforte">D'Arminio Monforte</a>, <a class=rr id="cite_davido" href="#ref_davido">Davido</a>, <a class=rr id="cite_esper" href="#ref_esper">Esper</a>, <a class=rr id="cite_ferreira" href="#ref_ferreira">Ferreira</a>, <a class=rr id="cite_gao" href="#ref_gao">Gao (B)</a>, <a class=rr id="cite_gao2" href="#ref_gao2">Gao (C)</a>, <a class=rr id="cite_gautretjaa" href="#ref_gautretjaa">Gautret</a>, <a class=rr id="cite_gautrettmaid" href="#ref_gautrettmaid">Gautret (B)</a>, <a class=rr id="cite_guerin" href="#ref_guerin">Guérin</a>, <a class=rr id="cite_huangnsr" href="#ref_huangnsr">Huang</a>, <a class=rr id="cite_huangjmcb" href="#ref_huangjmcb">Huang (B)</a>, <a class=rr id="cite_izoulet" href="#ref_izoulet">Izoulet</a>, <a class=rr id="cite_jiang" href="#ref_jiang">Jiang</a>, <a class=rr id="cite_khurana" href="#ref_khurana">Khurana</a>, <a class=rr id="cite_kim" href="#ref_kim">Kim</a>, <a class=rr id="cite_lagier" href="#ref_lagier">Lagier</a>, <a class=rr id="cite_lee" href="#ref_lee">Lee</a>, <a class=rr id="cite_membrillo" href="#ref_membrillo">Membrillo de Novales</a>, <a class=rr id="cite_meo" href="#ref_meo">Meo</a>, <a class=rr id="cite_mikami" href="#ref_mikami">Mikami</a>, <a class=rr id="cite_million" href="#ref_million">Million</a>, <a class=rr id="cite_otea" href="#ref_otea">Otea</a>, <a class=rr id="cite_pirnay" href="#ref_pirnay">Pirnay</a>, <a class=rr id="cite_sbidian" href="#ref_sbidian">Sbidian</a>, <a class=rr id="cite_scholz" href="#ref_scholz">Scholz</a>, <a class=rr id="cite_xue" href="#ref_xue">Xue (B)</a>, <a class=rr id="cite_yu" href="#ref_yu">Yu</a>, <a class=rr id="cite_zhong" href="#ref_zhong">Zhong</a>]</span>, 14 present negative
results (also of varying degrees and confidence)
<span class=refn>[<a class=rr id="cite_an" href="#ref_an">An</a>, <a class=rr id="cite_barbosa" href="#ref_barbosa">Barbosa</a>, <a class=rr id="cite_borba" href="#ref_borba">Borba</a>, <a class=rr id="cite_cavalcanti" href="#ref_cavalcanti">Cavalcanti</a>, <a class=rr id="cite_chenmedsci" href="#ref_chenmedsci">Chen (C)</a>, <a class=rr id="cite_giacomelli" href="#ref_giacomelli">Giacomelli</a>, <a class=rr id="cite_recovery" href="#ref_recovery">Horby</a>, <a class=rr id="cite_ip" href="#ref_ip">Ip</a>, <a class=rr id="cite_magagnoli" href="#ref_magagnoli">Magagnoli</a>, <a class=rr id="cite_mehevas" href="#ref_mehevas">Mahévas</a>, <a class=rr id="cite_molina" href="#ref_molina">Molina</a>, <a class=rr id="cite_rosenberg" href="#ref_rosenberg">Rosenberg</a>, <a class=rr id="cite_singh" href="#ref_singh">Singh</a>, <a class=rr id="cite_tang" href="#ref_tang">Tang</a>]</span>, while the remainder are either inconclusive
or were retracted. <a class=tr id="tcite_paperstats" href="#table_paperstats">Table 1</a> shows a distribution of studies based
on treatment time.</div>


<div id='table_paperstats' class=tablediv>
<table class=studydist>
<tr><td>Study type</td><td><i>In Vitro</i></td><td>PrEP</td><td>PEP</td><td>Early treatment</td><td>Late treatment</td></tr>
<tr><td>Number of studies</td><td>12</td><td>7</td><td>3</td>
  <td>15</td><td>42</td></tr>
<tr>
  <td>Percentage positive</td>
  <td>100%</td>
  <td>100%</td>
  <td>100%</td>
  <td>100%</td>
  <td>62%</td></tr>
</table>


<a class=tt id="table_paperstats" href="#tcite_paperstats"><div class=tcaption><span class=tnum>Table 1.</span></a> Distribution of studies regarding HCQ for COVID-19.
Note that the degree of positive or negative effect, and confidence therein
varies widely.</div></div>

<div class=par><a class=st id="late" href="#late"><div class=head2>Late treatment studies.</div></a> 
Most studies focus on late treatment with hospitalized
patients, and the results are very mixed. We found 23
of the studies reported positive effectiveness, while
14 reported negative effectiveness, both with varying
degrees of effect and confidence. We do not consider the late treatment
studies further here since we are concerned with early treatment, other than
to note that these studies suggest HCQ may potentially be beneficial in a
hospital setting if used very quickly and with patients that have not reached
a more advanced stage of the disease; and it may be of limited or negative
value with later stage disease. Three studies consider higher dosages than
typically used <span class=refn>[<a class=rr id="cite_borba" href="#ref_borba">Borba</a>, <a class=rr id="cite_recovery" href="#ref_recovery">Horby</a>, <a class=rr id="cite_solidarity" href="#ref_solidarity">World Health Organization (B)</a>]</span>, and the results suggest
that these dosages in late stage patients may be harmful.</div>



<div class=par><a class=st id="prep" href="#prep"><div class=head2>Pre-Exposure Prophylaxis (PrEP) studies.</div></a> 
We found 7 PrEP studies
<span class=refn>[<a class=rr id="cite_bhattacharya" href="#ref_bhattacharya">Bhattacharya</a>, <a class=rr id="cite_chatterjee" href="#ref_chatterjee">Chatterjee</a>, <a class=rr id="cite_ferreira" href="#ref_ferreira">Ferreira</a>, <a class=rr id="cite_gendelman" href="#ref_gendelman">Gendelman</a>, <a class=rr id="cite_khurana" href="#ref_khurana">Khurana</a>, <a class=rr id="cite_macias" href="#ref_macias">Macias</a>, <a class=rr id="cite_zhong" href="#ref_zhong">Zhong</a>]</span>.

<span class=refn>[<a class=rr id="cite_khurana" href="#ref_khurana">Khurana</a>]</span> presents a study of hospital health care workers showing HCQ prophylaxis reduces COVID-19 significantly, OR 0.30, p=0.02. 94 positive health care workers with a matched sample of 87 testing negative. The actual benefit of HCQ may be larger because the severity of symptoms are not considered; <span class=refn>[<a class=rr id="cite_zhong" href="#ref_zhong">Zhong</a>]</span> analyzed 6,228 patients with autoimmune rheumatic diseases with 55 COVID positive members of families exposed to COVID-19, showing that patients on HCQ had a lower risk of COVID-19 than those on other disease-modifying anti-rheumatic drugs with OR 0.09 (0.01–0.94), p=0.044; <span class=refn>[<a class=rr id="cite_ferreira" href="#ref_ferreira">Ferreira</a>]</span> analyze 26,815 patients showing that chronic HCQ treatment (77 patients) provides protection against COVID-19, odds ratio 0.51 (0.37-0.70); <span class=refn>[<a class=rr id="cite_bhattacharya" href="#ref_bhattacharya">Bhattacharya</a>]</span> shows PrEP HCQ reduced cases from 38% to 7% with 106 people; <span class=refn>[<a class=rr id="cite_chatterjee" href="#ref_chatterjee">Chatterjee</a>]</span> shows PrEP HCQ of 4+ doses was associated with a significant decline in the odds of getting infected, along with a dose-response relationship, based on 378 treatment and 373 control cases; <span class=refn>[<a class=rr id="cite_gendelman" href="#ref_gendelman">Gendelman</a>]</span> presents a small study of rheumatic disease/autoimmune disorder patients showing no significant difference but with only 3 chronic HCQ patient cases. Taking into account the significantly increased susceptibility to and incidence of infections for SLE, RA, and other autoimmune conditions the results could potentially show a significant benefit for HCQ, however it is inconclusive with such a small sample size; and <span class=refn>[<a class=rr id="cite_macias" href="#ref_macias">Macias</a>]</span> analyzes incidence among patients with rheumatic disease, however with only 3 confirmed cases, and not adjusting for significant differences between groups and the expected infection rates based on patient conditions, we consider this study inconclusive. For details of the significantly increased susceptibility to and incidence of
infections for SLE, RA, and other autoimmune conditions see
<span class=refn>[<a class=rr id="cite_bouza" href="#ref_bouza">Bouza</a>, <a class=rr id="cite_bultink" href="#ref_bultink">Bultink</a>, <a class=rr id="cite_herrinton" href="#ref_herrinton">Herrinton</a>, <a class=rr id="cite_iliopoulos" href="#ref_iliopoulos">Iliopoulos</a>, <a class=rr id="cite_kimrheum" href="#ref_kimrheum">Kim (B)</a>, <a class=rr id="cite_lirheum" href="#ref_lirheum">Li</a>, <a class=rr id="cite_listing" href="#ref_listing">Listing</a>]</span>. The
more recent studies <span class=refn>[<a class=rr id="cite_ferreira" href="#ref_ferreira">Ferreira</a>, <a class=rr id="cite_zhong" href="#ref_zhong">Zhong</a>]</span> with rheumatic disease/autoimmune
condition patients provide higher confidence.</div>

<div class=par><a class=st id="pep" href="#pep"><div class=head2>Post-Exposure Prophylaxis (PEP) studies.</div></a> 
We found 3 PEP studies <span class=refn>[<a class=rr id="cite_boulwarepep" href="#ref_boulwarepep">Boulware</a>, <a class=rr id="cite_lee" href="#ref_lee">Lee</a>, <a class=rr id="cite_mitjapep" href="#ref_mitjapep">Mitjà</a>]</span>.

<span class=refn>[<a class=rr id="cite_lee" href="#ref_lee">Lee</a>]</span> studies post exposure prophylaxis of 211 high-risk people in a long-term care hospital after a major exposure event, with no positive cases after 14 days. </div>

<div class=par><span class=refn>[<a class=rr id="cite_boulwarepep" href="#ref_boulwarepep">Boulware</a>]</span> reports a lack of efficacy due to
statistical significance not being reached, however multiple secondary
analyses show statistically significant and positive results. Due to this
difference, we provide a detailed explanation. The paper shows a 17% reduction
in cases, p=0.35 due to the small sample size - we can say this is
inconclusive, but not negative (it is more likely to be positive than
negative). Authors initially believed 3 days post exposure was the maximum
enrollment delay of interest, however there was a mid-trial modification
extending this to allow an addional day delay. With the original trial
specification, they show a 30% reduction in cases for treatment, p=0.13. If
the trial was not ended early, and if the observed trend continued, p=0.05
would have been reached at ~840 patients total (the original trial
specification was 1,242 patients).</div>


<div class=par>In the supplementary appendix, we can see that COVID-19 cases
are reduced by [49%, 29%, 16%] respectively when taken within ~[70, 94, 118]
hours of exposure (including shipping delay), as shown in <a class=fr id="fcite_boulware" href="#fig_boulware">Figure 6</a>.
<i>A priori</i> the most important cases to consider are the treatment
delay-response relationship and the shortest delay to treatment (~70 hours on
average in this case). The shortest delay to treatment is significant @94%
versus all placebo. By simulation, assuming that cases occur randomly
according to the observed frequency, we found the probability that the results
follow the observed beneficial delay-reponse relationship is 0.2%
<span class=refn>[<a class=rr id="cite_c19boulware" href="#ref_c19boulware">CovidAnalysis</a>]</span>. Since we have performed 2 tests, conservative
Bonferroni adjustment <span class=refn>[<a class=rr id="cite_jafari" href="#ref_jafari">Jafari</a>]</span> gives us <i>p</i> = 0.004. The efficacy
of treatment has also been shown in another secondary analysis
<span class=refn>[<a class=rr id="cite_watanabe" href="#ref_watanabe">Watanabe</a>]</span>.</div>


<div class=par><i>A priori</i> we expect an effective treatment here to be
more effective when administered sooner <span class=refn>[<a class=rr id="cite_cohen" href="#ref_cohen">Cohen</a>]</span>. Extrapolating the
treatment delay-response trend suggests 93% reduction in cases for immediate
treatment, of course we have little confidence in this prediction, however it
would be consistent with the data and can not be ruled out.</div>


<div class=par>The effectiveness found is even more notable considering the
limitations of the study. Treatment was relatively late, with enrollment up to
4 days after exposure, and an unspecified shipping delay. While the paper does
not provide shipping details, the study protocol gives some information. While
not clear, it indicates no shipping on the weekends and a possible 12pm cutoff
for same day dispensing and mailing, from which we estimate the treatment
delay as ~70 to 140 hours after exposure on average for the 1-4 days since
enrollment specified in the paper (we will update this when authors respond to
our request for details). There was only 75% medication adherence, including
16% who did not take the medication at all, so the actual effectiveness is
likely to be higher. The study relies on Internet surveys, and false surveys
were received (identified by 555 numbers), suggesting there could be
additional unidentified false entries.</div>

<div class=par>The accompanying editorial to this paper also notes that in a
small-animal model of SARS-CoV-2 <span class=refn>[<a class=rr id="cite_sheahan" href="#ref_sheahan">Sheahan</a>]</span>, prevention of infection or
more severe disease was observed only when the antiviral agent was given
before or shortly after exposure <span class=refn>[<a class=rr id="cite_cohen" href="#ref_cohen">Cohen</a>]</span>. Research also shows that the
placebo used in the US (folate) may be protective for COVID-19
<span class=refn>[<a class=rr id="cite_acostaelias" href="#ref_acostaelias">Acosta-Elias</a>]</span>. More details on this analysis can be found in
<span class=refn>[<a class=rr id="cite_c19boulware" href="#ref_c19boulware">CovidAnalysis</a>]</span>.</div>







<div id='fig_boulware' class=chartdiv><img class=chart3 src=boulwarep.svg>
<div class=fcaption><a class=ft href="#fcite_boulware"><span class=tnum>Figure 6.</span></a> Treatment delay-response relationship
from <span class=refn>[<a class=rr id="cite_boulwarepep" href="#ref_boulwarepep">Boulware</a>]</span>.</div></div>

<div class=par><span class=refn>[<a class=rr id="cite_mitjapep" href="#ref_mitjapep">Mitjà</a>]</span> perform a highly delayed PEP treatment study
which suggests efficacy but lacks statistical significance due to  the small
number of cases. Death rates reduced from 0.6% to 0.4%, RR 0.71, not
statistically significant due to low incidence (8 control cases, 5 treatment
cases).</div>

<div class=par>Enrollment was up to 7 days after exposure and the treatment
delay in this study is unclear, without details of the exposure event timing
or medication dispensing. They appear to identify index cases based on the
date of a positive test for a contact, which is likely to be much later than
the actual exposure time. Due to quarantine at the time and likely
cohabitation of a majority of the contacts, it is likely that the actual
exposure time was significantly earlier. 13.1% of patients already tested
positive at baseline, which is consistent with the actual exposure time being
significantly earlier. Nasopharyngeal viral load analysis is subject to test
unreliability and temporo-spatial differences in viral shedding
<span class=refn>[<a class=rr id="cite_wangnasal" href="#ref_wangnasal">Wang (C)</a>]</span>. PCR testing has a very high false-negative rate in early
stages (e.g., 100% on day 1, 67% on day 4, and 20% on day 8 <span class=refn>[<a class=rr id="cite_kucirka" href="#ref_kucirka">Kucirka</a>]</span>,
hence it is likely that a much higher percentage were infected at an unknown
time before enrollment. </div>

<div class=par>Given the enrollment delay, PCR test delay, and PCR false
negative rate at early stages, the treatment delay in general for this study
was very long and could be over 2 weeks.</div>

<div class=par>This study focuses on the existence of symptoms or PCR-positive
results, however severity of symptoms is more important. Research has shown
HCQ concentrations may be much higher in the lung compared to plasma
<span class=refn>[<a class=rr id="cite_browning" href="#ref_browning">Browning</a>]</span>, which may help minimize the occurrence of severe cases and
death. The outcome analyzed here may not be highly relevant to the goal of
reducing mortality. For positive symptomatic cases, they find RR=0.89,
favoring treatment but not statistically significant. The RR for non-PCR
positive at baseline is 0.74, which is consistent with earlier treatment being
more effective. A greater effect is seen for nursing home residents, RR=0.49,
possibly because the exposure events are identified faster in this context,
versus home exposure where testing of the source may be more delayed. There is
a treatment-delay response relationship consistent with an effective
treatment.</div>


<div class=par>The paper does not mention zinc. Zinc deficiency in Spain has
been reported at 83% <span class=refn>[<a class=rr id="cite_olza" href="#ref_olza">Olza</a>]</span>, this may significantly reduce
effectiveness to the extent that zinc is important for the success of HCQ
treatment. </div>


<div class=par>The definition of COVID-19 symptoms is very broad - just
existence of a headache alone or muscle pain alone was considered COVID-19.
There was an overall very low incidence of confirmed COVID-19 (138 cases
across both arms). There were no serious adverse events that were adjudicated
as being treatment related. Authors exclude those with symptoms in the
previous two weeks, however, those with symptoms up to several months before
may still test PCR-positive even though there may be no viable virus. There
appears to be inaccurate data in the paper. Table 2, secondary outcomes,
control, hospital/vital records shows that 8 of 1042 is 9.7%. </div>

<div class=par>In summary, this study appears positive in the context of very
delayed treatment and the small number of cases.
</div>




<div class=par><a class=st id="early" href="#early"><div class=head2>Early treatment studies.</div></a> 
We found 15 early treatment studies
<span class=refn>[<a class=rr id="cite_ahmad" href="#ref_ahmad">Ahmad</a>, <a class=rr id="cite_ashraf" href="#ref_ashraf">Ashraf</a>, <a class=rr id="cite_chen" href="#ref_chen">Chen</a>, <a class=rr id="cite_esper" href="#ref_esper">Esper</a>, <a class=rr id="cite_gautretjaa" href="#ref_gautretjaa">Gautret</a>, <a class=rr id="cite_gautrettmaid" href="#ref_gautrettmaid">Gautret (B)</a>, <a class=rr id="cite_guerin" href="#ref_guerin">Guérin</a>, <a class=rr id="cite_izoulet" href="#ref_izoulet">Izoulet</a>, <a class=rr id="cite_lagier" href="#ref_lagier">Lagier</a>, <a class=rr id="cite_meo" href="#ref_meo">Meo</a>, <a class=rr id="cite_million" href="#ref_million">Million</a>, <a class=rr id="cite_mitja" href="#ref_mitja">Mitjà (B)</a>, <a class=rr id="cite_otea" href="#ref_otea">Otea</a>, <a class=rr id="cite_scholz" href="#ref_scholz">Scholz</a>, <a class=rr id="cite_skipper" href="#ref_skipper">Skipper</a>]</span> which all show some degree of
effectiveness.

<span class=refn>[<a class=rr id="cite_scholz" href="#ref_scholz">Scholz</a>]</span> performs a retrospective analysis of 518 patients (141 treated, 377 control) showing that early treatment with HCQ+AZ+Z results in 84% lower hospitalization and 80% lower death - hospitalization OR 0.16 (p<0.001), death OR 0.2 (p=0.16); <span class=refn>[<a class=rr id="cite_lagier" href="#ref_lagier">Lagier</a>]</span> analyzed 3,737 patients showing that early treatment leads to significantly better clinical outcome and faster viral load reduction with matched sample mortality HR 0.41 p=0.048; <span class=refn>[<a class=rr id="cite_chen" href="#ref_chen">Chen</a>]</span> showed significantly faster clinical recovery and shorter time to RNA negative (from 7.0 days to 2.0 days (HCQ), p=0.01 with 67 mild/moderate cases; <span class=refn>[<a class=rr id="cite_otea" href="#ref_otea">Otea</a>]</span> showed HCQ+AZ appears to reduce serious complications and death with 80 patients; <span class=refn>[<a class=rr id="cite_guerin" href="#ref_guerin">Guérin</a>]</span> performed a small retrospective study with 88 patients and found mean recovery time reduced from 26 days to 9 days with HCQ+AZ, p<0.0001 or to 13 days with AZ, including a case control analysis with matched patients; <span class=refn>[<a class=rr id="cite_ahmad" href="#ref_ahmad">Ahmad</a>]</span> treated 54 patients in long term care facilities with 6% death, compared to 22% using a naive indirect comparison; <span class=refn>[<a class=rr id="cite_million" href="#ref_million">Million</a>]</span> showed HCQ+AZ is safe and results in a low fatality rate with a retrospective analysis of 1,061 patients; <span class=refn>[<a class=rr id="cite_ashraf" href="#ref_ashraf">Ashraf</a>]</span> concluded that HCQ improved clinical outcome with a small limited trial of 100 patients in Iran; <span class=refn>[<a class=rr id="cite_izoulet" href="#ref_izoulet">Izoulet</a>]</span> compares the dynamics of daily deaths in the 10 days following the 3rd death in countries using and not using [H]CQ. They show dramatically lower death in [H]CQ countries, but do not attempt to account for other differences between the countries; <span class=refn>[<a class=rr id="cite_esper" href="#ref_esper">Esper</a>]</span> analyzed 636 patients showing HCQ+AZ reduced hospitalization 79% when used within 7 days (65% overall); <span class=refn>[<a class=rr id="cite_gautrettmaid" href="#ref_gautrettmaid">Gautret (B)</a>]</span> presented a pilot study suggesting improvement with HCQ+AZ and recommending further study; and <span class=refn>[<a class=rr id="cite_gautretjaa" href="#ref_gautretjaa">Gautret</a>]</span> in an early and small trial with significant limitations, showed that HCQ was associated with viral load reduction and that this was enhanced with AZ. In addition, <span class=refn>[<a class=rr id="cite_risch2" href="#ref_risch2">Risch</a>]</span> presents an updated meta analysis that includes several studies that are currently unpublished. 7 new studies of high-risk outpatients are reported, for a total of 12 studies, all showing significant benefit.
</div>

<div class=par> <span class=refn>[<a class=rr id="cite_mitja" href="#ref_mitja">Mitjà (B)</a>]</span> present a randomized trial of 293 low-risk
patients with no deaths, no serious adverse events, and no statistically
significant improvements. There was a 25% reduction in hospitalization and 16%
reduction in the median time to symptom resolution for HCQ, without
statistical significance due to small samples. However, this paper has
inconsistent data - some of the values reported in Table 2 and the abstract
correspond to 12 control hospitalizations, while others correspond to 11
control hospitalizations, hence we are unsure of other data reported here.
This paper also does not specify the treatment delay, reporting only an
enrollment delay of up to 120 hours post symptoms, plus an additional
unspecified delay where medication was provided to patients at the first home
visit. They do not break down results by treatment delay. Undetectable viral
load was changed to 3 log10 copies/mL potentially partially masking
effectiveness. For viral load with nasopharyngeal swabs, we note that viral
activity in the lung may be especially important for COVID-19, and that HCQ
concentration in the lung may be significantly higher (for example, about 30
times blood concentration in <span class=refn>[<a class=rr id="cite_chhonker" href="#ref_chhonker">Chhonker</a>]</span>). Nasopharyngeal viral load
analysis is subject to test unreliability and temporo-spatial differences in
viral shedding <span class=refn>[<a class=rr id="cite_wangnasal" href="#ref_wangnasal">Wang (C)</a>]</span>. Viral detection by PCR does not equate to
viable virus <span class=refn>[<a class=rr id="cite_singaporeviral" href="#ref_singaporeviral">Academy of Medicine</a>]</span>. PCR testing does not distinguish
between live virus and fragments of dead virus cells, which may take months to
clear <span class=refn>[<a class=rr id="cite_koreafalse" href="#ref_koreafalse">Bo-gyung</a>]</span>.</div>



<div class=par> <span class=refn>[<a class=rr id="cite_skipper" href="#ref_skipper">Skipper</a>]</span> present an RCT with Internet surveys of 423
patients. As with the companion PEP study, we find the results significantly
more positive than typically reported. They show ~70 to 140 hour delayed
treatment with HCQ reduced combined hospitalization/death by 50%, p=0.29 (5
HCQ cases, 10 control cases), and reduced hospitalization by 60%, p=0.17.
There was one hospitalized control death and one non-hospitalized HCQ death.
It is unclear why there was a non-hospitalized death, external factors such as
lack of standard care may be involved. Excluding that case results in one
control death and zero HCQ deaths (not statistically significant but noted as
reducing mortality is the most important outcome). Details for the
hospitalizations and deaths such as medication adherence and treatment delay
may be informative but are not provided.</div>

<div class=par>The paper states the end point was changed from
hospitalization/death to symptom severity because they would have required
6,000 participants. However, if the observed trend continued, they would hit
95% significance on the reduction in hospitalization at ~725 patients, and 95%
on the reduction in combined hospitalization/death at ~1,145 patients, both of
which are less than the original plan of 1,242 patients. We hope this trial
can be continued for statistical significance.</div>

<div class=par>As with the companion PEP trial, treatment in this trial was
relatively late, with an unspecified shipping delay, which we estimate as ~70
to 140 hours after symptoms for enrollment days 1 to 4. We note there is no
overlap with the more typical delays used such as 0 - 36 hours for
oseltamivir.</div>


<div class=par>The paper compares 0 - 36 hour delayed treatment with
oseltamivir (influenza) and ~70 to 140 hour delayed treatment with HCQ
(COVID-19), noting that oseltamivir seemed more effective. However, a more
comparable study is <span class=refn>[<a class=rr id="cite_mclean" href="#ref_mclean">McLean</a>]</span> who showed that 48 - 119 hour delayed
treatment with oseltamivir has no effect. This suggests that HCQ is more
effective than oseltamivir, and that HCQ may still have significant effect for
some amount of delay beyond the delay where oseltamivir is effective.</div>

<div class=par>6 people were included that enrolled with >4d symptoms,
although they do not match the study inclusion criteria. This reduces observed
effectiveness. Patients in this study are relatively young and most of them
recover without assistance. This reduces the room for a treatment to make
improvements. The maximum improvement of an effective treatment would be
expected before all patients approach recovery. For symptoms, authors focus on
the end result where most have recovered, but it is more informative to
examine the curve and the point of maximum effectiveness. Authors did not
collect data for every day but they do have interim results for days 3, 5, 10.
The results are consistent with an effective treatment and show a
statistically significant improvement, p = 0.05, at day 10 (other unreported
days might show increased effectiveness). Results also show a larger treatment
effect for those >50, not statistically significant due to the small sample,
but noted as COVID-19 risk dramatically increases with age.</div>

<div class=par>As with the companion PEP trial, this study relies on Internet
surveys. Known fake surveys were submitted to the PEP trial and there could be
an unknown number of undetected fake surveys in both trials. Research shows
the placebo used in the US may be protective for COVID-19
<span class=refn>[<a class=rr id="cite_acostaelias" href="#ref_acostaelias">Acosta-Elias</a>]</span> so the true effectiveness of HCQ could be higher than
observed. Medication adherence was only 77% also making the true effect of
treatment likely to be higher. Authors note that the results are not
generalizable to the COVID high-risk population.</div>






</div>

<a class=st id="discussion" href="#discussion"><div class=head1>Discussion</div></a>


<div class=section>

<div class=par>All studies have some limitations, for HCQ study limitations
may include confounding factors; sample sizes that are too small; sub-optimal
treatment regimens; dosing regimens that may be too low, too high, or
insufficiently account for the long half-life of HCQ; excessive treatment
delays; reliance on Internet surveys; inclusion/exclusion criteria; using
tests that may be inaccurate or poor measures of disease severity; and patient
characteristics that are very different from the most at-risk
population.</div>

<div class=par><a id='rct' href='#rct'>While</a> this trial is a Randomized
Controlled Trial (there is a control group, people are randomly allocated to
the treatment and control groups without regard to their medical status, and
those assignments have been controlled by the countries analyzed as opposed to
occurring in a natural experiment), it has distinct advantages and
disadvantages. Benefits include the very large scale, lack of barriers to
implementation, and lack of inclusion/exclusion criteria.</div>

<div class=par>The primary disdavantage is the coarse country-based
randomization which requires us to address differences between countries, and
the most significant limitation at present is likely to be the varying degrees
of spread between countries. We have reviewed available seroprevalance data
<span class=refn>[<a class=rr id="cite_indiasero" href="#ref_indiasero">BBC</a>, <a class=rr id="cite_cdcsero" href="#ref_cdcsero">CDC (B)</a>, <a class=rr id="cite_eckerle" href="#ref_eckerle">Eckerle</a>, <a class=rr id="cite_russiasero" href="#ref_russiasero">European University</a>, <a class=rr id="cite_fontanet" href="#ref_fontanet">Fontanet</a>, <a class=rr id="cite_fontanet2" href="#ref_fontanet2">Fontanet (B)</a>, <a class=rr id="cite_havers" href="#ref_havers">Havers</a>, <a class=rr id="cite_ioannidis" href="#ref_ioannidis">Ioannidis</a>, <a class=rr id="cite_lewis" href="#ref_lewis">Lewis</a>, <a class=rr id="cite_uksero" href="#ref_uksero">Public Health England</a>, <a class=rr id="cite_salje" href="#ref_salje">Salje</a>, <a class=rr id="cite_skowronski" href="#ref_skowronski">Skowronski</a>, <a class=rr id="cite_slot" href="#ref_slot">Slot</a>, <a class=rr id="cite_swedensero" href="#ref_swedensero">Swedish Public Health Agency</a>, <a class=rr id="cite_indiasero3" href="#ref_indiasero3">The Hindu</a>, <a class=rr id="cite_indiasero2" href="#ref_indiasero2">The Indian Express</a>, <a class=rr id="cite_irelandsero" href="#ref_irelandsero">The Irish Times</a>, <a class=rr id="cite_israelsero" href="#ref_israelsero">The Jerusalem Post</a>, <a class=rr id="cite_valenti" href="#ref_valenti">Valenti</a>]</span>,
but the sparse nature, different time periods, and different geographic
coverage prevents conclusions at this time. We expect that increased
seroprevalence data will allow improved analysis over time.</div>

<div class=par><a id='blind' href='#blind'>While</a> this is not a
double-blind trial, this should not significantly affect the results.
<span class=refn>[<a class=rr id="cite_wood" href="#ref_wood">Wood</a>]</span>, based on an analysis of 1,346 trials, show that allocation
concealment and blinding are only important for subjective outcomes, and
should not significantly effect the objective outcome here.</div>

<div class=par>Imperfect medication adherence, imperfect co-administration of
treatments, imperfect dosing regimens, and counterfeit HCQ may decrease the
observed effectiveness of treatment.</div>











<div class=par>The results here are consistent with the positive results of
other early treatment trials as discussed in the previous section. There are
many other examples that are consistent with effectiveness, some of these in
Brazil and Switzerland are discussed by <span class=refn>[<a class=rr id="cite_rafaeli2" href="#ref_rafaeli2">Rafaeli</a>, <a class=rr id="cite_rischnewsweek" href="#ref_rischnewsweek">Risch (B)</a>]</span>. We
provide a few more examples.</div>


<div class=par><span class=refn>[<a class=rr id="cite_mitchell" href="#ref_mitchell">Mitchell</a>]</span> provide an extensive discussion of the
differences between the death rates of New York City and Lagos, Nigeria, which
both received infected travelers around the same time. NYC's high rate has
been linked to population density, poverty, overcrowding, and ethnicity. Lagos
is a crowded urban center of about 22 million people with 30 families often in
a single building sharing the same bathroom, and none of the factors mentioned
favor reduced death rates in Lagos. Lagos further has lower quality of medical
care. Yet NYC had a death rate 600 times higher. The younger population can
only account for a small part of this difference. Mitchell concludes that
there is a crossover prophylactic effect of antimalarial agents against
COVID-19.</div>



<div class=par>In France, early treatment with HCQ has not been widely used,
but one exception is in Marseille. <a class=tr id="tcite_marseille" href="#table_marseille">Table 2</a> shows the death
statistics until the end of May for these two locations for 2020 and compared
with the previous two years. Paris shows a large increase, while Marseille
does not <span class=refn>[<a class=rr id="cite_marseillevsparis" href="#ref_marseillevsparis">Covid19Crusher (B)</a>]</span>.</div>


<div id='table_marseille' class=tablediv>
<table class=marseillet>
<tr><td colspan=4></td> <td colspan=2><b>Change from previous years</b></td> </tr>
<tr style='border-bottom:1px solid #aaa'><td></td> <td>2018</td> <td>2019</td>
  <td>2020</td> <td><b>2020/2018</b></td> <td><b>2020/2019</b></td> </tr>
<tr><td>Paris</td> <td>6,055</td> <td>5,927</td> <td>7,972</td>
  <td><b>+32%</b></td> <td><b>+35%</b></td> </tr>
<tr><td>Marseille</td> <td>1,321</td> <td>1,509</td> <td>1,304</td>
  <td><b>-1%</b></td> <td><b>-14%</b></td> </tr>
</table>

<a class=tt id="table_marseille" href="#tcite_marseille"><div class=tcaption><span class=tnum>Table 2.</span></a> Deaths as of the end of May each year for Marseille
(using early treatment with HCQ) vs. Paris (generally not using early
treatment with HCQ) <span class=refn>[<a class=rr id="cite_marseillevsparis" href="#ref_marseillevsparis">Covid19Crusher (B)</a>]</span>.</div></div>


<div class=par>For countries that started and/or stopped early HCQ treatment
it is possible to examine the resulting change in statistics. Many examples
can be found from <span class=refn>[<a class=rr id="cite_covid19crusher" href="#ref_covid19crusher">Covid19Crusher (C)</a>]</span>.</div>




<div class=par>We welcome feedback and will improve and update this study over
time.</div>

</div>





<a class=st id="references" href="#references"><div class=head1>References</div></a>



<div class=section>

<div id='ref_singaporeviral' class=refl><div class=refln>1.</div><a class=rt href="#cite_singaporeviral"><span class=refa>Academy of Medicine</span></a>,
<span class=reft>Position Statement from the National Centre for Infectious Diseases and the Chapter of Infectious Disease Physicians, Academy of Medicine, Singapore – 23 May 2020</span>,
<span class=refu><a href="https://www.ams.edu.sg/view-pdf.aspx?file=media%5c5556_fi_331.pdf&ofile=Period+of+Infectivity+Position+Statement+(final)+23-5-20+(logos).pdf">https://www.ams.edu.sg/view-pdf.as..tement+(final)+23-5-20+(logos).pdf</a></span>.
</div>

<div id='ref_acostaelias' class=refl><div class=refln>2.</div><a class=rt href="#cite_acostaelias"><span class=refa>Acosta-Elias</span> et al., Front. Pharmacol., 16 July 2020, doi:10.3389/fphar.2020.01062</a>,
<span class=reft>The Folate Concentration and/or Folic Acid Metabolites in Plasma as Factor for COVID-19 Infection</span>,
<span class=refu><a href="https://www.frontiersin.org/articles/10.3389/fphar.2020.01062/full">https://www.frontiersin.org/articles/10.3389/fphar.2020.01062/full</a></span>.
</div>

<div id='ref_ahmad' class=refl><div class=refln>3.</div><a class=rt href="#cite_ahmad"><span class=refa>Ahmad</span> et al., doi:10.1101/2020.05.18.20066902</a>,
<span class=reft>Doxycycline and Hydroxychloroquine as Treatment for High-Risk COVID-19 Patients: Experience from Case Series of 54 Patients in Long-Term Care Facilities</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.05.18.20066902v1">https://www.medrxiv.org/content/10.1101/2020.05.18.20066902v1</a></span>.
</div>

<div id='ref_alberici' class=refl><div class=refln>4.</div><a class=rt href="#cite_alberici"><span class=refa>Alberici</span> et al., Kidney Int., 98:1, 20-26, July 1, 2020, doi:10.1016/j.kint.2020.04.030 (preprint 5/10)</a>,
<span class=reft>A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection</span>,
<span class=refu><a href="https://www.kidney-international.org/article/S0085-2538(20)30508-1/fulltext">https://www.kidney-international.o..cle/S0085-2538(20)30508-1/fulltext</a></span>.
</div>

<div id='ref_an' class=refl><div class=refln>5.</div><a class=rt href="#cite_an"><span class=refa>An</span> et al., medRxiv, doi:10.1101/2020.07.04.20146548</a>,
<span class=reft>Treatment Response to Hydroxychloroquine and Antibiotics for mild to moderate COVID-19: a retrospective cohort study from South Korea</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.07.04.20146548v1">https://www.medrxiv.org/content/10.1101/2020.07.04.20146548v1</a></span>.
</div>

<div id='ref_andreani' class=refl><div class=refln>6.</div><a class=rt href="#cite_andreani"><span class=refa>Andreani</span> et al., Microbial Pathogenesis, doi:/10.1016/j.micpath.2020.104228</a>,
<span class=reft>In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect</span>,
<span class=refu><a href="https://www.sciencedirect.com/science/article/pii/S0882401020305155">https://www.sciencedirect.com/science/article/pii/S0882401020305155</a></span>.
</div>

<div id='ref_arshad' class=refl><div class=refln>7.</div><a class=rt href="#cite_arshad"><span class=refa>Arshad</span> et al., Int. J. Infect. Dis., July 1 2020, doi:10.1016/j.ijid.2020.06.099</a>,
<span class=reft>Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19</span>,
<span class=refu><a href="https://www.ijidonline.com/article/S1201-9712(20)30534-8/fulltext">https://www.ijidonline.com/article/S1201-9712(20)30534-8/fulltext</a></span>.
</div>

<div id='ref_ashraf' class=refl><div class=refln>8.</div><a class=rt href="#cite_ashraf"><span class=refa>Ashraf</span> et al., medRxiv doi:10.1101/2020.04.20.20072421.t</a>,
<span class=reft>COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes</span>,
<span class=refu><a href="https://www.researchgate.net/publication/341197843_COVID-19_in_Iran_a_comprehensive_investigation_from_exposure_to_treatment_outcomes">https://www.researchgate.net/publi..rom_exposure_to_treatment_outcomes</a></span>.
</div>

<div id='ref_ayerbe' class=refl><div class=refln>9.</div><a class=rt href="#cite_ayerbe"><span class=refa>Ayerbe</span> et al., Journal of Thrombosis and Thrombolysis, doi: 10.1007/s11239-020-02162-z</a>,
<span class=reft>The association between treatment with heparin and survival in patients with Covid-19</span>,
<span class=refu><a href="https://doi.org/10.1101/2020.05.27.20114694">https://doi.org/10.1101/2020.05.27.20114694</a></span>.
</div>

<div id='ref_barbosa' class=refl><div class=refln>10.</div><a class=rt href="#cite_barbosa"><span class=refa>Barbosa</span> et al., Preprint</a>,
<span class=reft>Clinical outcomes of hydroxychloroquine in hospitalized patients with COVID-19: a quasi-randomized comparative study</span>,
<span class=refu><a href="https://bibliovid.org/en/clinical-outcomes-of-hydroxychloroquine-in-hospitalized-patients-with-covid-19-a-302">https://bibliovid.org/en/clinical-..lized-patients-with-covid-19-a-302</a></span>.
</div>

<div id='ref_indiasero' class=refl><div class=refln>11.</div><a class=rt href="#cite_indiasero"><span class=refa>BBC</span></a>,
<span class=reft>India coronavirus: Nearly one in four in Delhi had Covid-19, study says</span>,
<span class=refu><a href="https://www.bbc.com/news/world-asia-india-53485039">https://www.bbc.com/news/world-asia-india-53485039</a></span>.
</div>

<div id='ref_bernaola' class=refl><div class=refln>12.</div><a class=rt href="#cite_bernaola"><span class=refa>Bernaola</span> et al., medRxiv, doi:10.1101/2020.07.17.20155960</a>,
<span class=reft>Observational Study of the Efficiency of Treatments in Patients Hospitalized with Covid-19 in Madrid</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.07.17.20155960v1">https://www.medrxiv.org/content/10.1101/2020.07.17.20155960v1</a></span>.
</div>

<div id='ref_bhattacharya' class=refl><div class=refln>13.</div><a class=rt href="#cite_bhattacharya"><span class=refa>Bhattacharya</span> et al., medRxix, doi:10.1101/2020.06.09.20116806</a>,
<span class=reft>Pre exposure Hydroxychloroquine use is associated with reduced COVID19 risk in healthcare workers</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.06.09.20116806v1">https://www.medrxiv.org/content/10.1101/2020.06.09.20116806v1</a></span>.
</div>

<div id='ref_koreafalse' class=refl><div class=refln>14.</div><a class=rt href="#cite_koreafalse"><span class=refa>Bo-gyung</span>, K., The Korea Herald</a>,
<span class=reft>Tests in recovered patients found false positives, not reinfections, experts say</span>,
<span class=refu><a href="http://www.koreaherald.com/view.php?ud=20200429000724">http://www.koreaherald.com/view.php?ud=20200429000724</a></span>.
</div>

<div id='ref_borba' class=refl><div class=refln>15.</div><a class=rt href="#cite_borba"><span class=refa>Borba</span> et al., JAMA Network Open, doi:10.1001/jamanetworkopen.2020.8857</a>,
<span class=reft>Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: Preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 Study)</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.04.07.20056424v2">https://www.medrxiv.org/content/10.1101/2020.04.07.20056424v2</a></span>.
</div>

<div id='ref_boulwarepep' class=refl><div class=refln>16.</div><a class=rt href="#cite_boulwarepep"><span class=refa>Boulware</span> et al., NEJM, June 3 2020, doi:10.1056/NEJMoa2016638</a>,
<span class=reft>A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19</span>,
<span class=refu><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2016638">https://www.nejm.org/doi/full/10.1056/NEJMoa2016638</a></span>.
</div>

<div id='ref_bouza' class=refl><div class=refln>17.</div><a class=rt href="#cite_bouza"><span class=refa>Bouza</span> et al., Infect. Dis. Clin. North. Am., 2001 Jun, 15:2, 335-61, doi:10.1016/s0891-5520(05)70149-5</a>,
<span class=reft>Infections in Systemic Lupus Erythematosus and Rheumatoid Arthritis</span>,
<span class=refu><a href="https://pubmed.ncbi.nlm.nih.gov/11447699/">https://pubmed.ncbi.nlm.nih.gov/11447699/</a></span>.
</div>

<div id='ref_browning' class=refl><div class=refln>18.</div><a class=rt href="#cite_browning"><span class=refa>Browning</span>, D., Hydroxychloroquine and Chloroquine Retinopathy, April 4, 2014, 35–63, doi:10.1007/978-1-4939-0597-3_2</a>,
<span class=reft>Pharmacology of Chloroquine and Hydroxychloroquine</span>,
<span class=refu><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122276/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122276/</a></span>.
</div>

<div id='ref_brufsky' class=refl><div class=refln>19.</div><a class=rt href="#cite_brufsky"><span class=refa>Brufsky</span>, A., J. Medical Virology, doi:10.1002/jmv.25887</a>,
<span class=reft>Hyperglycemia, hydroxychloroquine, and the COVID‐19 pandemic</span>,
<span class=refu><a href="https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25887">https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25887</a></span>.
</div>

<div id='ref_bultink' class=refl><div class=refln>20.</div><a class=rt href="#cite_bultink"><span class=refa>Bultink</span> et al., Rheumatology, doi:10.1093/rheumatology/keaa267</a>,
<span class=reft>Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls</span>,
<span class=refu><a href="https://academic.oup.com/rheumatology/article/doi/10.1093/rheumatology/keaa267/5870413">https://academic.oup.com/rheumatol...1093/rheumatology/keaa267/5870413</a></span>.
</div>

<div id='ref_carlucci' class=refl><div class=refln>21.</div><a class=rt href="#cite_carlucci"><span class=refa>Carlucci</span> et al., doi:10.1101/2020.05.02.20080036</a>,
<span class=reft>Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.05.02.20080036v1">https://www.medrxiv.org/content/10.1101/2020.05.02.20080036v1</a></span>.
</div>

<div id='ref_cavalcanti' class=refl><div class=refln>22.</div><a class=rt href="#cite_cavalcanti"><span class=refa>Cavalcanti</span> et al., NEJM, July 23, 2020, doi:10.1056/NEJMoa201901</a>,
<span class=reft>Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19</span>,
<span class=refu><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2019014">https://www.nejm.org/doi/full/10.1056/NEJMoa2019014</a></span>.
</div>

<div id='ref_cdchcq' class=refl><div class=refln>23.</div><a class=rt href="#cite_cdchcq"><span class=refa>CDC</span></a>,
<span class=reft>Medicines for the Prevention of Malaria While Traveling Hydroxychloroquine (Plaquenil™)</span>,
<span class=refu><a href="https://www.cdc.gov/malaria/resources/pdf/fsp/drugs/Hydroxychloroquine.pdf">https://www.cdc.gov/malaria/resour..f/fsp/drugs/Hydroxychloroquine.pdf</a></span>.
</div>

<div id='ref_cdcsero' class=refl><div class=refln>24.</div><a class=rt href="#cite_cdcsero"><span class=refa>CDC (B)</span></a>,
<span class=reft>Commercial Laboratory Seroprevalence Survey Data</span>,
<span class=refu><a href="https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/commercial-lab-surveys.html">https://www.cdc.gov/coronavirus/20..pdates/commercial-lab-surveys.html</a></span>.
</div>

<div id='ref_hcqcost' class=refl><div class=refln>25.</div><a class=rt href="#cite_hcqcost"><span class=refa>Centers for Medicare and Medicaid Services</span></a>,
<span class=reft>National Average Drug Acquisition Cost</span>,
<span class=refu><a href="https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-08-07/m7ng-9e3x">https://data.medicaid.gov/Drug-Pri..t/NADAC-as-of-2019-08-07/m7ng-9e3x</a></span>.
</div>

<div id='ref_chamieh' class=refl><div class=refln>26.</div><a class=rt href="#cite_chamieh"><span class=refa>Chamieh</span> et al., medRxiv 2020.05.28.20114835, doi:10.1101/2020.05.28.20114835</a>,
<span class=reft>Viral Dynamics Matter in COVID-19 Pneumonia: the success of early treatment with hydroxychloroquine and azithromycin in Lebanon</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.05.28.20114835v1">https://www.medrxiv.org/content/10.1101/2020.05.28.20114835v1</a></span>.
</div>

<div id='ref_chatterjee' class=refl><div class=refln>27.</div><a class=rt href="#cite_chatterjee"><span class=refa>Chatterjee</span> et al., Indian J. Med. Res., June 20, 2020, doi:10.4103/ijmr.IJMR_2234_20</a>,
<span class=reft>Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19</span>,
<span class=refu><a href="http://www.ijmr.org.in/preprintarticle.asp?id=285520">http://www.ijmr.org.in/preprintarticle.asp?id=285520</a></span>.
</div>

<div id='ref_chen' class=refl><div class=refln>28.</div><a class=rt href="#cite_chen"><span class=refa>Chen</span> et al., medRxiv, doi:10.1101/2020.06.19.20136093</a>,
<span class=reft>Efficacy and safety of chloroquine or hydroxychloroquine in moderate type of COVID-19: a prospective open-label randomized controlled study</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.06.19.20136093v1">https://www.medrxiv.org/content/10.1101/2020.06.19.20136093v1</a></span>.
</div>

<div id='ref_chenrct' class=refl><div class=refln>29.</div><a class=rt href="#cite_chenrct"><span class=refa>Chen (B)</span> et al., medRxiv doi:10.1101/2020.03.22.20040758</a>,
<span class=reft>Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.03.22.20040758v3">https://www.medrxiv.org/content/10.1101/2020.03.22.20040758v3</a></span>.
</div>

<div id='ref_chenmedsci' class=refl><div class=refln>30.</div><a class=rt href="#cite_chenmedsci"><span class=refa>Chen (C)</span> et al., J. Zhejiang University (Med Sci), doi:10.3785/j.issn.1008-9292.2020.03.03</a>,
<span class=reft>A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19)</span>,
<span class=refu><a href="http://www.zjujournals.com/med/EN/article/downloadArticleFile.do?attachType=PDF&id=41137">http://www.zjujournals.com/med/EN/..cleFile.do?attachType=PDF&id=41137</a></span>.
</div>

<div id='ref_chhonker' class=refl><div class=refln>31.</div><a class=rt href="#cite_chhonker"><span class=refa>Chhonker</span> et al., Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences, 22 Nov 2017, 1072:320-327
doi:10.1016/j.jchromb.2017.11.026 </a>,
<span class=reft>Simultaneous quantitation of hydroxychloroquine and its metabolites in mouse blood and tissues using LC-ESI-MS/MS: An application for pharmacokinetic studies</span>,
<span class=refu><a href="https://europepmc.org/article/med/29207305">https://europepmc.org/article/med/29207305</a></span>.
</div>

<div id='ref_ciaobesity' class=refl><div class=refln>32.</div><a class=rt href="#cite_ciaobesity"><span class=refa>CIA</span></a>,
<span class=reft>Obesity - Adult Prevalence Rate</span>,
<span class=refu><a href="https://www.cia.gov/library/publications/the-world-factbook/rankorder/2228rank.html">https://www.cia.gov/library/public..d-factbook/rankorder/2228rank.html</a></span>.
</div>

<div id='ref_clementi' class=refl><div class=refln>33.</div><a class=rt href="#cite_clementi"><span class=refa>Clementi</span> et al., Front. Microbiol., 10 July 2020, doi:10.3389/fmicb.2020.01704 (preprint 3/31)</a>,
<span class=reft>Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro</span>,
<span class=refu><a href="https://www.frontiersin.org/articles/10.3389/fmicb.2020.01704/full?utm_source=S-TWT&utm_medium=SNET&utm_campaign=ECO_FCIMB_XXXXXXXX_auto-dlvrit">https://www.frontiersin.org/articl..ign=ECO_FCIMB_XXXXXXXX_auto-dlvrit</a></span>.
</div>

<div id='ref_cohen' class=refl><div class=refln>34.</div><a class=rt href="#cite_cohen"><span class=refa>Cohen</span>, M., NEJM, doi:10.1056/NEJMe2020388</a>,
<span class=reft>Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence</span>,
<span class=refu><a href="https://www.nejm.org/doi/full/10.1056/NEJMe2020388">https://www.nejm.org/doi/full/10.1056/NEJMe2020388</a></span>.
</div>

<div id='ref_colson' class=refl><div class=refln>35.</div><a class=rt href="#cite_colson"><span class=refa>Colson</span> et al., Int J. Antimicrob Agents, doi: 10.1016/j.ijantimicag.2020.105932. Epub 2020 Mar 4.</a>,
<span class=reft>Chloroquine and Hydroxychloroquine as Available Weapons to Fight COVID-19</span>,
<span class=refu><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135139/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135139/</a></span>.
</div>

<div id='ref_fakehcq' class=refl><div class=refln>36.</div><a class=rt href="#cite_fakehcq"><span class=refa>Covid19Crusher</span></a>,
<span class=reft>Fake Hydroxychloroquine has appeared in Brazil</span>,
<span class=refu><a href="https://twitter.com/Covid19Crusher/status/1277526066152837122">https://twitter.com/Covid19Crusher/status/1277526066152837122</a></span>.
</div>

<div id='ref_marseillevsparis' class=refl><div class=refln>37.</div><a class=rt href="#cite_marseillevsparis"><span class=refa>Covid19Crusher (B)</span></a>,
<span class=reft>Marseille vs. Paris Death Statistics</span>,
<span class=refu><a href="https://twitter.com/Covid19Crusher/status/1278009960115376129">https://twitter.com/Covid19Crusher/status/1278009960115376129</a></span>.
</div>

<div id='ref_covid19crusher' class=refl><div class=refln>38.</div><a class=rt href="#cite_covid19crusher"><span class=refa>Covid19Crusher (C)</span></a>,
<span class=refu><a href="https://twitter.com/Covid19Crusher">https://twitter.com/Covid19Crusher</a></span>.
</div>

<div id='ref_c19boulware' class=refl><div class=refln>39.</div><a class=rt href="#cite_c19boulware"><span class=refa>CovidAnalysis</span></a>,
<span class=reft>Boulware et al. comments</span>,
<span class=refu><a href="https://c19study.com/boulware.html">https://c19study.com/boulware.html</a></span>.
</div>

<div id='ref_darminiomonforte' class=refl><div class=refln>40.</div><a class=rt href="#cite_darminiomonforte"><span class=refa>D'Arminio Monforte</span> et al., Int. J. Infectious Diseases, doi:10.1016/j.ijid.2020.07.056</a>,
<span class=reft>Effectiveness of Hydroxychloroquine in COVID-19 disease: A done and dusted situation?</span>,
<span class=refu><a href="https://www.ijidonline.com/article/S1201-9712(20)30600-7/fulltext">https://www.ijidonline.com/article/S1201-9712(20)30600-7/fulltext</a></span>.
</div>

<div id='ref_davido' class=refl><div class=refln>41.</div><a class=rt href="#cite_davido"><span class=refa>Davido</span> et al., Int. J. Antimicrobial Agents, 2020, doi:10.1016/j.ijantimicag.2020.106129</a>,
<span class=reft>Impact of medical care including anti-infective agents use on the prognosis of COVID-19 hospitalized patients over time</span>,
<span class=refu><a href="https://www.sciencedirect.com/science/article/pii/S0924857920303125">https://www.sciencedirect.com/science/article/pii/S0924857920303125</a></span>.
</div>

<div id='ref_davidopp' class=refl><div class=refln>42.</div><a class=rt href="#cite_davidopp"><span class=refa>Davido (B)</span> et al., medRxiv, doi:10.1101/2020.05.05.2008875</a>,
<span class=reft>Hydroxychloroquine plus azithromycin: a potential interest in reducing in hospital morbidity due to COVID-19 pneumonia (HI-ZY-COVID)?</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.05.05.20088757v1.full.pdf">https://www.medrxiv.org/content/10.1101/2020.05.05.20088757v1.full.pdf</a></span>.
</div>

<div id='ref_dewilde' class=refl><div class=refln>43.</div><a class=rt href="#cite_dewilde"><span class=refa>de Wilde</span> et al., Antimicrobial Agents and Chemotherapy, Jul 2014, 58:8, 4875-4884, doi:10.1128/AAC.03011-14</a>,
<span class=reft>Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture</span>,
<span class=refu><a href="https://aac.asm.org/content/58/8/4875">https://aac.asm.org/content/58/8/4875</a></span>.
</div>

<div id='ref_derendorf' class=refl><div class=refln>44.</div><a class=rt href="#cite_derendorf"><span class=refa>Derendorf</span>, H., Int. J. Antimicrobial Agents, 7 May 2020, doi:10.1016/j.ijantimicag.2020.106007</a>,
<span class=reft>Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin</span>,
<span class=refu><a href="https://www.sciencedirect.com/science/article/pii/S0924857920301655?via%3Dihub">https://www.sciencedirect.com/scie..e/pii/S0924857920301655?via%3Dihub</a></span>.
</div>

<div id='ref_derwand' class=refl><div class=refln>45.</div><a class=rt href="#cite_derwand"><span class=refa>Derwand</span> and Scholz, Medical Hypotheses, 142, doi:10.1016/j.mehy.2020.109815</a>,
<span class=reft>Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?</span>,
<span class=refu><a href="https://www.sciencedirect.com/science/article/pii/S0306987720306435?via%3Dihub">https://www.sciencedirect.com/scie..e/pii/S0306987720306435?via%3Dihub</a></span>.
</div>

<div id='ref_devaux' class=refl><div class=refln>46.</div><a class=rt href="#cite_devaux"><span class=refa>Devaux</span> et al., International Journal of Antimicrobial Agents, doi:10.1016/j.ijantimicag.2020.105938</a>,
<span class=reft>New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?</span>,
<span class=refu><a href="https://www.sciencedirect.com/science/article/pii/S0924857920300881">https://www.sciencedirect.com/science/article/pii/S0924857920300881</a></span>.
</div>

<div id='ref_eckerle' class=refl><div class=refln>47.</div><a class=rt href="#cite_eckerle"><span class=refa>Eckerle</span> et al., Lancet, July 6, 2020, doi:10.1016/S0140-6736(20)31482-3</a>,
<span class=reft>SARS-CoV-2 seroprevalence in COVID-19 hotspots</span>,
<span class=refu><a href="https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(20)31482-3.pdf">https://www.thelancet.com/pdfs/jou..ancet/PIIS0140-6736(20)31482-3.pdf</a></span>.
</div>

<div id='ref_esper' class=refl><div class=refln>48.</div><a class=rt href="#cite_esper"><span class=refa>Esper</span> et al., Prevent Senior Institute, São Paulo, Brazil</a>,
<span class=reft>Empirical treatment with hydroxychloroquine and azithromycin for suspected cases of COVID-19 followed-up by telemedicine</span>,
<span class=refu><a href="https://www.dropbox.com/s/5qm58cd4fneeci2/2020.04.15%20journal%20manuscript%20final.pdf">https://www.dropbox.com/s/5qm58cd4..20journal%20manuscript%20final.pdf</a></span>.
</div>

<div id='ref_russiasero' class=refl><div class=refln>49.</div><a class=rt href="#cite_russiasero"><span class=refa>European University</span> at St. Petersburg</a>,
<span class=reft>6% of People in St. Petersburg, Russia have had COVID-19</span>,
<span class=refu><a href="https://eusp.org/en/news/press-release-6-of-people-in-st-petersburg-russia-have-had-covid-19-0">https://eusp.org/en/news/press-rel..ersburg-russia-have-had-covid-19-0</a></span>.
</div>

<div id='ref_ferreira' class=refl><div class=refln>50.</div><a class=rt href="#cite_ferreira"><span class=refa>Ferreira</span> et al., J. Medical Virology, July 9, 2020, doi:10.1002/jmv.26286 (preprint 6/29)</a>,
<span class=reft>Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.06.26.20056507v1">https://www.medrxiv.org/content/10.1101/2020.06.26.20056507v1</a></span>.
</div>

<div id='ref_fitch' class=refl><div class=refln>51.</div><a class=rt href="#cite_fitch"><span class=refa>Fitch</span>, C., Trans. Am. Clin. Climatol. Assoc., 1997, 109:97-105, PMCID:PMC2194336</a>,
<span class=reft>Involvement of heme in the antimalarial action of chloroquine</span>,
<span class=refu><a href="https://europepmc.org/article/med/9601131">https://europepmc.org/article/med/9601131</a></span>.
</div>

<div id='ref_fontanet' class=refl><div class=refln>52.</div><a class=rt href="#cite_fontanet"><span class=refa>Fontanet</span> et al., medRxiv, 10.1101/2020.04.18.20071134</a>,
<span class=reft>Cluster of COVID-19 in northern France: A retrospective closed cohort study</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.04.18.20071134v1">https://www.medrxiv.org/content/10.1101/2020.04.18.20071134v1</a></span>.
</div>

<div id='ref_fontanet2' class=refl><div class=refln>53.</div><a class=rt href="#cite_fontanet2"><span class=refa>Fontanet (B)</span> et al., medRxiv, doi:10.1101/2020.06.25.20140178</a>,
<span class=reft>SARS-CoV-2 infection in primary schools in northern France: A retrospective cohort study in an area of high transmission</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.06.25.20140178v2">https://www.medrxiv.org/content/10.1101/2020.06.25.20140178v2</a></span>.
</div>

<div id='ref_gaohyper' class=refl><div class=refln>54.</div><a class=rt href="#cite_gaohyper"><span class=refa>Gao</span> et al., European Heart Journal, Volume 41, Issue 22, 7 June 2020, 2058–2066, doi:10.1093/eurheartj/ehaa433</a>,
<span class=reft>Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study</span>,
<span class=refu><a href="https://academic.oup.com/eurheartj/article/41/22/2058/5851436">https://academic.oup.com/eurheartj/article/41/22/2058/5851436</a></span>.
</div>

<div id='ref_gao' class=refl><div class=refln>55.</div><a class=rt href="#cite_gao"><span class=refa>Gao (B)</span> et al., BioScience Trends, 2020, doi:10.5582/bst.2020.01047</a>,
<span class=reft>Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies</span>,
<span class=refu><a href="https://www.jstage.jst.go.jp/article/bst/advpub/0/advpub_2020.01047/_article">https://www.jstage.jst.go.jp/artic..dvpub/0/advpub_2020.01047/_article</a></span>.
</div>

<div id='ref_gao2' class=refl><div class=refln>56.</div><a class=rt href="#cite_gao2"><span class=refa>Gao (C)</span> et al., Biosci Trends, May 21, 2020, 14:2, 156-158, doi:10.5582/bst.2020.03072, Epub Apr 13, 2020</a>,
<span class=reft>Update on Use of Chloroquine/Hydroxychloroquine to Treat Coronavirus Disease 2019 (COVID-19)</span>,
<span class=refu><a href="https://pubmed.ncbi.nlm.nih.gov/32281583/">https://pubmed.ncbi.nlm.nih.gov/32281583/</a></span>.
</div>

<div id='ref_gautretjaa' class=refl><div class=refln>57.</div><a class=rt href="#cite_gautretjaa"><span class=refa>Gautret</span> et al., Int. J. of Antimicrobial Agents, 17 March 2020, doi:10.1016/j.ijantimicag.2020.105949</a>,
<span class=reft>Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial</span>,
<span class=refu><a href="https://www.mediterranee-infection.com/wp-content/uploads/2020/03/Hydroxychloroquine_final_DOI_IJAA.pdf">https://www.mediterranee-infection..roxychloroquine_final_DOI_IJAA.pdf</a></span>.
</div>

<div id='ref_gautrettmaid' class=refl><div class=refln>58.</div><a class=rt href="#cite_gautrettmaid"><span class=refa>Gautret (B)</span> et al., Travel Medicine and Infectious Disease, doi:10.1016/j.tmaid.2020.101663</a>,
<span class=reft>Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study</span>,
<span class=refu><a href="https://www.sciencedirect.com/science/article/pii/S1477893920301319">https://www.sciencedirect.com/science/article/pii/S1477893920301319</a></span>.
</div>

<div id='ref_gebhard' class=refl><div class=refln>59.</div><a class=rt href="#cite_gebhard"><span class=refa>Gebhard</span> et al., Biol. Sex Differ., 2020, 11:29, doi:10.1186/s13293-020-00304-9</a>,
<span class=reft>Impact of sex and gender on COVID-19 outcomes in Europe</span>,
<span class=refu><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247289/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247289/</a></span>.
</div>

<div id='ref_geleris' class=refl><div class=refln>60.</div><a class=rt href="#cite_geleris"><span class=refa>Geleris</span> et al., NEJM, May 7, 2020, doi:10.1056/NEJMoa2012410</a>,
<span class=reft>Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19</span>,
<span class=refu><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2012410">https://www.nejm.org/doi/full/10.1056/NEJMoa2012410</a></span>.
</div>

<div id='ref_gendelman' class=refl><div class=refln>61.</div><a class=rt href="#cite_gendelman"><span class=refa>Gendelman</span> et al., Autoimmunity Reviews, 19:7, July 2020, doi:10.1016/j.autrev.2020.102566</a>,
<span class=reft>Continuous Hydroxychloroquine or Colchicine Therapy Does Not Prevent Infection With SARS-CoV-2: Insights From a Large Healthcare Database Analysis</span>,
<span class=refu><a href="https://www.sciencedirect.com/science/article/pii/S1568997220301282?via%3Dihub">https://www.sciencedirect.com/scie..e/pii/S1568997220301282?via%3Dihub</a></span>.
</div>

<div id='ref_giacomelli' class=refl><div class=refln>62.</div><a class=rt href="#cite_giacomelli"><span class=refa>Giacomelli</span> et al., medRxiv, doi:10.1101/2020.06.05.20123299</a>,
<span class=reft>Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: a retrospective cohort study</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.06.05.20123299v1">https://www.medrxiv.org/content/10.1101/2020.06.05.20123299v1</a></span>.
</div>

<div id='ref_guerin' class=refl><div class=refln>63.</div><a class=rt href="#cite_guerin"><span class=refa>Guérin</span> et al., Asian J. Medicine and Health, July 15, 2020, doi:10.9734/ajmah/2020/v18i730224 (preprint 5/31)</a>,
<span class=reft>Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19</span>,
<span class=refu><a href="https://www.preprints.org/manuscript/202005.0486/v1">https://www.preprints.org/manuscript/202005.0486/v1</a></span>.
</div>

<div id='ref_havers' class=refl><div class=refln>64.</div><a class=rt href="#cite_havers"><span class=refa>Havers</span> et al., JAMA Intern. Med., July 21, 2020, doi:10.1001/jamainternmed.2020.4130</a>,
<span class=reft>Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020</span>,
<span class=refu><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2768834">https://jamanetwork.com/journals/j..ternalmedicine/fullarticle/2768834</a></span>.
</div>

<div id='ref_herrinton' class=refl><div class=refln>65.</div><a class=rt href="#cite_herrinton"><span class=refa>Herrinton</span> et al., J. Rheumatology, 2016, 43(8), doi:10.3899/jrheum</a>,
<span class=reft>Risk of Serious Infection for Patients With Systemic Lupus Erythematosus Starting Glucocorticoids With or Without Antimalarials</span>,
<span class=refu><a href="https://pubmed.ncbi.nlm.nih.gov/27370880/">https://pubmed.ncbi.nlm.nih.gov/27370880/</a></span>.
</div>

<div id='ref_hoffmann' class=refl><div class=refln>66.</div><a class=rt href="#cite_hoffmann"><span class=refa>Hoffmann</span> et al., Nature, (2020), doi:10.1038/s41586-020-2575-3</a>,
<span class=reft>Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2</span>,
<span class=refu><a href="https://www.nature.com/articles/s41586-020-2575-3">https://www.nature.com/articles/s41586-020-2575-3</a></span>.
</div>

<div id='ref_recovery' class=refl><div class=refln>67.</div><a class=rt href="#cite_recovery"><span class=refa>Horby</span> et al., medRxiv, 7/15/2020, doi:10.1101/2020.07.15.20151852 (press release 6/5)</a>,
<span class=reft>Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.07.15.20151852v1">https://www.medrxiv.org/content/10.1101/2020.07.15.20151852v1</a></span>.
</div>

<div id='ref_howard' class=refl><div class=refln>68.</div><a class=rt href="#cite_howard"><span class=refa>Howard</span> et al., Preprints, doi:10.20944/preprints202004.0203.v1</a>,
<span class=reft>Face Masks Against COVID-19: An Evidence Review</span>,
<span class=refu><a href="https://www.preprints.org/manuscript/202004.0203/v1">https://www.preprints.org/manuscript/202004.0203/v1</a></span>.
</div>

<div id='ref_hunature' class=refl><div class=refln>69.</div><a class=rt href="#cite_hunature"><span class=refa>Hu</span> et al., Nature Nanotechnology, 15, 247–249, 2020, doi:10.1038/s41565-020-0674-9</a>,
<span class=reft>Insights from nanomedicine into chloroquine efficacy against COVID-19</span>,
<span class=refu><a href="https://www.nature.com/articles/s41565-020-0674-9">https://www.nature.com/articles/s41565-020-0674-9</a></span>.
</div>

<div id='ref_huangnsr' class=refl><div class=refln>70.</div><a class=rt href="#cite_huangnsr"><span class=refa>Huang</span> et al., National Science Review, nwaa113, doi:10.1093/nsr/nwaa113</a>,
<span class=reft>Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19</span>,
<span class=refu><a href="https://academic.oup.com/nsr/advance-article/doi/10.1093/nsr/nwaa113/5848167">https://academic.oup.com/nsr/advan..le/doi/10.1093/nsr/nwaa113/5848167</a></span>.
</div>

<div id='ref_huangjmcb' class=refl><div class=refln>71.</div><a class=rt href="#cite_huangjmcb"><span class=refa>Huang (B)</span> et al., Journal of Molecular Cell Biology, Volume 12, Issue 4, April 2020, 322–325, doi:10.1093/jmcb/mjaa014</a>,
<span class=reft>Treating COVID-19 with Chloroquine</span>,
<span class=refu><a href="https://academic.oup.com/jmcb/article/12/4/322/5814655">https://academic.oup.com/jmcb/article/12/4/322/5814655</a></span>.
</div>

<div id='ref_iglay' class=refl><div class=refln>72.</div><a class=rt href="#cite_iglay"><span class=refa>Iglay</span> et al., Curr. Med. Res. Opin., July 2016, 32:7, 1243-52, doi:10.1185/03007995.2016.1168291</a>,
<span class=reft>Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus</span>,
<span class=refu><a href="https://pubmed.ncbi.nlm.nih.gov/26986190/">https://pubmed.ncbi.nlm.nih.gov/26986190/</a></span>.
</div>

<div id='ref_iliopoulos' class=refl><div class=refln>73.</div><a class=rt href="#cite_iliopoulos"><span class=refa>Iliopoulos</span> et al., Semin. Arthritis Rheum., 1996 Apr, 25(5):318-36</a>,
<span class=reft>Immunopathogenesis and Spectrum of Infections in Systemic Lupus Erythematosus</span>,
<span class=refu><a href="https://pubmed.ncbi.nlm.nih.gov/8778988/">https://pubmed.ncbi.nlm.nih.gov/8778988/</a></span>.
</div>

<div id='ref_wbdiabetes' class=refl><div class=refln>74.</div><a class=rt href="#cite_wbdiabetes"><span class=refa>International Diabetes Federation</span>, Diabetes Atlas</a>,
<span class=reft>World Bank Diabetes Prevalence</span>,
<span class=refu><a href="https://data.worldbank.org/indicator/SH.STA.DIAB.ZS">https://data.worldbank.org/indicator/SH.STA.DIAB.ZS</a></span>.
</div>

<div id='ref_ioannidis' class=refl><div class=refln>75.</div><a class=rt href="#cite_ioannidis"><span class=refa>Ioannidis</span>, J., medRxiv, doi:10.1101/2020.05.13.20101253</a>,
<span class=reft>The infection fatality rate of COVID-19 inferred from seroprevalence data</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.05.13.20101253v3">https://www.medrxiv.org/content/10.1101/2020.05.13.20101253v3</a></span>.
</div>

<div id='ref_ip' class=refl><div class=refln>76.</div><a class=rt href="#cite_ip"><span class=refa>Ip</span> et al., medRxiv, doi:10.1101/2020.05.21.20109207</a>,
<span class=reft>Hydroxychloroquine and Tocilizumab Therapy in COVID-19 Patients - An Observational Study</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.05.21.20109207v1">https://www.medrxiv.org/content/10.1101/2020.05.21.20109207v1</a></span>.
</div>

<div id='ref_izoulet' class=refl><div class=refln>77.</div><a class=rt href="#cite_izoulet"><span class=refa>Izoulet</span> M., SSRN, doi:10.2139/ssrn.3575899</a>,
<span class=reft>Countries which Primarily Use Antimalarial Drugs As COVID-19 Treatment See Slower Dynamic of Daily Deaths</span>,
<span class=refu><a href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3575899">https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3575899</a></span>.
</div>

<div id='ref_jafari' class=refl><div class=refln>78.</div><a class=rt href="#cite_jafari"><span class=refa>Jafari</span> et al., Cell J. 2019, 20:4, 604–607, doi:10.22074/cellj.2019.5992</a>,
<span class=reft>Why, When and How to Adjust Your P Values?</span>,
<span class=refu><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099145/pdf/Cell-J-20-604.pdf">https://www.ncbi.nlm.nih.gov/pmc/a..s/PMC6099145/pdf/Cell-J-20-604.pdf</a></span>.
</div>

<div id='ref_jamil' class=refl><div class=refln>79.</div><a class=rt href="#cite_jamil"><span class=refa>Jamil</span> et al., medRxiv, doi:10.1101/2020.03.29.20046706</a>,
<span class=reft>No evidence for temperature-dependence of the COVID-19 epidemic</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.03.29.20046706v2">https://www.medrxiv.org/content/10.1101/2020.03.29.20046706v2</a></span>.
</div>

<div id='ref_jiang' class=refl><div class=refln>80.</div><a class=rt href="#cite_jiang"><span class=refa>Jiang</span> et al., Chin. J. Tuberc. Respir. Dis., 2020, 43, doi:10.3760/cma.j.issn.1001-0939.2020.0019</a>,
<span class=reft>Expert Consensus on Chloroquine Phosphate for the Treatment of Novel Coronavirus Pneumonia</span>,
<span class=refu><a href="http://rs.yiigle.com/yufabiao/1182323.htm">http://rs.yiigle.com/yufabiao/1182323.htm</a></span>.
</div>

<div id='ref_kamran' class=refl><div class=refln>81.</div><a class=rt href="#cite_kamran"><span class=refa>Kamran</span> et al., medRxiv, doi:10.1101/2020.07.30.20165365</a>,
<span class=reft>Clearing the fog: Is HCQ effective in reducing COVID-19 progression: A randomized controlled trial</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.07.30.20165365v1">https://www.medrxiv.org/content/10.1101/2020.07.30.20165365v1</a></span>.
</div>

<div id='ref_keyaerts' class=refl><div class=refln>82.</div><a class=rt href="#cite_keyaerts"><span class=refa>Keyaerts</span> et al., Biochem. Biophys. Res. Comm., 323:1, 8 October 2004, doi:10.1016/j.bbrc.2004.08.085</a>,
<span class=reft>In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine</span>,
<span class=refu><a href="https://www.sciencedirect.com/science/article/pii/S0006291X0401839X">https://www.sciencedirect.com/science/article/pii/S0006291X0401839X</a></span>.
</div>

<div id='ref_keyaertsaac' class=refl><div class=refln>83.</div><a class=rt href="#cite_keyaertsaac"><span class=refa>Keyaerts (B)</span> et al., Antimicrob. Agents Chemother, August 2009, 53(8), doi:0.1128/AAC.01509-08</a>,
<span class=reft>Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn Mice</span>,
<span class=refu><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715625/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715625/</a></span>.
</div>

<div id='ref_khurana' class=refl><div class=refln>84.</div><a class=rt href="#cite_khurana"><span class=refa>Khurana</span> et al., medRxiv, doi:10.1101/2020.07.21.20159301</a>,
<span class=reft>Prevalence and clinical correlates of COVID-19 outbreak among healthcare workers in a tertiary level hospital</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.07.21.20159301v1">https://www.medrxiv.org/content/10.1101/2020.07.21.20159301v1</a></span>.
</div>

<div id='ref_kim' class=refl><div class=refln>85.</div><a class=rt href="#cite_kim"><span class=refa>Kim</span> et al., medRxiv, doi:10.1101/2020.05.13.20094193</a>,
<span class=reft>Treatment Response to Hydroxychloroquine, Lopinavir/Ritonavir, and Antibiotics for Moderate COVID 19: A First Report on the Pharmacological Outcomes from South Korea</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.05.13.20094193v1">https://www.medrxiv.org/content/10.1101/2020.05.13.20094193v1</a></span>.
</div>

<div id='ref_kimrheum' class=refl><div class=refln>86.</div><a class=rt href="#cite_kimrheum"><span class=refa>Kim (B)</span> et al., Rheumatology (Oxford), 2018 Jul, 57:26–33, doi: 10.1093/rheumatology/kex523</a>,
<span class=reft>Risk of human papillomavirus infection in women with rheumatic disease: cervical cancer screening and prevention</span>,
<span class=refu><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099129/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099129/</a></span>.
</div>

<div id='ref_kono' class=refl><div class=refln>87.</div><a class=rt href="#cite_kono"><span class=refa>Kono</span> et al., Antiviral Research, 77:2, February 2008, 150-152, 10.1016/j.antiviral.2007.10.011</a>,
<span class=reft>Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: Involvement of p38 MAPK and ERK</span>,
<span class=refu><a href="https://www.sciencedirect.com/science/article/pii/S0166354207004597">https://www.sciencedirect.com/science/article/pii/S0166354207004597</a></span>.
</div>

<div id='ref_kucirka' class=refl><div class=refln>88.</div><a class=rt href="#cite_kucirka"><span class=refa>Kucirka</span> et al., Annals of Internal Medicine, doi:10.7326/M20-1495</a>,
<span class=reft>Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure</span>,
<span class=refu><a href="https://www.acpjournals.org/doi/10.7326/M20-1495">https://www.acpjournals.org/doi/10.7326/M20-1495</a></span>.
</div>

<div id='ref_lagier' class=refl><div class=refln>89.</div><a class=rt href="#cite_lagier"><span class=refa>Lagier</span> et al., Travel Med. Infect. Dis. 101791, Jun 25, 2020, doi:10.1016/j.tmaid.2020.101791</a>,
<span class=reft>Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis</span>,
<span class=refu><a href="https://www.sciencedirect.com/science/article/pii/S1477893920302817">https://www.sciencedirect.com/science/article/pii/S1477893920302817</a></span>.
</div>

<div id='ref_lee' class=refl><div class=refln>90.</div><a class=rt href="#cite_lee"><span class=refa>Lee</span> at al., Int. J. Antimicrob. Agents, 2020, Apr 17, doi:10.1016/j.ijantimicag.2020.105988</a>,
<span class=reft>Can Post-Exposure Prophylaxis for COVID-19 Be Considered as an Outbreak Response Strategy in Long-Term Care Hospitals?</span>,
<span class=refu><a href="https://pubmed.ncbi.nlm.nih.gov/32305587/">https://pubmed.ncbi.nlm.nih.gov/32305587/</a></span>.
</div>

<div id='ref_leffler' class=refl><div class=refln>91.</div><a class=rt href="#cite_leffler"><span class=refa>Leffler</span> et al., Preprint</a>,
<span class=reft>Association of country-wide coronavirus mortality with demographics, testing, lockdowns, and public wearing of masks (Update June 15, 2020)</span>,
<span class=refu><a href="https://www.researchgate.net/publication/342198360_Association_of_country-wide_coronavirus_mortality_with_demographics_testing_lockdowns_and_public_wearing_of_masks_Update_June_15_2020">https://www.researchgate.net/publi..aring_of_masks_Update_June_15_2020</a></span>.
</div>

<div id='ref_lewis' class=refl><div class=refln>92.</div><a class=rt href="#cite_lewis"><span class=refa>Lewis</span>, N., Climate Etc.</a>,
<span class=reft>The progress of the COVID-19 epidemic in Sweden: an analysis</span>,
<span class=refu><a href="https://judithcurry.com/2020/06/28/the-progress-of-the-covid-19-epidemic-in-sweden-an-analysis/">https://judithcurry.com/2020/06/28..19-epidemic-in-sweden-an-analysis/</a></span>.
</div>

<div id='ref_lirheum' class=refl><div class=refln>93.</div><a class=rt href="#cite_lirheum"><span class=refa>Li</span> et al., Ann. Rheum. Dis, 2019 Jul, 78:7, 941-946, doi:10.1136/annrheumdis-2018-214844</a>,
<span class=reft>Risk of Severe Herpes Simplex Virus Infection in Systemic Lupus Erythematosus: Analysis of Epidemiology and Risk Factors Analysis in Taiwan</span>,
<span class=refu><a href="https://pubmed.ncbi.nlm.nih.gov/30954968/">https://pubmed.ncbi.nlm.nih.gov/30954968/</a></span>.
</div>

<div id='ref_listing' class=refl><div class=refln>94.</div><a class=rt href="#cite_listing"><span class=refa>Listing</span> et al., Rheumatology (Oxford), 2013 Jan, 5:1, 53-61, doi:10.1093/rheumatology/kes305</a>,
<span class=reft>The Risk of Infections Associated With Rheumatoid Arthritis, With Its Comorbidity and Treatment</span>,
<span class=refu><a href="https://pubmed.ncbi.nlm.nih.gov/23192911/">https://pubmed.ncbi.nlm.nih.gov/23192911/</a></span>.
</div>

<div id='ref_liu' class=refl><div class=refln>95.</div><a class=rt href="#cite_liu"><span class=refa>Liu</span> et al., Cell Discovery 6, 16 (2020), doi:10.1038/s41421-020-0156-0</a>,
<span class=reft>Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro</span>,
<span class=refu><a href="https://www.nature.com/articles/s41421-020-0156-0">https://www.nature.com/articles/s41421-020-0156-0</a></span>.
</div>

<div id='ref_macias' class=refl><div class=refln>96.</div><a class=rt href="#cite_macias"><span class=refa>Macias</span> et al., medRxiv, 10.1101/2020.05.16.20104141</a>,
<span class=reft>Similar incidence of Coronavirus Disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.05.16.20104141v1.full.pdf">https://www.medrxiv.org/content/10.1101/2020.05.16.20104141v1.full.pdf</a></span>.
</div>

<div id='ref_magagnoli' class=refl><div class=refln>97.</div><a class=rt href="#cite_magagnoli"><span class=refa>Magagnoli</span> et al., Med (2020), doi:10.1016/j.medj.2020.06.001 (preprint 4/21)</a>,
<span class=reft>Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19</span>,
<span class=refu><a href="https://www.cell.com/med/pdf/S2666-6340(20)30006-4.pdf">https://www.cell.com/med/pdf/S2666-6340(20)30006-4.pdf</a></span>.
</div>

<div id='ref_mehevas' class=refl><div class=refln>98.</div><a class=rt href="#cite_mehevas"><span class=refa>Mahévas</span> et al., BMJ 2020, 369, doi: https://doi.org/10.1136/bmj.m1844</a>,
<span class=reft>Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data</span>,
<span class=refu><a href="https://www.bmj.com/content/369/bmj.m1844">https://www.bmj.com/content/369/bmj.m1844</a></span>.
</div>

<div id='ref_maisonnasse' class=refl><div class=refln>99.</div><a class=rt href="#cite_maisonnasse"><span class=refa>Maisonnasse</span> et al., Nature, 2020, doi:10.1038/s41586-020-2558-4 (preprint 5/6)</a>,
<span class=reft>Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates</span>,
<span class=refu><a href="https://www.nature.com/articles/s41586-020-2558-4_reference.pdf">https://www.nature.com/articles/s41586-020-2558-4_reference.pdf</a></span>.
</div>

<div id='ref_maret' class=refl><div class=refln>100.</div><a class=rt href="#cite_maret"><span class=refa>Maret</span> W., Int. J. Mol. Sci. 2017, 18:11, doi:10.3390/ijms18112285</a>,
<span class=reft>Zinc in Cellular Regulation: The Nature and Significance of “Zinc Signals”</span>,
<span class=refu><a href="https://www.mdpi.com/1422-0067/18/11/2285">https://www.mdpi.com/1422-0067/18/11/2285</a></span>.
</div>

<div id='ref_mclean' class=refl><div class=refln>101.</div><a class=rt href="#cite_mclean"><span class=refa>McLean</span> et al., Open Forum Infect. Dis. September 2015, 2:3, doi:10.1093/ofid/ofv100</a>,
<span class=reft>Impact of Late Oseltamivir Treatment on Influenza Symptoms in the Outpatient Setting: Results of a Randomized Trial</span>,
<span class=refu><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525010/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525010/</a></span>.
</div>

<div id='ref_mehra' class=refl><div class=refln>102.</div><a class=rt href="#cite_mehra"><span class=refa>Mehra</span> et al., The Lancet, May 22, 2020, doi: 10.1016/S0140-6736(20)31180-6</a>,
<span class=reft>Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis</span>,
<span class=refu><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31180-6/fulltext">https://www.thelancet.com/journals../PIIS0140-6736(20)31180-6/fulltext</a></span>.
</div>

<div id='ref_membrillo' class=refl><div class=refln>103.</div><a class=rt href="#cite_membrillo"><span class=refa>Membrillo de Novales</span> et al., Preprints 2020, 2020050057, doi:10.20944/preprints202005.0057.v1</a>,
<span class=reft>Early Hydroxychloroquine Is Associated with an Increase of Survival in COVID-19 Patients: An Observational Study</span>,
<span class=refu><a href="https://www.preprints.org/manuscript/202005.0057">https://www.preprints.org/manuscript/202005.0057</a></span>.
</div>

<div id='ref_meo' class=refl><div class=refln>104.</div><a class=rt href="#cite_meo"><span class=refa>Meo</span> et al., Eur. Rev. Med. Pharmacol. Sci. 2020, 24 (8), 4539-4547, doi:10.26355/eurrev_202004_21038</a>,
<span class=reft>Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19</span>,
<span class=refu><a href="https://www.europeanreview.org/article/21038">https://www.europeanreview.org/article/21038</a></span>.
</div>

<div id='ref_mikami' class=refl><div class=refln>105.</div><a class=rt href="#cite_mikami"><span class=refa>Mikami</span> et al., J. Gen. Intern. Med., doi:10.1007/s11606-020-05983-z</a>,
<span class=reft>Risk Factors for Mortality in Patients with COVID-19 in New York City</span>,
<span class=refu><a href="https://link.springer.com/article/10.1007/s11606-020-05983-z">https://link.springer.com/article/10.1007/s11606-020-05983-z</a></span>.
</div>

<div id='ref_million' class=refl><div class=refln>106.</div><a class=rt href="#cite_million"><span class=refa>Million</span> et al., Travel Med Infect Dis., 2020 May 5, doi:10.1016/j.tmaid.2020.101738</a>,
<span class=reft>Early Treatment of COVID-19 Patients With Hydroxychloroquine and Azithromycin: A Retrospective Analysis of 1061 Cases in Marseille, France</span>,
<span class=refu><a href="https://pubmed.ncbi.nlm.nih.gov/32387409/">https://pubmed.ncbi.nlm.nih.gov/32387409/</a></span>.
</div>

<div id='ref_mills' class=refl><div class=refln>107.</div><a class=rt href="#cite_mills"><span class=refa>Mills</span> et al., Circulation, Aug 9, 2016, 134:6, 441–450, doi:10.1161/circulationaha.115.018912</a>,
<span class=reft>Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-based Studies from 90 Countries</span>,
<span class=refu><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979614/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979614/</a></span>.
</div>

<div id='ref_mitchell' class=refl><div class=refln>108.</div><a class=rt href="#cite_mitchell"><span class=refa>Mitchell</span>, G., SSRN Preprint, June 16, 2020, doi:10.2139/ssrn.3628644</a>,
<span class=reft>A Tale of Two Cities – Lagos, Nigeria’s Apparent Success in the War Against COVID-19</span>,
<span class=refu><a href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3628644">https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3628644</a></span>.
</div>

<div id='ref_mitjapep' class=refl><div class=refln>109.</div><a class=rt href="#cite_mitjapep"><span class=refa>Mitjà</span> et al., medRxiv, doi:10.1101/2020.07.20.20157651</a>,
<span class=reft>A Cluster-Randomized Trial of Hydroxychloroquine as Prevention of Covid-19 Transmission and Disease</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.07.20.20157651v1">https://www.medrxiv.org/content/10.1101/2020.07.20.20157651v1</a></span>.
</div>

<div id='ref_mitja' class=refl><div class=refln>110.</div><a class=rt href="#cite_mitja"><span class=refa>Mitjà (B)</span> et al., Clinical Infectious Diseases, ciaa1009, doi:10.1093/cid/ciaa1009</a>,
<span class=reft>Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial</span>,
<span class=refu><a href="https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa1009/5872589#.XxCYlMdGoJM.twitter">https://academic.oup.com/cid/artic..a1009/5872589#.XxCYlMdGoJM.twitter</a></span>.
</div>

<div id='ref_molina' class=refl><div class=refln>111.</div><a class=rt href="#cite_molina"><span class=refa>Molina</span> et al., Médecine et Maladies Infectieuses, 50:4, June 2020, 10.1016/j.medmal.2020.03.006 (preprint 3/28)</a>,
<span class=reft>No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection</span>,
<span class=refu><a href="https://www.sciencedirect.com/science/article/pii/S0399077X20300858">https://www.sciencedirect.com/science/article/pii/S0399077X20300858</a></span>.
</div>

<div id='ref_nihzinc' class=refl><div class=refln>112.</div><a class=rt href="#cite_nihzinc"><span class=refa>NIH</span></a>,
<span class=reft>Zinc Fact Sheet for Health Professionals</span>,
<span class=refu><a href="https://ods.od.nih.gov/factsheets/Zinc-HealthProfessional/">https://ods.od.nih.gov/factsheets/Zinc-HealthProfessional/</a></span>.
</div>

<div id='ref_olza' class=refl><div class=refln>113.</div><a class=rt href="#cite_olza"><span class=refa>Olza</span> et al., Nutrients 2017, 9:7, 697, doi:10.3390/nu9070697</a>,
<span class=reft>Reported Dietary Intake and Food Sources of Zinc, Selenium, and Vitamins A, E and C in the Spanish Population: Findings from the ANIBES Study</span>,
<span class=refu><a href="https://www.mdpi.com/2072-6643/9/7/697">https://www.mdpi.com/2072-6643/9/7/697</a></span>.
</div>

<div id='ref_otea' class=refl><div class=refln>114.</div><a class=rt href="#cite_otea"><span class=refa>Otea</span> et al., medRxiv, doi:10.1101/2020.06.10.20101105</a>,
<span class=reft>A short therapeutic regimen based on hydroxychloroquine plus azithromycin for the treatment of COVID-19 in patients with non-severe disease. A strategy associated with a reduction in hospital admissions and complications.</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.06.10.20101105v1">https://www.medrxiv.org/content/10.1101/2020.06.10.20101105v1</a></span>.
</div>

<div id='ref_ourworldindata' class=refl><div class=refln>115.</div><a class=rt href="#cite_ourworldindata"><span class=refa>Our World in Data</span></a>,
<span class=reft>Data on COVID-19 (coronavirus) by Our World in Data</span>,
<span class=refu><a href="https://github.com/owid/covid-19-data/tree/master/public/data">https://github.com/owid/covid-19-data/tree/master/public/data</a></span>.
</div>

<div id='ref_owidlife' class=refl><div class=refln>116.</div><a class=rt href="#cite_owidlife"><span class=refa>Our World in Data (B)</span></a>,
<span class=reft>Life Expectancy</span>,
<span class=refu><a href="https://ourworldindata.org/life-expectancy">https://ourworldindata.org/life-expectancy</a></span>.
</div>

<div id='ref_owidtests' class=refl><div class=refln>117.</div><a class=rt href="#cite_owidtests"><span class=refa>Our World in Data (C)</span></a>,
<span class=reft>Total COVID-19 tests per 1,000 people</span>,
<span class=refu><a href="https://ourworldindata.org/grapher/full-list-cumulative-total-tests-per-thousand-bar-chart">https://ourworldindata.org/grapher..total-tests-per-thousand-bar-chart</a></span>.
</div>

<div id='ref_owiddensity' class=refl><div class=refln>118.</div><a class=rt href="#cite_owiddensity"><span class=refa>Our World in Data (D)</span></a>,
<span class=reft>Population Density</span>,
<span class=refu><a href="https://ourworldindata.org/grapher/population-density">https://ourworldindata.org/grapher/population-density</a></span>.
</div>

<div id='ref_owiddata' class=refl><div class=refln>119.</div><a class=rt href="#cite_owiddata"><span class=refa>Our World in Data (E)</span></a>,
<span class=reft>Coronavirus Source Data</span>,
<span class=refu><a href="https://ourworldindata.org/coronavirus-source-data">https://ourworldindata.org/coronavirus-source-data</a></span>.
</div>

<div id='ref_owidstringency' class=refl><div class=refln>120.</div><a class=rt href="#cite_owidstringency"><span class=refa>Our World in Data (F)</span></a>,
<span class=reft>COVID-19: Government Response Stringency Index</span>,
<span class=refu><a href="https://ourworldindata.org/grapher/covid-stringency-index">https://ourworldindata.org/grapher/covid-stringency-index</a></span>.
</div>

<div id='ref_paccoud' class=refl><div class=refln>121.</div><a class=rt href="#cite_paccoud"><span class=refa>Paccoud</span> et al., Clinical Infectious Diseases, doi:10.1093/cid/ciaa791</a>,
<span class=reft>Compassionate use of hydroxychloroquine in clinical practice for patients with mild to severe Covid-19 in a French university hospital</span>,
<span class=refu><a href="https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa791/5859555">https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa791/5859555</a></span>.
</div>

<div id='ref_pagliano' class=refl><div class=refln>122.</div><a class=rt href="#cite_pagliano"><span class=refa>Pagliano</span> et al., Clin. Infect. Dis., 2020 Mar 24, doi:10.1093/cid/ciaa320</a>,
<span class=reft>Is Hydroxychloroquine a Possible Post-Exposure Prophylaxis Drug to Limit the Transmission to Health Care Workers Exposed to COVID19?</span>,
<span class=refu><a href="https://pubmed.ncbi.nlm.nih.gov/32211764/">https://pubmed.ncbi.nlm.nih.gov/32211764/</a></span>.
</div>

<div id='ref_pirnay' class=refl><div class=refln>123.</div><a class=rt href="#cite_pirnay"><span class=refa>Pirnay</span> et al., Hosp. Pharm. and Clinician, doi:10.1016/j.phclin.2020.06.001</a>,
<span class=reft>Beneficial effect of Hydroxychloroquine-Azithromycin combination in the treatment of elderly patients with Covid-19: results of an observational study</span>,
<span class=refu><a href="https://www.sciencedirect.com/science/article/pii/S2211104220300771">https://www.sciencedirect.com/science/article/pii/S2211104220300771</a></span>.
</div>

<div id='ref_uksero' class=refl><div class=refln>124.</div><a class=rt href="#cite_uksero"><span class=refa>Public Health England</span></a>,
<span class=reft>Sero-surveillance of COVID-19</span>,
<span class=refu><a href="https://www.gov.uk/government/publications/national-covid-19-surveillance-reports/sero-surveillance-of-covid-19">https://www.gov.uk/government/publ..orts/sero-surveillance-of-covid-19</a></span>.
</div>

<div id='ref_rafaeli2' class=refl><div class=refln>125.</div><a class=rt href="#cite_rafaeli2"><span class=refa>Rafaeli</span>, F., Medium, July 23, 2020</a>,
<span class=reft>Hydroxychloroquine: The Narrative That it Doesn’t Work is the Biggest Hoax in Recent Human History</span>,
<span class=refu><a href="https://truthabouthcq.com/hcq-works/">https://truthabouthcq.com/hcq-works/</a></span>.
</div>

<div id='ref_risch2' class=refl><div class=refln>126.</div><a class=rt href="#cite_risch2"><span class=refa>Risch</span>, H., American Journal of Epidemiology, July 20, 2020, doi:10.1093/aje/kwaa152</a>,
<span class=reft>Response to: “Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients” and “Re: Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis”</span>,
<span class=refu><a href="https://academic.oup.com/aje/article/doi/10.1093/aje/kwaa152/5873640">https://academic.oup.com/aje/article/doi/10.1093/aje/kwaa152/5873640</a></span>.
</div>

<div id='ref_rischnewsweek' class=refl><div class=refln>127.</div><a class=rt href="#cite_rischnewsweek"><span class=refa>Risch (B)</span>, H., Newsweek, July 23, 2020</a>,
<span class=reft>The Key to Defeating COVID-19 Already Exists. We Need to Start Using It</span>,
<span class=refu><a href="https://www.newsweek.com/key-defeating-covid-19-already-exists-we-need-start-using-it-opinion-1519535">https://www.newsweek.com/key-defea..eed-start-using-it-opinion-1519535</a></span>.
</div>

<div id='ref_rosenberg' class=refl><div class=refln>128.</div><a class=rt href="#cite_rosenberg"><span class=refa>Rosenberg</span> et al., JAMA, May 11, 2020, doi:10.1001/jama.2020.8630</a>,
<span class=reft>Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State</span>,
<span class=refu><a href="https://jamanetwork.com/journals/jama/fullarticle/2766117">https://jamanetwork.com/journals/jama/fullarticle/2766117</a></span>.
</div>

<div id='ref_salje' class=refl><div class=refln>129.</div><a class=rt href="#cite_salje"><span class=refa>Salje</span> et al., Science  10 Jul 2020, 369:6500, 208-211 doi:10.1126/science.abc3517</a>,
<span class=reft>Estimating the burden of SARS-CoV-2 in France</span>,
<span class=refu><a href="https://science.sciencemag.org/content/369/6500/208">https://science.sciencemag.org/content/369/6500/208</a></span>.
</div>

<div id='ref_sauder' class=refl><div class=refln>130.</div><a class=rt href="#cite_sauder"><span class=refa>Sauder</span> et al., Advances in Methods and Practices in Psychological Science, 2:1, 26-44, 2019, doi:10.1177/2515245918808784</a>,
<span class=reft>An Updated Recommendation for Multiple Comparisons</span>,
<span class=refu><a href="https://journals.sagepub.com/doi/full/10.1177/2515245918808784">https://journals.sagepub.com/doi/full/10.1177/2515245918808784</a></span>.
</div>

<div id='ref_savarino2' class=refl><div class=refln>131.</div><a class=rt href="#cite_savarino2"><span class=refa>Savarino</span> et al., Lancet Infect. Dis., doi:10.1016/S1473-3099(06)70361-9</a>,
<span class=reft>New insights into the antiviral effects of chloroquine</span>,
<span class=refu><a href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(06)70361-9/fulltext">https://www.thelancet.com/journals../PIIS1473-3099(06)70361-9/fulltext</a></span>.
</div>

<div id='ref_savarino' class=refl><div class=refln>132.</div><a class=rt href="#cite_savarino"><span class=refa>Savarino (B)</span> et al., Lancet Infect. Dis., doi:10.1016/S1473-3099(03)00806-5</a>,
<span class=reft>Effects of chloroquine on viral infections: an old drug against today's diseases</span>,
<span class=refu><a href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(03)00806-5/fulltext">https://www.thelancet.com/journals../PIIS1473-3099(03)00806-5/fulltext</a></span>.
</div>

<div id='ref_sbidian' class=refl><div class=refln>133.</div><a class=rt href="#cite_sbidian"><span class=refa>Sbidian</span> et al., medRxiv, doi:10.1101/2020.06.16.20132597</a>,
<span class=reft>Hydroxychloroquine with or without azithromycin and in-hospital mortality or discharge in patients hospitalized for COVID-19 infection: a cohort study of 4,642 in-patients in France</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.06.16.20132597v1">https://www.medrxiv.org/content/10.1101/2020.06.16.20132597v1</a></span>.
</div>

<div id='ref_scherrmann' class=refl><div class=refln>134.</div><a class=rt href="#cite_scherrmann"><span class=refa>Scherrmann</span>, AAPS J 22, 86 (2020), doi:10.1208/s12248-020-00465-w</a>,
<span class=reft>Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy</span>,
<span class=refu><a href="https://link.springer.com/article/10.1208/s12248-020-00465-w">https://link.springer.com/article/10.1208/s12248-020-00465-w</a></span>.
</div>

<div id='ref_scholz' class=refl><div class=refln>135.</div><a class=rt href="#cite_scholz"><span class=refa>Scholz</span> et al., Preprints 2020, 2020070025, doi:10.20944/preprints202007.0025.v1</a>,
<span class=reft>COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series Study</span>,
<span class=refu><a href="https://www.preprints.org/manuscript/202007.0025/v1">https://www.preprints.org/manuscript/202007.0025/v1</a></span>.
</div>

<div id='ref_schrezenmeier' class=refl><div class=refln>136.</div><a class=rt href="#cite_schrezenmeier"><span class=refa>Schrezenmeier</span> et al., Nat. Rev. Rheumatol. 2020 Mar, 16:3, 155-166, doi:10.1038/s41584-020-0372-x</a>,
<span class=reft>Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology</span>,
<span class=refu><a href="https://pubmed.ncbi.nlm.nih.gov/32034323/">https://pubmed.ncbi.nlm.nih.gov/32034323/</a></span>.
</div>

<div id='ref_sheaff' class=refl><div class=refln>137.</div><a class=rt href="#cite_sheaff"><span class=refa>Sheaff</span>, R., bioRxiv, doi:10.1101/2020.08.02.232892</a>,
<span class=reft>A New Model of SARS-CoV-2 Infection Based on (Hydroxy)Chloroquine Activity</span>,
<span class=refu><a href="https://www.biorxiv.org/content/10.1101/2020.08.02.232892v1">https://www.biorxiv.org/content/10.1101/2020.08.02.232892v1</a></span>.
</div>

<div id='ref_sheahan' class=refl><div class=refln>138.</div><a class=rt href="#cite_sheahan"><span class=refa>Sheahan</span> et al., Science Translational Medicine, 29 Apr 2020, 12:541, doi:10.1126/scitranslmed.abb5883</a>,
<span class=reft>An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice</span>,
<span class=refu><a href="https://stm.sciencemag.org/content/12/541/eabb5883">https://stm.sciencemag.org/content/12/541/eabb5883</a></span>.
</div>

<div id='ref_shen' class=refl><div class=refln>139.</div><a class=rt href="#cite_shen"><span class=refa>Shen</span> et al., Am. J. Physiol., May 1994, 266, 493-501, doi:10.1152/ajplung.1994.266.5.L493</a>,
<span class=reft>Calu-3: a human airway epithelial cell line that shows AMP-dependent Cl- secretion</span>,
<span class=refu><a href="https://journals.physiology.org/doi/pdf/10.1152/ajplung.1994.266.5.L493">https://journals.physiology.org/do..df/10.1152/ajplung.1994.266.5.L493</a></span>.
</div>

<div id='ref_shittu' class=refl><div class=refln>140.</div><a class=rt href="#cite_shittu"><span class=refa>Shittu</span> et al., Le Infezioni in Medicina, 28:2, 192-197, 2020</a>,
<span class=reft>Improving the efficacy of chloroquine and hydroxychloroquine against SARS-CoV-2 may require zinc additives - A better synergy for future COVID-19 clinical trials</span>,
<span class=refu><a href="https://www.infezmed.it/index.php/article?Anno=2020&numero=2&ArticoloDaVisualizzare=Vol_28_2_2020_192">https://www.infezmed.it/index.php/..loDaVisualizzare=Vol_28_2_2020_192</a></span>.
</div>

<div id='ref_singh' class=refl><div class=refln>141.</div><a class=rt href="#cite_singh"><span class=refa>Singh</span> et al., medRxiv, doi:10.1101/2020.05.12.20099028</a>,
<span class=reft>Outcomes of Hydroxychloroquine Treatment Among Hospitalized COVID-19 Patients in the United States- Real-World Evidence From a Federated Electronic Medical Record Network</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.05.12.20099028v1">https://www.medrxiv.org/content/10.1101/2020.05.12.20099028v1</a></span>.
</div>

<div id='ref_skipper' class=refl><div class=refln>142.</div><a class=rt href="#cite_skipper"><span class=refa>Skipper</span> et al., Annals of Internal Medicine, doi:10.7326/M20-4207</a>,
<span class=reft>Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial</span>,
<span class=refu><a href="https://www.acpjournals.org/doi/10.7326/M20-4207">https://www.acpjournals.org/doi/10.7326/M20-4207</a></span>.
</div>

<div id='ref_skowronski' class=refl><div class=refln>143.</div><a class=rt href="#cite_skowronski"><span class=refa>Skowronski</span> et al., medRxiv, doi:10.1101/2020.07.13.20153148</a>,
<span class=reft>Low SARS-CoV-2 sero-prevalence based on anonymized residual sero-survey before and after first wave measures in British Columbia, Canada, March-May 2020</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.07.13.20153148v1">https://www.medrxiv.org/content/10.1101/2020.07.13.20153148v1</a></span>.
</div>

<div id='ref_slot' class=refl><div class=refln>144.</div><a class=rt href="#cite_slot"><span class=refa>Slot</span> et al., Research Square, doi:10.21203/rs.3.rs-25862/v1</a>,
<span class=reft>Herd immunity is not a realistic exit strategy during a COVID-19 outbreak</span>,
<span class=refu><a href="https://www.researchsquare.com/article/rs-25862/v1">https://www.researchsquare.com/article/rs-25862/v1</a></span>.
</div>

<div id='ref_stutt' class=refl><div class=refln>145.</div><a class=rt href="#cite_stutt"><span class=refa>Stutt</span> et al., Proc. Royal Society A, doi:10.1098/rspa.2020.0376</a>,
<span class=reft>A modelling framework to assess the likely effectiveness of facemasks in combination with ‘lock-down’ in managing the COVID-19 pandemic</span>,
<span class=refu><a href="https://royalsocietypublishing.org/doi/10.1098/rspa.2020.0376">https://royalsocietypublishing.org/doi/10.1098/rspa.2020.0376</a></span>.
</div>

<div id='ref_swedensero' class=refl><div class=refln>146.</div><a class=rt href="#cite_swedensero"><span class=refa>Swedish Public Health Agency</span></a>,
<span class=reft>Första resultaten om antikroppar efter genomgången covid-19 hos blodgivare</span>,
<span class=refu><a href="https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2020/juni/forsta-resultaten-om-antikroppar-efter-genomgangen-covid-19-hos-blodgivare/">https://www.folkhalsomyndigheten.s..nomgangen-covid-19-hos-blodgivare/</a></span>.
</div>

<div id='ref_tang' class=refl><div class=refln>147.</div><a class=rt href="#cite_tang"><span class=refa>Tang</span> et al., BMJ 2020, 369, doi:10.1136/bmj.m1849</a>,
<span class=reft>Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial</span>,
<span class=refu><a href="https://www.bmj.com/content/369/bmj.m1849">https://www.bmj.com/content/369/bmj.m1849</a></span>.
</div>

<div id='ref_te' class=refl><div class=refln>148.</div><a class=rt href="#cite_te"><span class=refa>te Velthuis</span> et al., PLOS Pathogens 2010, 6:11, doi:10.1371/journal.ppat.1001176</a>,
<span class=reft>Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture</span>,
<span class=refu><a href="https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1001176">https://journals.plos.org/plospath..le?id=10.1371/journal.ppat.1001176</a></span>.
</div>

<div id='ref_indiasero3' class=refl><div class=refln>149.</div><a class=rt href="#cite_indiasero3"><span class=refa>The Hindu</span></a>,
<span class=reft>Initial results of survey show ‘high’ seroprevalence in Delhi: officials</span>,
<span class=refu><a href="https://www.thehindu.com/news/cities/Delhi/initial-results-of-survey-show-high-seroprevalence-in-delhi-officials/article32025471.ece/amp/">https://www.thehindu.com/news/citi..officials/article32025471.ece/amp/</a></span>.
</div>

<div id='ref_indiasero2' class=refl><div class=refln>150.</div><a class=rt href="#cite_indiasero2"><span class=refa>The Indian Express</span></a>,
<span class=reft>India not in community transmission stage, states cannot lower guard, says ICMR</span>,
<span class=refu><a href="https://indianexpress.com/article/india/india-not-in-community-transmission-stage-yet-health-ministry-6454183/">https://indianexpress.com/article/..stage-yet-health-ministry-6454183/</a></span>.
</div>

<div id='ref_irelandsero' class=refl><div class=refln>151.</div><a class=rt href="#cite_irelandsero"><span class=refa>The Irish Times</span></a>,
<span class=reft>The Irish Times view on Ireland’s Covid-19 antibody study: still susceptible</span>,
<span class=refu><a href="https://www.irishtimes.com/opinion/editorial/the-irish-times-view-on-ireland-s-covid-19-antibody-study-still-susceptible-1.4309176">https://www.irishtimes.com/opinion..-study-still-susceptible-1.4309176</a></span>.
</div>

<div id='ref_israelsero' class=refl><div class=refln>152.</div><a class=rt href="#cite_israelsero"><span class=refa>The Jerusalem Post</span></a>,
<span class=reft>Coronavirus herd immunity? Not in Israel, according to a serological study</span>,
<span class=refu><a href="https://www.jpost.com/israel-news/coronavirus-herd-immunity-not-in-israel-according-to-a-serological-study-630059">https://www.jpost.com/israel-news/..ding-to-a-serological-study-630059</a></span>.
</div>

<div id='ref_unage' class=refl><div class=refln>153.</div><a class=rt href="#cite_unage"><span class=refa>United Nations</span></a>,
<span class=reft>Population Dynamics</span>,
<span class=refu><a href="http://population.un.org/wpp/Download/Standard/Population/">http://population.un.org/wpp/Download/Standard/Population/</a></span>.
</div>

<div id='ref_stringency' class=refl><div class=refln>154.</div><a class=rt href="#cite_stringency"><span class=refa>University of Oxford</span></a>,
<span class=reft>Intervention Stringency Index</span>,
<span class=refu><a href="https://www.bsg.ox.ac.uk/research/research-projects/coronavirus-government-response-tracker">https://www.bsg.ox.ac.uk/research/..avirus-government-response-tracker</a></span>.
</div>

<div id='ref_valenti' class=refl><div class=refln>155.</div><a class=rt href="#cite_valenti"><span class=refa>Valenti</span> et al., medRxiv, doi:10.1101/2020.05.11.20098442</a>,
<span class=reft>SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak</span>,
<span class=refu><a href="https://www.medrxiv.org/content/10.1101/2020.05.11.20098442v2">https://www.medrxiv.org/content/10.1101/2020.05.11.20098442v2</a></span>.
</div>

<div id='ref_verity' class=refl><div class=refln>156.</div><a class=rt href="#cite_verity"><span class=refa>Verity</span> et al., Lancet Infect. Dis., 2020, doi:10.1016/S1473-3099(20)30243-7</a>,
<span class=refu><a href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30243-7/fulltext">https://www.thelancet.com/journals../PIIS1473-3099(20)30243-7/fulltext</a></span>.
</div>

<div id='ref_vincent' class=refl><div class=refln>157.</div><a class=rt href="#cite_vincent"><span class=refa>Vincent</span> et al., Virol. J. 2:69, 2005, doi:10.1186/1743-422X-2-69</a>,
<span class=reft>Chloroquine is a potent inhibitor of SARS coronavirus infection and spread</span>,
<span class=refu><a href="https://virologyj.biomedcentral.com/articles/10.1186/1743-422X-2-69">https://virologyj.biomedcentral.com/articles/10.1186/1743-422X-2-69</a></span>.
</div>

<div id='ref_wang' class=refl><div class=refln>158.</div><a class=rt href="#cite_wang"><span class=refa>Wang</span> et al., bioRxiv, doi:10.1101/2020.06.22.164665</a>,
<span class=reft>Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of COVID-19 Spike pseudotype virus</span>,
<span class=refu><a href="https://www.biorxiv.org/content/10.1101/2020.06.22.164665v1">https://www.biorxiv.org/content/10.1101/2020.06.22.164665v1</a></span>.
</div>

<div id='ref_wangcell' class=refl><div class=refln>159.</div><a class=rt href="#cite_wangcell"><span class=refa>Wang (B)</span> et al., Cell Res. 30, 269–271, doi:L10.1038/s41422-020-0282-0</a>,
<span class=reft>Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro</span>,
<span class=refu><a href="https://www.nature.com/articles/s41422-020-0282-0?fbclid=IwAR0sG1G81fFcpaEubHB_oCyNsiVs8_7R1KkwOuqjRhx7psfHV6iSDRD1cM0">https://www.nature.com/articles/s4..iVs8_7R1KkwOuqjRhx7psfHV6iSDRD1cM0</a></span>.
</div>

<div id='ref_wangnasal' class=refl><div class=refln>160.</div><a class=rt href="#cite_wangnasal"><span class=refa>Wang (C)</span> et al., Chest Journal, June 19, 2020, doi:10.1016/j.chest.2020.06.015</a>,
<span class=reft>Differences of SARS-CoV-2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With COVID-19</span>,
<span class=refu><a href="https://journal.chestnet.org/article/S0012-3692(20)31718-9/fulltext">https://journal.chestnet.org/article/S0012-3692(20)31718-9/fulltext</a></span>.
</div>

<div id='ref_watanabe' class=refl><div class=refln>161.</div><a class=rt href="#cite_watanabe"><span class=refa>Watanabe</span>, M., arXiv.org, arXiv:2007.09477</a>,
<span class=reft>Efficacy of Hydroxychloroquine as Prophylaxis for Covid-19</span>,
<span class=refu><a href="https://arxiv.org/abs/2007.09477">https://arxiv.org/abs/2007.09477</a></span>.
</div>

<div id='ref_wikimasks' class=refl><div class=refln>162.</div><a class=rt href="#cite_wikimasks"><span class=refa>Wikipedia</span></a>,
<span class=reft>Face masks during the COVID-19 pandemic</span>,
<span class=refu><a href="https://en.wikipedia.org/wiki/Face_masks_during_the_COVID-19_pandemic#Mask_use_and_policies_by_country_and_territory">https://en.wikipedia.org/wiki/Face.._policies_by_country_and_territory</a></span>.
</div>

<div id='ref_williamson' class=refl><div class=refln>163.</div><a class=rt href="#cite_williamson"><span class=refa>Williamson</span> et al., Nature, 2020, doi:10.1038/s41586-020-2521-4</a>,
<span class=reft>OpenSAFELY: factors associated with COVID-19 death in 17 million patients</span>,
<span class=refu><a href="https://www.nature.com/articles/s41586-020-2521-4">https://www.nature.com/articles/s41586-020-2521-4</a></span>.
</div>

<div id='ref_wood' class=refl><div class=refln>164.</div><a class=rt href="#cite_wood"><span class=refa>Wood</span> et al., BMJ, 2008, 336, doi:10.1136/bmj.39465.451748.AD</a>,
<span class=reft>Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study</span>,
<span class=refu><a href="https://www.bmj.com/content/336/7644/601.full">https://www.bmj.com/content/336/7644/601.full</a></span>.
</div>

<div id='ref_wburban' class=refl><div class=refln>165.</div><a class=rt href="#cite_wburban"><span class=refa>World Bank</span></a>,
<span class=reft>World Bank, Urban population (% of total population)</span>,
<span class=refu><a href="https://data.worldbank.org/indicator/SP.URB.TOTL.IN.ZS">https://data.worldbank.org/indicator/SP.URB.TOTL.IN.ZS</a></span>.
</div>

<div id='ref_whoessential' class=refl><div class=refln>166.</div><a class=rt href="#cite_whoessential"><span class=refa>World Health Organization</span></a>,
<span class=reft>WHO Model Lists of Essential Medicines</span>,
<span class=refu><a href="https://www.who.int/medicines/publications/essentialmedicines/en/">https://www.who.int/medicines/publications/essentialmedicines/en/</a></span>.
</div>

<div id='ref_solidarity' class=refl><div class=refln>167.</div><a class=rt href="#cite_solidarity"><span class=refa>World Health Organization (B)</span>, study not available yet</a>,
<span class=reft>“Solidarity” clinical trial for COVID-19 treatments</span>,
<span class=refu><a href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments">https://www.who.int/emergencies/di..ical-trial-for-covid-19-treatments</a></span>.
</div>

<div id='ref_xueplos' class=refl><div class=refln>168.</div><a class=rt href="#cite_xueplos"><span class=refa>Xue</span> et al., PLoS One, 9:10, 2014, 10.1371/journal.pone.0109180</a>,
<span class=reft>Chloroquine Is a Zinc Ionophore</span>,
<span class=refu><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182877/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182877/</a></span>.
</div>

<div id='ref_xue' class=refl><div class=refln>169.</div><a class=rt href="#cite_xue"><span class=refa>Xue (B)</span> et al., J. Med. Virology, June 17, 2020, doi:10.1002/jmv.26193</a>,
<span class=reft>Hydroxychloroquine treatment in COVID-19: a descriptive observational analysis of 30 cases from a single center in Wuhan, China</span>,
<span class=refu><a href="https://onlinelibrary.wiley.com/doi/10.1002/jmv.26193">https://onlinelibrary.wiley.com/doi/10.1002/jmv.26193</a></span>.
</div>

<div id='ref_yan' class=refl><div class=refln>170.</div><a class=rt href="#cite_yan"><span class=refa>Yan</span> et al., Cell Research, 23, 300–302, doi:10.1038/cr.2012.165</a>,
<span class=reft>Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model</span>,
<span class=refu><a href="https://www.nature.com/articles/cr2012165">https://www.nature.com/articles/cr2012165</a></span>.
</div>

<div id='ref_yu' class=refl><div class=refln>171.</div><a class=rt href="#cite_yu"><span class=refa>Yu</span> et al., Sci China Life Sci., 2020 May 15, 1-7, doi:10.1007/s11427-020-1732-2</a>,
<span class=reft>Low Dose of Hydroxychloroquine Reduces Fatality of Critically Ill Patients With COVID-19</span>,
<span class=refu><a href="https://pubmed.ncbi.nlm.nih.gov/32418114/">https://pubmed.ncbi.nlm.nih.gov/32418114/</a></span>.
</div>

<div id='ref_zhong' class=refl><div class=refln>172.</div><a class=rt href="#cite_zhong"><span class=refa>Zhong</span> et al., Lancent Rheumatology, 10.1016/S2665-9913(20)30227-7</a>,
<span class=reft>COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study</span>,
<span class=refu><a href="https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30227-7/fulltext">https://www.thelancet.com/journals../PIIS2665-9913(20)30227-7/fulltext</a></span>.
</div>
</div>



<div class=nobreak>
<div class=head1><a class=at id="appendix_countrystats" href="#acite_countrystats">Appendix 1. Country Statistics</a></div>



<div class=section>
<div id='table_countrystats' class=tablediv>
<table class=ctable>
<tr class=ctr>
<td>Country</td>

<td>Age 0-9</td>

<td>Age 10-19</td>

<td>Age 20-29</td>

<td>Age 30-39</td>

<td>Age 40-49</td>

<td>Age 50-59</td>

<td>Age 60-69</td>

<td>Age 70-79</td>

<td>Age 80+</td>
<td>Age factor</td>
</tr>


<td>Algeria</td>

<td>22.1%</td>

<td>15.3%</td>

<td>15.0%</td>

<td>16.6%</td>

<td>12.4%</td>

<td>8.7%</td>

<td>5.8%</td>

<td>2.8%</td>

<td>1.3%</td>
<td>3.14</td>
</tr>

<td>Canada</td>

<td>10.5%</td>

<td>10.5%</td>

<td>13.5%</td>

<td>14.0%</td>

<td>12.8%</td>

<td>13.7%</td>

<td>12.5%</td>

<td>8.0%</td>

<td>4.4%</td>
<td>1.28</td>
</tr>

<td>Costa Rica</td>

<td>13.9%</td>

<td>14.1%</td>

<td>16.2%</td>

<td>16.2%</td>

<td>12.8%</td>

<td>11.8%</td>

<td>8.3%</td>

<td>4.5%</td>

<td>2.2%</td>
<td>2.10</td>
</tr>

<td>Cuba</td>

<td>10.6%</td>

<td>11.0%</td>

<td>12.5%</td>

<td>13.4%</td>

<td>13.8%</td>

<td>17.4%</td>

<td>10.4%</td>

<td>7.1%</td>

<td>3.8%</td>
<td>1.42</td>
</tr>

<td>France</td>

<td>11.5%</td>

<td>12.1%</td>

<td>11.3%</td>

<td>12.3%</td>

<td>12.8%</td>

<td>13.2%</td>

<td>11.9%</td>

<td>8.8%</td>

<td>6.2%</td>
<td>1.12</td>
</tr>

<td>Greece</td>

<td>8.5%</td>

<td>10.3%</td>

<td>10.1%</td>

<td>12.8%</td>

<td>15.1%</td>

<td>14.4%</td>

<td>12.1%</td>

<td>9.2%</td>

<td>7.5%</td>
<td>1.00</td>
</tr>

<td>India</td>

<td>17.0%</td>

<td>18.3%</td>

<td>17.4%</td>

<td>15.6%</td>

<td>12.3%</td>

<td>9.3%</td>

<td>6.3%</td>

<td>2.8%</td>

<td>1.0%</td>
<td>3.24</td>
</tr>

<td>Indonesia</td>

<td>17.5%</td>

<td>16.9%</td>

<td>15.9%</td>

<td>15.1%</td>

<td>13.8%</td>

<td>10.7%</td>

<td>6.4%</td>

<td>2.8%</td>

<td>0.9%</td>
<td>3.22</td>
</tr>

<td>Ireland</td>

<td>13.6%</td>

<td>13.5%</td>

<td>11.5%</td>

<td>14.1%</td>

<td>15.5%</td>

<td>12.2%</td>

<td>9.7%</td>

<td>6.7%</td>

<td>3.2%</td>
<td>1.60</td>
</tr>

<td>Israel</td>

<td>19.3%</td>

<td>16.2%</td>

<td>13.8%</td>

<td>13.0%</td>

<td>12.0%</td>

<td>9.2%</td>

<td>8.1%</td>

<td>5.3%</td>

<td>3.0%</td>
<td>1.89</td>
</tr>

<td>Mexico</td>

<td>17.2%</td>

<td>17.3%</td>

<td>16.9%</td>

<td>14.6%</td>

<td>12.8%</td>

<td>9.9%</td>

<td>6.4%</td>

<td>3.2%</td>

<td>1.6%</td>
<td>2.77</td>
</tr>

<td>Morocco</td>

<td>18.3%</td>

<td>16.5%</td>

<td>15.9%</td>

<td>15.2%</td>

<td>12.1%</td>

<td>10.1%</td>

<td>7.4%</td>

<td>3.2%</td>

<td>1.2%</td>
<td>2.83</td>
</tr>

<td>Netherlands</td>

<td>10.2%</td>

<td>11.4%</td>

<td>12.2%</td>

<td>12.2%</td>

<td>12.6%</td>

<td>14.7%</td>

<td>12.4%</td>

<td>9.3%</td>

<td>4.9%</td>
<td>1.17</td>
</tr>

<td>Russia</td>

<td>12.8%</td>

<td>10.5%</td>

<td>10.7%</td>

<td>16.8%</td>

<td>14.0%</td>

<td>12.9%</td>

<td>12.7%</td>

<td>5.9%</td>

<td>3.9%</td>
<td>1.46</td>
</tr>

<td>Sweden</td>

<td>11.8%</td>

<td>11.2%</td>

<td>12.6%</td>

<td>13.1%</td>

<td>12.5%</td>

<td>12.8%</td>

<td>10.8%</td>

<td>9.8%</td>

<td>5.3%</td>
<td>1.16</td>
</tr>

<td>Turkey</td>

<td>15.9%</td>

<td>16.1%</td>

<td>15.6%</td>

<td>15.1%</td>

<td>13.6%</td>

<td>10.6%</td>

<td>7.3%</td>

<td>4.0%</td>

<td>1.7%</td>
<td>2.43</td>
</tr>

<td>U.K.</td>

<td>11.8%</td>

<td>11.3%</td>

<td>12.6%</td>

<td>13.7%</td>

<td>12.7%</td>

<td>13.5%</td>

<td>10.7%</td>

<td>8.6%</td>

<td>5.1%</td>
<td>1.23</td>
</tr>

<td>USA</td>

<td>12.0%</td>

<td>12.8%</td>

<td>13.9%</td>

<td>13.5%</td>

<td>12.2%</td>

<td>12.7%</td>

<td>11.6%</td>

<td>7.3%</td>

<td>4.0%</td>
<td>1.40</td>
</tr>

<td>Ukraine</td>

<td>10.5%</td>

<td>10.0%</td>

<td>11.2%</td>

<td>16.5%</td>

<td>14.6%</td>

<td>13.5%</td>

<td>12.7%</td>

<td>6.8%</td>

<td>4.2%</td>
<td>1.36</td>
</tr>
</table>

<a class=tt id="table_countrystats" href="#tcite_countrystats"><div class=tcaption><span class=tnum>Table 3.</span></a> Country age distributions <span class=refn>[<a class=rr id="cite_unage" href="#ref_unage">United Nations</a>]</span> and the computed age factor.</div>
</div>


<div id='table_countrystats2' class=tablediv>
<table class=ctable>
<tr class=ctr>
<td>Country</td>
<td><span class=desktop>Population</span><span class=mobile>Pop.</span></td>
<td><span class=desktop>Urban percentage</span><span class=mobile>Urban percentage</span></td>
<td>Average intervention stringency index</td>
<td><span class=desktop>Population density</span><span class=mobile>Pop. density</span></td>
<td>Males per 100 females</td>
<td>Gender factor</td>
</tr>



<td>Algeria</td>
<td>44M</td>

<td>73.2</td>

<td>0.29</td>

<td>17</td>

<td>102.1</td>
<td>1.00</td>
</tr>

<td>Canada</td>
<td>38M</td>

<td>81.5</td>

<td>0.26</td>

<td>4</td>

<td>98.5</td>
<td>1.00</td>
</tr>

<td>Costa Rica</td>
<td>5M</td>

<td>80.1</td>

<td>0.29</td>

<td>96</td>

<td>99.8</td>
<td>1.00</td>
</tr>

<td>Cuba</td>
<td>11M</td>

<td>77.1</td>

<td>0.30</td>

<td>110</td>

<td>98.6</td>
<td>1.00</td>
</tr>

<td>France</td>
<td>65M</td>

<td>80.7</td>

<td>0.27</td>

<td>123</td>

<td>93.8</td>
<td>1.01</td>
</tr>

<td>Greece</td>
<td>10M</td>

<td>79.4</td>

<td>0.26</td>

<td>83</td>

<td>96.4</td>
<td>1.01</td>
</tr>

<td>India</td>
<td>1.4B</td>

<td>34.5</td>

<td>0.32</td>

<td>450</td>

<td>108.2</td>
<td>0.99</td>
</tr>

<td>Indonesia</td>
<td>274M</td>

<td>56.0</td>

<td>0.25</td>

<td>146</td>

<td>101.4</td>
<td>1.00</td>
</tr>

<td>Ireland</td>
<td>5M</td>

<td>63.4</td>

<td>0.27</td>

<td>70</td>

<td>98.6</td>
<td>1.00</td>
</tr>

<td>Israel</td>
<td>9M</td>

<td>92.5</td>

<td>0.30</td>

<td>403</td>

<td>99.1</td>
<td>1.00</td>
</tr>

<td>Mexico</td>
<td>129M</td>

<td>80.4</td>

<td>0.28</td>

<td>66</td>

<td>95.8</td>
<td>1.01</td>
</tr>

<td>Morocco</td>
<td>37M</td>

<td>63.0</td>

<td>0.33</td>

<td>80</td>

<td>98.5</td>
<td>1.00</td>
</tr>

<td>Netherlands</td>
<td>17M</td>

<td>91.9</td>

<td>0.26</td>

<td>509</td>

<td>99.3</td>
<td>1.00</td>
</tr>

<td>Russia</td>
<td>146M</td>

<td>74.6</td>

<td>0.30</td>

<td>9</td>

<td>86.4</td>
<td>1.02</td>
</tr>

<td>Sweden</td>
<td>10M</td>

<td>87.7</td>

<td>0.16</td>

<td>25</td>

<td>100.4</td>
<td>1.00</td>
</tr>

<td>Turkey</td>
<td>84M</td>

<td>75.6</td>

<td>0.26</td>

<td>105</td>

<td>97.5</td>
<td>1.00</td>
</tr>

<td>U.K.</td>
<td>68M</td>

<td>83.7</td>

<td>0.28</td>

<td>273</td>

<td>97.7</td>
<td>1.00</td>
</tr>

<td>USA</td>
<td>331M</td>

<td>82.5</td>

<td>0.28</td>

<td>36</td>

<td>97.9</td>
<td>1.00</td>
</tr>

<td>Ukraine</td>
<td>44M</td>

<td>69.5</td>

<td>0.29</td>

<td>77</td>

<td>86.3</td>
<td>1.02</td>
</tr>
</table>

<a class=tt id="table_countrystats2" href="#tcite_countrystats2"><div class=tcaption><span class=tnum>Table 4.</span></a> Country statistics <span class=refn>[<a class=rr id="cite_owiddensity" href="#ref_owiddensity">Our World in Data (D)</a>, <a class=rr id="cite_owidstringency" href="#ref_owidstringency">Our World in Data (F)</a>, <a class=rr id="cite_ungender" href="#ref_ungender">United Nations (B)</a>, <a class=rr id="cite_stringency" href="#ref_stringency">University of Oxford</a>, <a class=rr id="cite_wburban" href="#ref_wburban">World Bank</a>]</span> and the computed gender factor.</div>
</div>


<div id='table_countrystats3' class=tablediv>
<table class=ctable>
<tr class=ctr>
<td>Country</td>
<td>Life expectancy</td>
<td>Diabetes prevalence</td>
<td>Obesity prevalence</td>
<td>Hypertension prevalence</td>
<td>Tests per thousand</td>
</tr>


<td>Algeria</td>

<td>76.9</td>

<td>6.7</td>

<td>27.4</td>

<td>32.1</td>

<td>N/A</td>
</tr>
<td>Canada</td>

<td>82.4</td>

<td>7.6</td>

<td>29.4</td>

<td>23.3</td>

<td>110.7</td>
</tr>
<td>Costa Rica</td>

<td>80.3</td>

<td>9.1</td>

<td>25.7</td>

<td>24.0</td>

<td>15.8</td>
</tr>
<td>Cuba</td>

<td>78.8</td>

<td>9.6</td>

<td>24.6</td>

<td>38.8</td>

<td>24.2</td>
</tr>
<td>France</td>

<td>82.7</td>

<td>4.8</td>

<td>21.6</td>

<td>38.2</td>

<td>53.5</td>
</tr>
<td>Greece</td>

<td>82.2</td>

<td>4.7</td>

<td>24.9</td>

<td>37.8</td>

<td>54.2</td>
</tr>
<td>India</td>

<td>69.7</td>

<td>10.4</td>

<td>3.9</td>

<td>27.5</td>

<td>14.6</td>
</tr>
<td>Indonesia</td>

<td>71.7</td>

<td>6.3</td>

<td>6.9</td>

<td>24.9</td>

<td>3.3</td>
</tr>
<td>Ireland</td>

<td>82.3</td>

<td>3.2</td>

<td>25.3</td>

<td>39.1</td>

<td>128.8</td>
</tr>
<td>Israel</td>

<td>83.0</td>

<td>9.7</td>

<td>26.1</td>

<td>37.0</td>

<td>196.7</td>
</tr>
<td>Mexico</td>

<td>75.0</td>

<td>13.5</td>

<td>28.9</td>

<td>28.9</td>

<td>7.2</td>
</tr>
<td>Morocco</td>

<td>76.7</td>

<td>7.0</td>

<td>26.1</td>

<td>33.2</td>

<td>35.7</td>
</tr>
<td>Netherlands</td>

<td>82.3</td>

<td>5.4</td>

<td>20.4</td>

<td>36.5</td>

<td>56.2</td>
</tr>
<td>Russia</td>

<td>72.6</td>

<td>6.1</td>

<td>23.1</td>

<td>40.7</td>

<td>200.1</td>
</tr>
<td>Sweden</td>

<td>82.8</td>

<td>4.8</td>

<td>20.6</td>

<td>39.4</td>

<td>28.7</td>
</tr>
<td>Turkey</td>

<td>77.7</td>

<td>11.1</td>

<td>32.1</td>

<td>36.7</td>

<td>58.4</td>
</tr>
<td>U.K.</td>

<td>81.3</td>

<td>3.9</td>

<td>27.8</td>

<td>30.8</td>

<td>144.6</td>
</tr>
<td>USA</td>

<td>78.9</td>

<td>10.8</td>

<td>36.2</td>

<td>31.5</td>

<td>173.8</td>
</tr>
<td>Ukraine</td>

<td>72.1</td>

<td>6.1</td>

<td>24.1</td>

<td>49.2</td>

<td>24.4</td>
</tr>
</table>

<a class=tt id="table_countrystats3" href="#tcite_countrystats3"><div class=tcaption><span class=tnum>Table 5.</span></a> Country statistics <span class=refn>[<a class=rr id="cite_ciaobesity" href="#ref_ciaobesity">CIA</a>, <a class=rr id="cite_wbdiabetes" href="#ref_wbdiabetes">International Diabetes Federation</a>, <a class=rr id="cite_mills" href="#ref_mills">Mills</a>, <a class=rr id="cite_owidlife" href="#ref_owidlife">Our World in Data (B)</a>, <a class=rr id="cite_owidtests" href="#ref_owidtests">Our World in Data (C)</a>]</span>.</div>
</div>


<div id='table_countrystats4' class=tablediv>
<table class=ctable>
<tr class=ctr>
<td>Country</td>
<td>Diabetes factor</td>
<td>Obesity factor</td>
<td>Hypertension factor</td>
</tr>


<tr>
<td>Algeria</td>
<td>1.04</td>
<td>1.11</td>
<td>1.36</td>
</tr>

<tr>
<td>Canada</td>
<td>1.05</td>
<td>1.12</td>
<td>1.26</td>
</tr>

<tr>
<td>Costa Rica</td>
<td>1.06</td>
<td>1.10</td>
<td>1.27</td>
</tr>

<tr>
<td>Cuba</td>
<td>1.06</td>
<td>1.10</td>
<td>1.44</td>
</tr>

<tr>
<td>France</td>
<td>1.03</td>
<td>1.09</td>
<td>1.43</td>
</tr>

<tr>
<td>Greece</td>
<td>1.03</td>
<td>1.10</td>
<td>1.42</td>
</tr>

<tr>
<td>India</td>
<td>1.07</td>
<td>1.02</td>
<td>1.31</td>
</tr>

<tr>
<td>Indonesia</td>
<td>1.04</td>
<td>1.03</td>
<td>1.28</td>
</tr>

<tr>
<td>Ireland</td>
<td>1.02</td>
<td>1.10</td>
<td>1.44</td>
</tr>

<tr>
<td>Israel</td>
<td>1.06</td>
<td>1.10</td>
<td>1.41</td>
</tr>

<tr>
<td>Mexico</td>
<td>1.09</td>
<td>1.12</td>
<td>1.32</td>
</tr>

<tr>
<td>Morocco</td>
<td>1.04</td>
<td>1.10</td>
<td>1.37</td>
</tr>

<tr>
<td>Netherlands</td>
<td>1.03</td>
<td>1.08</td>
<td>1.41</td>
</tr>

<tr>
<td>Russia</td>
<td>1.04</td>
<td>1.09</td>
<td>1.46</td>
</tr>

<tr>
<td>Sweden</td>
<td>1.03</td>
<td>1.08</td>
<td>1.44</td>
</tr>

<tr>
<td>Turkey</td>
<td>1.07</td>
<td>1.13</td>
<td>1.41</td>
</tr>

<tr>
<td>U.K.</td>
<td>1.02</td>
<td>1.11</td>
<td>1.34</td>
</tr>

<tr>
<td>USA</td>
<td>1.07</td>
<td>1.14</td>
<td>1.35</td>
</tr>

<tr>
<td>Ukraine</td>
<td>1.04</td>
<td>1.10</td>
<td>1.55</td>
</tr>
</table>

<a class=tt id="table_countrystats4" href="#tcite_countrystats4"><div class=tcaption><span class=tnum>Table 6.</span></a> Health adjustment factors.</div>
</div>

</div>




















<div class=nobreak>
<div class=head1><a class=at id="appendix_diabetes" href="#acite_diabetes">Appendix 2. Diabetes</a></div>

<div id='fig_diabetes' class=mchartdiv><img class=chart2 src=plot/diabetes.svg>
<div class=fcaption><a class=ft href="#fcite_diabetes"><span class=tnum>Figure 7.</span></a> Diabetes prevalence <span class=refn>[<a class=rr id="cite_wbdiabetes" href="#ref_wbdiabetes">International Diabetes Federation</a>]</span> versus adjusted
deaths per million, r<sup>2</sup> =
0.00.</div>
</div>
</div>













<div class=nobreak>
<div class=head1><a class=at id="appendix_obesity" href="#acite_obesity">Appendix 3. Obesity</a></div>

<div id='fig_obesity' class=mchartdiv><img class=chart2 src=plot/obesity.svg>
<div class=fcaption><a class=ft href="#fcite_obesity"><span class=tnum>Figure 8.</span></a> Obesity prevalence <span class=refn>[<a class=rr id="cite_ciaobesity" href="#ref_ciaobesity">CIA</a>]</span> versus adjusted
deaths per million, r<sup>2</sup> =
0.09.</div>
</div>
</div>













<div class=nobreak>
<div class=head1><a class=at id="appendix_hypertension" href="#acite_hypertension">Appendix 4. Hypertension</a></div>

<div id='fig_hypertension' class=mchartdiv><img class=chart2 src=plot/hypertension.svg>
<div class=fcaption><a class=ft href="#fcite_hypertension"><span class=tnum>Figure 9.</span></a> Hypertension prevalence <span class=refn>[<a class=rr id="cite_mills" href="#ref_mills">Mills</a>]</span> versus adjusted
deaths per million, r<sup>2</sup> =
0.01.</div>
</div>
</div>













<div class=nobreak>
<div class=head1><a class=at id="appendix_life_expectancy" href="#acite_life_expectancy">Appendix 5. Life Expectancy</a></div>

<div id='fig_life_expectancy' class=mchartdiv><img class=chart2 src=plot/life_expectancy.svg>
<div class=fcaption><a class=ft href="#fcite_life_expectancy"><span class=tnum>Figure 10.</span></a> Life expectancy <span class=refn>[<a class=rr id="cite_owidlife" href="#ref_owidlife">Our World in Data (B)</a>]</span> versus adjusted
deaths per million, r<sup>2</sup> =
0.09.</div>
</div>
</div>













<div class=nobreak>
<div class=head1><a class=at id="appendix_urbanization" href="#acite_urbanization">Appendix 6. Urbanization</a></div>

<div id='fig_urban' class=mchartdiv><img class=chart2 src=plot/urban.svg>
<div class=fcaption><a class=ft href="#fcite_urban"><span class=tnum>Figure 11.</span></a> <span class=desktop>Urban percentage</span><span class=mobile>Urban percentage</span> <span class=refn>[<a class=rr id="cite_wburban" href="#ref_wburban">World Bank</a>]</span> versus adjusted
deaths per million, r<sup>2</sup> =
0.13.</div>
</div>
</div>













<div class=nobreak>
<div class=head1><a class=at id="appendix_gender" href="#acite_gender">Appendix 7. Gender</a></div>

<div id='fig_gender' class=mchartdiv><img class=chart2 src=plot/gender.svg>
<div class=fcaption><a class=ft href="#fcite_gender"><span class=tnum>Figure 12.</span></a> Males per 100 females <span class=refn>[<a class=rr id="cite_ungender" href="#ref_ungender">United Nations (B)</a>]</span> versus adjusted
deaths per million, r<sup>2</sup> =
0.00.</div>
</div>
</div>













<div class=nobreak>
<div class=head1><a class=at id="appendix_stringency" href="#acite_stringency">Appendix 8. Average Intervention Stringency Index</a></div>

<div id='fig_stringency_index' class=mchartdiv><img class=chart2 src=plot/stringency_index.svg>
<div class=fcaption><a class=ft href="#fcite_stringency_index"><span class=tnum>Figure 13.</span></a> Average intervention stringency index <span class=refn>[<a class=rr id="cite_owidstringency" href="#ref_owidstringency">Our World in Data (F)</a>, <a class=rr id="cite_stringency" href="#ref_stringency">University of Oxford</a>]</span> versus adjusted
deaths per million, r<sup>2</sup> =
0.12.</div>
</div>
</div>













<div class=nobreak>
<div class=head1><a class=at id="appendix_pop_density" href="#acite_pop_density">Appendix 9. Population Density</a></div>

<div id='fig_population_density' class=mchartdiv><img class=chart2 src=plot/population_density.svg>
<div class=fcaption><a class=ft href="#fcite_population_density"><span class=tnum>Figure 14.</span></a> <span class=desktop>Population density</span><span class=mobile>Pop. density</span> <span class=refn>[<a class=rr id="cite_owiddensity" href="#ref_owiddensity">Our World in Data (D)</a>]</span> versus adjusted
deaths per million, r<sup>2</sup> =
0.00.</div>
</div>
</div>













<div class=nobreak>
<div class=head1><a class=at id="appendix_testing" href="#acite_testing">Appendix 10. Test Volume</a></div>

<div id='fig_total_tests_per_thousand' class=mchartdiv><img class=chart2 src=plot/total_tests_per_thousand.svg>
<div class=fcaption><a class=ft href="#fcite_total_tests_per_thousand"><span class=tnum>Figure 15.</span></a> Tests per thousand <span class=refn>[<a class=rr id="cite_owidtests" href="#ref_owidtests">Our World in Data (C)</a>]</span> versus adjusted
deaths per million, r<sup>2</sup> =
0.04.</div>
</div>
</div>








<div class=nobreak>
<div class=head1><a class=at id="appendix_masks" href="#acite_masks">Appendix 11. Early Mask Adoption</a></div>

<div class=section>
<div id='table_masks' class=tablediv>
<table class=ctable2>
<tr class=ctr2>
<td class=ct2c>Country</td>
<td class=ct2d>Days adopted within</td>
<td>Comments</td>
</tr>

<tr>
<td>Antigua and Barbuda</td>
<td>28</td>
<td style='text-align:left;'>Masks were required in all public spaces on April 5. </td>
</tr>
<tr>
<td>Benin</td>
<td>26</td>
<td style='text-align:left;'>Masks were recommended in public on April 6, mandated on April 7, and enforced by police beginning April 8. </td>
</tr>
<tr>
<td>Bhutan</td>
<td>10</td>
<td style='text-align:left;'>On Mar. 11, the Ministry of Health advised wearing of masks in
     “a crowded place”. </td>
</tr>
<tr>
<td>Bosnia and Herzegovina</td>
<td>29</td>
<td style='text-align:left;'>Masks were required in public by March 29. </td>
</tr>
<tr>
<td>Cambodia</td>
<td>6</td>
<td style='text-align:left;'>Masks were widely used by the public by January 28. </td>
</tr>
<tr>
<td>Czechia</td>
<td>23</td>
<td style='text-align:left;'>Masks were required in public on March 19. </td>
</tr>
<tr>
<td>Côte d'Ivoire</td>
<td>29</td>
<td style='text-align:left;'>On April 4, senior health officials recommended masks when in public. </td>
</tr>
<tr>
<td>El Salvador</td>
<td>31</td>
<td style='text-align:left;'>The first death was reported March 31. Masks were mandated in public
    on April 8. </td>
</tr>
<tr>
<td>Grenada</td>
<td>18</td>
<td style='text-align:left;'>On April 3, the Ministry of Health recommended all wear a mask, which
    could be purchased at a pharmacy, to “prevent asymptomatic people from transmitting
    the disease unknowingly”. Masks were mandated outside the home on April 6. </td>
</tr>
<tr>
<td>Hong Kong</td>
<td>6</td>
<td style='text-align:left;'>Surgical masks were traditionally used, and also were recommended on public
    transport and in crowded places, on January 24, 2020. Surveys indicated that masks
    were worn by about 73% in the week of Jan. 21, and by 98% of the public by mid-February,
    which persisted into May. In February 2020, 94.8% of pedestrians were observed to wear
    masks, and 94.1% believed mass masking reduces the chance of community outbreak. A poll consistently found that 85% or more wore masks in public between Feb. 25 and
    Apr. 21, 2020. </td>
</tr>
<tr>
<td>Japan</td>
<td>5</td>
<td style='text-align:left;'>Public use of masks is traditional. Surveys indicate that 64% of adults
    habitually wore a mask in Winter. Public masking was manifest by Jan. 16 when the first
    domestic case was announced. The government initially recommended masks when in
    “confined, badly ventilated spaces”. One survey documented mask wear prevalence over
    60% by March 14, increasing to over 75% by April 12 In another poll, 62% indicated
    wearing a mask in public by March 17, and 76% by April 13, 2020 </td>
</tr>
<tr>
<td>Kenya</td>
<td>30</td>
<td style='text-align:left;'>The March 12 case had arrived from the U.S. on March 5. The first
    death was on March 26, of a man who arrived in Kenya on March 13. Masks were mandated
    in Kenya on public transport on April 2, and more broadly in public on April 4. A survey in Nairobi published on May 5, 2020 found that 89% had worn a face mask in the
    previous week, and 73% said they always did so outside the home. </td>
</tr>
<tr>
<td>Laos</td>
<td>0</td>
<td style='text-align:left;'>Health officials in Laos advised mask-wearing by March 6 and the
    public began wearing masks even before any cases were reported in the country </td>
</tr>
<tr>
<td>Macau</td>
<td>6</td>
<td style='text-align:left;'>Mask use is traditional. By Jan. 23, the government had implemented a mask
    distribution program for the public. </td>
</tr>
<tr>
<td>Malawi</td>
<td>20</td>
<td style='text-align:left;'>The first death was on April 7. The public was required to wear masks
    on April 4. A survey in Karonga from April 25 to May 23 found that 22% of
    urban residents and 5% of rural residents wore a mask. </td>
</tr>
<tr>
<td>Malaysia</td>
<td>10</td>
<td style='text-align:left;'>Masks were used by the public by January 30. A poll reported 55%
    wore a mask in public on Feb. 24, 69% on Mar. 23, and 82% on Apr 6. </td>
</tr>
<tr>
<td>Mongolia</td>
<td>0</td>
<td style='text-align:left;'>Mongolians began wearing masks in January. </td>
</tr>
</table>
</div>
<table class=ctable2>
<tr class=ctr2>
<td class=ct2c>Country</td>
<td class=ct2d>Days adopted within</td>
<td>Comments</td>
</tr>
<tr>
<td>Mozambique</td>
<td>18</td>
<td style='text-align:left;'> Masks were recommended by health authorities on April 4, and
    were required on public transport or in gatherings on April 8. </td>
</tr>
<tr>
<td>Philippines</td>
<td>5</td>
<td style='text-align:left;'>Masks were used extensively as early as Jan. 30. In a poll,
    60% indicated wearing a mask in public on Feb. 24, and 82% by March 30. Masks were
    mandated on April 2.</td>
</tr>
<tr>
<td>Sierra Leone</td>
<td>6</td>
<td style='text-align:left;'>Masks were recommended in public on April 1. Compliance has
    been incomplete. </td>
</tr>
<tr>
<td>Slovakia</td>
<td>13</td>
<td style='text-align:left;'>Masks were mandated in shops and transit on March 15, and
     more broadly in public on March 25. </td>
</tr>
<tr>
<td>South Korea</td>
<td>15</td>
<td style='text-align:left;'>Use of masks is traditional. The alert level was raised from yellow
     to orange on Jan. 27. Children were advised to wear masks at school by January 30. By Feb. 2, mask sales increased 373 times year-over-year. Stores were selling
     out of masks by February 3. A superspreader event in mid-February was associated
     with a religious group which did not use masks at their gatherings. South Korea
     initially had trouble obtaining enough masks, but at the end of February the government
     began to control the distribution of masks to the public. On Feb. 22, the government
     instructed the wearing of masks in the epidemic area. </td>
</tr>
<tr>
<td>Sudan</td>
<td>27</td>
<td style='text-align:left;'>The first death occurred on March 12. Masks were dispensed by pharmacists
    for free in Sudan by March 16. A survey from March 25 to April 4 of 2336
    adults found that 703 (30.1%) had been to a crowded area, and 1153 (49.4%) had
    worn a mask outside the home in the previous few days. </td>
</tr>
<tr>
<td>Taiwan</td>
<td>11</td>
<td style='text-align:left;'>Use of masks is traditional. By January 24, Taiwan banned the export
     of surgical masks. By January 27, the government had to limit mask exports and
     limit sales from pharmacies to those needed for personal use. On January 28, the
     government began releasing 6 million masks daily, with each resident able to purchase
     3 masks weekly at a set price. A poll consistently found over 80% wore a mask
     from Feb. 25 to Apr 21, 2020. </td>
</tr>
<tr>
<td>Thailand</td>
<td>20</td>
<td style='text-align:left;'>Masks, including N95 masks, were already worn outdoors in early January
    to combat smog. The Thai government was handing out masks and advising wearing of masks
    in public to prevent coronavirus by January 28, 2020. The recommendation of
    cloth masks for the public was reaffirmed by the Ministry of Public Health on
    March 3, 2020. Enforcement of a mask mandate on public transport began on
    March 26.102  One survey reported high mask-wearing: 73% by Feb. 24, 80% by March
    23, and 89% by March 30. During March 2020, another survey found masks were worn
    “all the time” by 14% of COVID19 cases and 24% of controls, and “some of the time” by
    38% of cases and 15% of controls. </td>
</tr>
<tr>
<td>Uzbekistan</td>
<td>19</td>
<td style='text-align:left;'>The first coronavirus death was on March 29. Masks were mandated on
     March 25. </td>
</tr>
<tr>
<td>Venezuela</td>
<td>5</td>
<td style='text-align:left;'>President Maduro demonstrated wearing of masks on live television on March 13
    (the day the first case was confirmed), and required masks on public transport. Masks were required in any public space by March 20. </td>
</tr>
<tr>
<td>Vietnam</td>
<td>9</td>
<td style='text-align:left;'>Masks were widely used by the public by January 27 and were mandated
    by the government on March 16. One survey found the prevalence of mask wear consistently
    from 85-90% from March 12 to April 14. A poll reported 59% wore a mask on March 23,
    and over 80% from March 30 to Apr. 20. From March 31 to April 6, 2020, 99.5% of
    respondents reported using a mask when outside. </td>
</tr>
<tr>
<td>Zambia</td>
<td>24</td>
<td style='text-align:left;'>The first death was recorded on April 2. On April 4, masks were
    recommended for the public “at all times” by the Zambian Minister of Health. This spurred the manufacture of cloth masks. On April 16, masks were mandated
    for the public. </td>
</tr>
</table>

<a class=tt id="table_masks" href="#tcite_masks"><div class=tcaption><span class=tnum>Table 7.</span></a> Countries that adopted masks early, and the number of days
from the estimated start of their outbreak, from <span class=refn>[<a class=rr id="cite_leffler" href="#ref_leffler">Leffler</a>]</span>.</div>
</div>
</div>





















<div class=head1><a class=at id="appendix_countryhcq" href="#acite_countryhcq">Appendix 12. Country HCQ Status</a></div>

<div class=section>



<div class=refsum>
<div class=refcountry><a class=ct id="andorra" href="#cite_andorra">Andorra</a>, <a class=ct id="anguilla" href="#cite_anguilla">Anguilla</a>, <a class=ct id="antigua_and_barbuda" href="#cite_antigua_and_barbuda">Antigua and Barbuda</a>, <a class=ct id="aruba" href="#cite_aruba">Aruba</a>, <a class=ct id="bahamas" href="#cite_bahamas">Bahamas</a>, <a class=ct id="barbados" href="#cite_barbados">Barbados</a>, <a class=ct id="belize" href="#cite_belize">Belize</a>, <a class=ct id="bermuda" href="#cite_bermuda">Bermuda</a>, <a class=ct id="british_virgin_islands" href="#cite_british_virgin_islands">British Virgin Islands</a>, <a class=ct id="cayman_islands" href="#cite_cayman_islands">Cayman Islands</a>, <a class=ct id="dominica" href="#cite_dominica">Dominica</a>, <a class=ct id="french_polynesia" href="#cite_french_polynesia">French Polynesia</a>, <a class=ct id="gibraltar" href="#cite_gibraltar">Gibraltar</a>, <a class=ct id="greenland" href="#cite_greenland">Greenland</a>, <a class=ct id="grenada" href="#cite_grenada">Grenada</a>, <a class=ct id="guam" href="#cite_guam">Guam</a>, <a class=ct id="iceland" href="#cite_iceland">Iceland</a>, <a class=ct id="isle_of_man" href="#cite_isle_of_man">Isle of Man</a>, <a class=ct id="liechtenstein" href="#cite_liechtenstein">Liechtenstein</a>, <a class=ct id="malta" href="#cite_malta">Malta</a>, <a class=ct id="monaco" href="#cite_monaco">Monaco</a>, <a class=ct id="montserrat" href="#cite_montserrat">Montserrat</a>, <a class=ct id="new_caledonia" href="#cite_new_caledonia">New Caledonia</a>, <a class=ct id="northern_mariana_islands" href="#cite_northern_mariana_islands">Northern Mariana Islands</a>, <a class=ct id="saint_kitts_and_nevis" href="#cite_saint_kitts_and_nevis">Saint Kitts and Nevis</a>, <a class=ct id="saint_lucia" href="#cite_saint_lucia">Saint Lucia</a>, <a class=ct id="saint_vincent_and_the_grenadines" href="#cite_saint_vincent_and_the_grenadines">Saint Vincent and the Grenadines</a>, <a class=ct id="san_marino" href="#cite_san_marino">San Marino</a>, <a class=ct id="sao_tome_and_principe" href="#cite_sao_tome_and_principe">Sao Tome and Principe</a>, <a class=ct id="seychelles" href="#cite_seychelles">Seychelles</a>, <a class=ct id="sint_maarten_(dutch_part)" href="#cite_sint_maarten_(dutch_part)">Sint Maarten (Dutch part)</a>, <a class=ct id="turks_and_caicos_islands" href="#cite_turks_and_caicos_islands">Turks and Caicos Islands</a>, <a class=ct id="united_states_virgin_islands" href="#cite_united_states_virgin_islands">United States Virgin Islands</a></div>
<div class=refcountryc>
These countries were excluded because their population is <1M.
</div>
</div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="afghanistan" href="#cite_afghanistan">Afghanistan</a>, <a class=ct id="angola" href="#cite_angola">Angola</a>, <a class=ct id="bahrain" href="#cite_bahrain">Bahrain</a>, <a class=ct id="benin" href="#cite_benin">Benin</a>, <a class=ct id="burkina_faso" href="#cite_burkina_faso">Burkina Faso</a>, <a class=ct id="burundi" href="#cite_burundi">Burundi</a>, <a class=ct id="cameroon" href="#cite_cameroon">Cameroon</a>, <a class=ct id="central_african_republic" href="#cite_central_african_republic">Central African Republic</a>, <a class=ct id="chad" href="#cite_chad">Chad</a>, <a class=ct id="comoros" href="#cite_comoros">Comoros</a>, <a class=ct id="congo" href="#cite_congo">Congo</a>, <a class=ct id="equatorial_guinea" href="#cite_equatorial_guinea">Equatorial Guinea</a>, <a class=ct id="ethiopia" href="#cite_ethiopia">Ethiopia</a>, <a class=ct id="gabon" href="#cite_gabon">Gabon</a>, <a class=ct id="gambia" href="#cite_gambia">Gambia</a>, <a class=ct id="ghana" href="#cite_ghana">Ghana</a>, <a class=ct id="guinea" href="#cite_guinea">Guinea</a>, <a class=ct id="guinea-bissau" href="#cite_guinea-bissau">Guinea-Bissau</a>, <a class=ct id="iraq" href="#cite_iraq">Iraq</a>, <a class=ct id="kenya" href="#cite_kenya">Kenya</a>, <a class=ct id="kuwait" href="#cite_kuwait">Kuwait</a>, <a class=ct id="liberia" href="#cite_liberia">Liberia</a>, <a class=ct id="madagascar" href="#cite_madagascar">Madagascar</a>, <a class=ct id="malawi" href="#cite_malawi">Malawi</a>, <a class=ct id="mali" href="#cite_mali">Mali</a>, <a class=ct id="mauritania" href="#cite_mauritania">Mauritania</a>, <a class=ct id="mozambique" href="#cite_mozambique">Mozambique</a>, <a class=ct id="niger" href="#cite_niger">Niger</a>, <a class=ct id="nigeria" href="#cite_nigeria">Nigeria</a>, <a class=ct id="oman" href="#cite_oman">Oman</a>, <a class=ct id="palestine" href="#cite_palestine">Palestine</a>, <a class=ct id="papua_new_guinea" href="#cite_papua_new_guinea">Papua New Guinea</a>, <a class=ct id="qatar" href="#cite_qatar">Qatar</a>, <a class=ct id="republic_of_congo" href="#cite_republic_of_congo">Republic of Congo</a>, <a class=ct id="rwanda" href="#cite_rwanda">Rwanda</a>, <a class=ct id="sao_tome_and_principe" href="#cite_sao_tome_and_principe">Sao Tome and Principe</a>, <a class=ct id="saudi_arabia" href="#cite_saudi_arabia">Saudi Arabia</a>, <a class=ct id="senegal" href="#cite_senegal">Senegal</a>, <a class=ct id="sierra_leone" href="#cite_sierra_leone">Sierra Leone</a>, <a class=ct id="somalia" href="#cite_somalia">Somalia</a>, <a class=ct id="south_sudan" href="#cite_south_sudan">South Sudan</a>, <a class=ct id="state_of_palestine" href="#cite_state_of_palestine">State of Palestine</a>, <a class=ct id="sudan" href="#cite_sudan">Sudan</a>, <a class=ct id="tajikistan" href="#cite_tajikistan">Tajikistan</a>, <a class=ct id="togo" href="#cite_togo">Togo</a>, <a class=ct id="uganda" href="#cite_uganda">Uganda</a>, <a class=ct id="united_arab_emirates" href="#cite_united_arab_emirates">United Arab Emirates</a>, <a class=ct id="western_sahara" href="#cite_western_sahara">Western Sahara</a>, <a class=ct id="yemen" href="#cite_yemen">Yemen</a>, <a class=ct id="zambia" href="#cite_zambia">Zambia</a>, <a class=ct id="zimbabwe" href="#cite_zimbabwe">Zimbabwe</a></div>
<div class=refcountryc>
These countries were excluded because <0.5% of the population is >80.
</div>
</div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="mongolia" href="#cite_mongolia">Mongolia</a>, <a class=ct id="laos" href="#cite_laos">Laos</a>, <a class=ct id="japan" href="#cite_japan">Japan</a>, <a class=ct id="venezuela" href="#cite_venezuela">Venezuela</a>, <a class=ct id="philippines" href="#cite_philippines">Philippines</a>, <a class=ct id="macau" href="#cite_macau">Macau</a>, <a class=ct id="hong_kong" href="#cite_hong_kong">Hong Kong</a>, <a class=ct id="sierra_leone" href="#cite_sierra_leone">Sierra Leone</a>, <a class=ct id="cambodia" href="#cite_cambodia">Cambodia</a>, <a class=ct id="vietnam" href="#cite_vietnam">Vietnam</a>, <a class=ct id="malaysia" href="#cite_malaysia">Malaysia</a>, <a class=ct id="bhutan" href="#cite_bhutan">Bhutan</a>, <a class=ct id="taiwan" href="#cite_taiwan">Taiwan</a>, <a class=ct id="slovakia" href="#cite_slovakia">Slovakia</a>, <a class=ct id="south_korea" href="#cite_south_korea">South Korea</a>, <a class=ct id="grenada" href="#cite_grenada">Grenada</a>, <a class=ct id="mozambique" href="#cite_mozambique">Mozambique</a>, <a class=ct id="uzbekistan" href="#cite_uzbekistan">Uzbekistan</a>, <a class=ct id="thailand" href="#cite_thailand">Thailand</a>, <a class=ct id="malawi" href="#cite_malawi">Malawi</a>, <a class=ct id="czechia" href="#cite_czechia">Czechia</a>, <a class=ct id="zambia" href="#cite_zambia">Zambia</a>, <a class=ct id="benin" href="#cite_benin">Benin</a>, <a class=ct id="sudan" href="#cite_sudan">Sudan</a>, <a class=ct id="antigua_and_barbuda" href="#cite_antigua_and_barbuda">Antigua and Barbuda</a>, <a class=ct id="bosnia_and_herzegovina" href="#cite_bosnia_and_herzegovina">Bosnia and Herzegovina</a>, <a class=ct id="côte_d'ivoire" href="#cite_côte_d'ivoire">Côte d'Ivoire</a>, <a class=ct id="kenya" href="#cite_kenya">Kenya</a>, <a class=ct id="el_salvador" href="#cite_el_salvador">El Salvador</a></div>
<div class=refcountryc>
These countries were excluded because they quickly adopted widespread mask use.
</div>
</div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="australia" href="#cite_australia">Australia</a>, <a class=ct id="new_zealand" href="#cite_new_zealand">New Zealand</a>, <a class=ct id="north_korea" href="#cite_north_korea">North Korea</a>, <a class=ct id="turkmenistan" href="#cite_turkmenistan">Turkmenistan</a>, <a class=ct id="solomon_islands" href="#cite_solomon_islands">Solomon Islands</a>, <a class=ct id="vanuata" href="#cite_vanuata">Vanuata</a>, <a class=ct id="samoa" href="#cite_samoa">Samoa</a>, <a class=ct id="kiribati" href="#cite_kiribati">Kiribati</a>, <a class=ct id="federated_states_of_micronesia" href="#cite_federated_states_of_micronesia">Federated States of Micronesia</a>, <a class=ct id="tonga" href="#cite_tonga">Tonga</a>, <a class=ct id="marshall_islands" href="#cite_marshall_islands">Marshall Islands</a>, <a class=ct id="palua" href="#cite_palua">Palua</a>, <a class=ct id="tuvalu" href="#cite_tuvalu">Tuvalu</a>, <a class=ct id="nauru" href="#cite_nauru">Nauru</a></div>
<div class=refcountryc>
These countries were excluded because they have no or very little spread to date. They may be included in the future if they experience significant spread.
</div>
</div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="algeria" href="#cite_algeria">Algeria</a><span class='refstatus refyes'> - widespread early treatment for high-risk patients for most of the outbreak</span></div>
<div class=refcountryc>
Adopted HCQ in early April and continued to use after WHO warning.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>The Africa Report</span>,
  <span class=refurl><a href="https://www.theafricareport.com/26264/coronavirus-didier-raoult-the-african-and-chloroquine-from-dakar-to-brazzaville/">https://www.theafricareport.c..ne-from-dakar-to-brazzaville/</a></span>,
  <span class=reftitle>Coronavirus: Didier Raoult the African and chloroquine, from Dakar to Brazzaville</span>, <span class=refdate>4/15</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Afrik.com</span>,
  <span class=refurl><a href="https://www.afrik.com/edouard-philippe-emporte-par-le-covid-didier-raoult-l-hydroxychloroquine-et-le-remdesivir">https://www.afrik.com/edouard..ychloroquine-et-le-remdesivir</a></span>,
  <span class=reftitle>Edouard Philippe emporté par le Covid, Didier Raoult, l’hydroxychloroquine et le… remdésivir</span>, <span class=refcomment>Follows the Raoult protocol</span>, <span class=refdate>7/6</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Gummi Bear</span>,
  <span class=refurl><a href="https://twitter.com/gummibear737/status/1256676533638479872">https://twitter.com/gummibear737/status/1256676533638479872</a></span>,
  <span class=reftitle>Adopted early April</span>, <span class=refdate>5/2</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Barron's</span>,
  <span class=refurl><a href="https://www.barrons.com/news/hydroxychloroquine-a-drug-dividing-the-world-01591006809">https://www.barrons.com/news/..ividing-the-world-01591006809</a></span>,
  <span class=reftitle>Hydroxychloroquine: A Drug Dividing The World</span>, <span class=refcomment>continue to promote</span>, <span class=refdate>6/1</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Covid19Crusher</span>,
  <span class=refurl><a href="https://twitter.com/Covid19Crusher/status/1258469706442444804">https://twitter.com/Covid19Cr..er/status/1258469706442444804</a></span>,
  <span class=reftitle>Algeria's Health Minister praises HCQ used since the end of March</span>, <span class=refdate>5/7</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Franceinfo</span>,
  <span class=refurl><a href="https://www.francetvinfo.fr/monde/afrique/senegal/ces-pays-africains-qui-ont-decide-de-continuer-a-soigner-le-covid-19-avec-l-hydroxychloroquine_3983239.html">https://www.francetvinfo.fr/m..droxychloroquine_3983239.html</a></span>,
  <span class=reftitle>Ces pays africains qui ont décidé de continuer à soigner le Covid-19 avec l'hydroxychloroquine</span>, <span class=refcomment>continue to use after WHO warning, positive results</span>, <span class=refdate>5/28</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="belarus" href="#cite_belarus">Belarus</a><span class='refstatus refmixed'> - mixed use of early treatment with HCQ</span></div>
<div class=refcountryc>
There was early HCQ use but it was suspended outside of hospitals on WHO recommendation 6/2.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Jared Young</span>,
  <span class=refurl><a href="https://twitter.com/jtyoung18/status/1258279092010586113">https://twitter.com/jtyoung18/status/1258279092010586113</a></span>,
  <span class=reftitle>In inpatient and outpatient protocols</span>, <span class=refdate>5/6</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>BelTA</span>,
  <span class=refurl><a href="https://eng.belta.by/society/view/belarus-to-receive-potential-effective-drug-for-covid-19-treatment-130102-2020/">https://eng.belta.by/society/..vid-19-treatment-130102-2020/</a></span>,
  <span class=reftitle>Belarus to receive potential effective drug for COVID-19 treatment</span>, <span class=refdate>4/29</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>BelTA</span>,
  <span class=refurl><a href="https://eng.belta.by/society/view/belarus-suspends-use-of-chloroquine-for-covid-19-outside-of-hospitals-130777-2020/">https://eng.belta.by/society/..ide-of-hospitals-130777-2020/</a></span>,
  <span class=reftitle>Belarus suspends use of chloroquine for COVID-19 outside of hospitals</span>, <span class=refdate>6/2</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="brazil" href="#cite_brazil">Brazil</a><span class='refstatus reflate'> - early HCQ treatment was adopted relatively late</span></div>
<div class=refcountryc>
Late and very mixed use, increasing over time.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Filipe Rafaeli</span>,
  <span class=refurl><a href="https://medium.com/@filiperafaeli/hydroxychloroquine-the-narrative-that-doesnt-work-is-the-biggest-hoax-in-recent-human-history-2685487ad717">https://medium.com/@filiperaf..nt-human-history-2685487ad717</a></span>,
  <span class=reftitle>Hydroxychloroquine: the narrative that it doesn’t work is the biggest hoax in recent human history</span>, <span class=refcomment>almost unanimity of Brazilian scientists are against the application of these drugs and repeat that “there is no scientific evidence” of the functioning</span>, <span class=refdate>7/23</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Covid19Crusher</span>,
  <span class=refurl><a href="https://twitter.com/Covid19Crusher/status/1273878906785972224">https://twitter.com/Covid19Cr..er/status/1273878906785972224</a></span>,
  <span class=reftitle>Clinical outcomes improve after adoption of HCQ starts</span>, <span class=refdate>6/19</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>CNN</span>,
  <span class=refurl><a href="https://www.cnnbrasil.com.br/saude/2020/05/20/governo-muda-protocolo-e-autoriza-hidroxicloroquina-para-casos-leves-de-covid-19">https://www.cnnbrasil.com.br/..-para-casos-leves-de-covid-19</a></span>,
  <span class=reftitle>Government changes protocol and authorizes hydroxychloroquine for mild cases of Covid-19</span>, <span class=refdate>5/20</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>The Verge</span>,
  <span class=refurl><a href="https://www.theverge.com/2020/3/30/21199845/twitter-tweets-brazil-venezuela-presidents-covid-19-coronavirus-jair-bolsonaro-maduro">https://www.theverge.com/2020..navirus-jair-bolsonaro-maduro</a></span>,
  <span class=reftitle>Twitter removes tweets by Brazil, Venezuela presidents for violating COVID-19 content rules</span>, <span class=refdate>3/30</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Covid19Crusher</span>,
  <span class=refurl><a href="https://twitter.com/Covid19Crusher/status/1279445536685383680">https://twitter.com/Covid19Cr..er/status/1279445536685383680</a></span>,
  <span class=reftitle>One by one municipalities are adopting HCQ</span>, <span class=refdate>7/4</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Diário de Uberlândia</span>,
  <span class=refurl><a href="https://diariodeuberlandia.com.br/noticia/25753/farmaceuticos-nao-podem-negar-venda-de-cloroquina-receitada-a-pacientes-com-covid-19">https://diariodeuberlandia.co..tada-a-pacientes-com-covid-19</a></span>,
  <span class=reftitle>Farmacêuticos não podem negar venda de cloroquina receitada a pacientes com Covid-19</span>, <span class=refcomment>high degree of controversy in Brazil</span>, <span class=refdate>7/3</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="canada" href="#cite_canada">Canada</a><span class='refstatus refno'> - limited early treatment with HCQ</span></div>
<div class=refcountryc>
Physicians not allowed to use. New Brunswick used briefly until stopped by Health Canada.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Maclean’s</span>,
  <span class=refurl><a href="https://www.macleans.ca/society/health/the-incalculable-rise-of-hydroxychloroquine/">https://www.macleans.ca/socie..e-rise-of-hydroxychloroquine/</a></span>,
  <span class=reftitle>The incalculable rise of hydroxychloroquine</span>, <span class=refcomment>Health Canada has not permitted physicians to administer HCQ for COVID</span>, <span class=refdate>5/21</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Acadie Nouvelle</span>,
  <span class=refurl><a href="https://www.acadienouvelle.com/actualites/2020/04/01/exclusif-un-traitement-experimental-contre-la-covid-19-deploye-au-n-b/">https://www.acadienouvelle.co..e-la-covid-19-deploye-au-n-b/</a></span>,
  <span class=reftitle>EXCLUSIF: un traitement expérimental contre la COVID-19 déployé au N.-B.</span>, <span class=refcomment>New Brunswick adopts HCQ</span>, <span class=refdate>4/2</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Acadie Nouvelle</span>,
  <span class=refurl><a href="https://www.acadienouvelle.com/actualites/2020/05/09/le-nouveau-brunswick-fait-marche-arriere-sur-le-traitement-experimental-de-la-covid-19/">https://www.acadienouvelle.co..-experimental-de-la-covid-19/</a></span>,
  <span class=reftitle>Le Nouveau-Brunswick fait marche arrière sur le traitement expérimental de la COVID-19</span>, <span class=refcomment>Health Canada ended New Brunswick's use of HCQ on 4/17</span>, <span class=refdate>5/10</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Covid19Crusher</span>,
  <span class=refurl><a href="https://twitter.com/Covid19Crusher/status/1256869896014704640">https://twitter.com/Covid19Cr..er/status/1256869896014704640</a></span>,
  <span class=reftitle>New Brunswick broke ranks with Canada adopting HCQ</span>, <span class=refdate>5/3</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>ChloroquineGorilla</span>,
  <span class=refurl><a href="https://twitter.com/ProlongingCovid/status/1277927519203635205">https://twitter.com/Prolongin..id/status/1277927519203635205</a></span>,
  <span class=reftitle>Quebec has some of the harshest anti-HCQ rules in the world</span>, <span class=refdate>6/30</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="chile" href="#cite_chile">Chile</a><span class='refstatus refmixed'> - mixed use of early treatment with HCQ</span></div>
<div class=refcountryc>
Stopped use after WHO/Lancet reports around May 26.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Cristian Navarro Merino</span>,
  <span class=refurl><a href="https://twitter.com/cnnavarro1/status/1272207814749020160">https://twitter.com/cnnavarro1/status/1272207814749020160</a></span>,
  <span class=reftitle>Stopping because of WHO/Lancet</span>, <span class=refdate>6/14</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Covid19Crusher</span>,
  <span class=refurl><a href="https://twitter.com/Covid19Crusher/status/1265400801507315712">https://twitter.com/Covid19Cr..er/status/1265400801507315712</a></span>,
  <span class=reftitle>Chile stops HCQ</span>, <span class=refdate>5/26</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Barron's</span>,
  <span class=refurl><a href="https://www.barrons.com/news/hydroxychloroquine-a-drug-dividing-the-world-01591006809">https://www.barrons.com/news/..ividing-the-world-01591006809</a></span>,
  <span class=reftitle>Hydroxychloroquine: A Drug Dividing The World</span>, <span class=refcomment>banned</span>, <span class=refdate>6/1</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Veronica Riveros</span>,
  <span class=refurl><a href="https://twitter.com/veronicariveroc/status/1270558291714867200">https://twitter.com/veronicar..oc/status/1270558291714867200</a></span>,
  <span class=reftitle>People fear HCQ</span>, <span class=refdate>6/9</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="costa_rica" href="#cite_costa_rica">Costa Rica</a><span class='refstatus refyes'> - widespread early treatment for high-risk patients for most of the outbreak</span></div>
<div class=refcountryc>
Used early based on recommendation from China 3/18.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>The Tico Times</span>,
  <span class=refurl><a href="https://ticotimes.net/2020/06/15/news-briefs-reopening-plans-on-track-hydroxychloroquine-use-to-continue-partnership-with-coursera">https://ticotimes.net/2020/06..nue-partnership-with-coursera</a></span>,
  <span class=reftitle>News briefs: Reopening plans on-track, hydroxychloroquine use to continue, partnership with Coursera</span>, <span class=refcomment>HCQ use continuing after FDA revoked EUA</span>, <span class=refdate>6/15</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Q Costa Rica</span>,
  <span class=refurl><a href="https://qcostarica.com/hydroxychloroquine-the-drug-costa-rica-uses-successfully-to-fight-covid-19/">https://qcostarica.com/hydrox..ccessfully-to-fight-covid-19/</a></span>,
  <span class=reftitle>Hydroxychloroquine: The Drug Costa Rica Uses Successfully To Fight Covid-19</span>, <span class=refdate>4/19</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Hydroxychloroquine News</span>,
  <span class=refurl><a href="https://twitter.com/niro60487270/status/1256675338853072896">https://twitter.com/niro60487270/status/1256675338853072896</a></span>,
  <span class=reftitle>Used early</span>, <span class=refdate>5/2</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Covid19Crusher</span>,
  <span class=refurl><a href="https://twitter.com/Covid19Crusher/status/1264837406802444288">https://twitter.com/Covid19Cr..er/status/1264837406802444288</a></span>,
  <span class=reftitle>First and only Central American country to immediately adopt</span>, <span class=refdate>5/25</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Rich Drake</span>,
  <span class=refurl><a href="https://twitter.com/drakerich/status/1284219391140343809">https://twitter.com/drakerich/status/1284219391140343809</a></span>,
  <span class=reftitle>Available OTC</span>, <span class=refdate>7/17</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>J David</span>,
  <span class=refurl><a href="https://twitter.com/badlandj/status/1267509994368503814">https://twitter.com/badlandj/status/1267509994368503814</a></span>,
  <span class=reftitle>Costa Rica refuses WHO recommendation to stop using HCQ</span>, <span class=refdate>6/1</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="cuba" href="#cite_cuba">Cuba</a><span class='refstatus refyes'> - widespread early treatment for high-risk patients for most of the outbreak</span></div>
<div class=refcountryc>
Using to treat at an early stage.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Pleno.News</span>,
  <span class=refurl><a href="https://pleno.news/saude/coronavirus/cuba-se-destaca-no-combate-a-covid-com-hidroxicloroquina.html">https://pleno.news/saude/coro..id-com-hidroxicloroquina.html</a></span>,
  <span class=reftitle>Cuba stands out in combating Covid with hydroxychloroquine</span>, <span class=refcomment>using low doses of HCQ to treat Covid-19 at an early stage</span>, <span class=refdate>7/12</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Anadolu Agency</span>,
  <span class=refurl><a href="https://www.aa.com.tr/en/americas/cuba-early-hydroxychloroquine-potent-against-covid-19/1905650">https://www.aa.com.tr/en/amer..tent-against-covid-19/1905650</a></span>,
  <span class=reftitle>Cuba: Early hydroxychloroquine potent against COVID-19</span>, <span class=refcomment>"We are aware of the polemics around this product. Physicians here mostly have a good opinion of the results it has achieved, provided that it is used at an early stage in low doses and only with patients without comorbidities, which could be complicated by hydroxychloroquine"</span>, <span class=refdate>7/10</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="czech_republic" href="#cite_czech_republic">Czech Republic</a><span class='refstatus refyes'> - widespread early treatment for high-risk patients for most of the outbreak</span></div>
<div class=refcountryc>
Supported use since early March.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Expats.cz</span>,
  <span class=refurl><a href="https://news.expats.cz/weekly-czech-news/czech-health-ministry-permits-temporary-use-of-hydroxychloroquine-in-hospitals-to-treat-covid-19/">https://news.expats.cz/weekly..-hospitals-to-treat-covid-19/</a></span>,
  <span class=reftitle>Czech Health Ministry permits temporary use of hydroxychloroquine to treat COVID-19</span>, <span class=refcomment>temporary permit for 8 months</span>, <span class=refdate>4/7</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Rozhodnutí Ministerstva zdravotnictví</span>,
  <span class=refurl><a href="https://www.mzcr.cz/rozhodnuti-o-docasnem-povoleni-neregistrovaneho-humanniho-leciveho-pripravku-hydroxychloroquine-sulfate-tablets/">https://www.mzcr.cz/rozhodnut..ychloroquine-sulfate-tablets/</a></span>,
  <span class=reftitle>Rozhodnutí o dočasném povolení neregistrovaného humánního léčivého přípravku HYDROXYCHLOROQUINE SULFATE TABLETS</span>, <span class=refcomment>authorization of HCQ</span>, <span class=refdate>4/30</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Hydroxychloroquine News</span>,
  <span class=refurl><a href="https://twitter.com/niro60487270/status/1257696987576557568">https://twitter.com/niro60487270/status/1257696987576557568</a></span>,
  <span class=reftitle>Support for HCQ in early March</span>, <span class=refdate>5/4</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="france" href="#cite_france">France</a><span class='refstatus refno'> - limited early treatment with HCQ</span></div>
<div class=refcountryc>
Banned post WHO/Lancet. Used late stage in hospitals. Limited early treatment, some exceptions, especially in Marseille. Media very negative.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Reuters</span>,
  <span class=refurl><a href="https://www.reuters.com/article/health-coronavirus-hydroxychloroquine-fr/eu-governments-ban-malaria-drug-for-covid-19-trial-paused-as-safety-fears-grow-idUSKBN2340A6">https://www.reuters.com/artic..fety-fears-grow-idUSKBN2340A6</a></span>,
  <span class=reftitle>EU governments ban malaria drug for COVID-19, trial paused as safety fears grow</span>, <span class=refcomment>banned May 27, previously generally only in hospitals</span>, <span class=refdate>5/27</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Afrik.com</span>,
  <span class=refurl><a href="https://www.afrik.com/edouard-philippe-emporte-par-le-covid-didier-raoult-l-hydroxychloroquine-et-le-remdesivir">https://www.afrik.com/edouard..ychloroquine-et-le-remdesivir</a></span>,
  <span class=reftitle>Edouard Philippe emporté par le Covid, Didier Raoult, l’hydroxychloroquine et le… remdésivir</span>, <span class=refcomment>HCQ prohibited outside hospitals</span>, <span class=refdate>7/6</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>CBS News</span>,
  <span class=refurl><a href="https://www.cbsnews.com/news/france-bans-use-of-hydroxychloroquine-drug-touted-by-trump-to-treat-coronavirus/?ftag=CNM-00-10aab7e&linkId=89534081">https://www.cbsnews.com/news/..NM-00-10aab7e&linkId=89534081</a></span>,
  <span class=reftitle>France bans use of hydroxychloroquine, drug touted by Trump, in coronavirus patients</span>, <span class=refdate>5/27</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Ian56</span>,
  <span class=refurl><a href="https://twitter.com/Ian56789/status/1272844272769867777">https://twitter.com/Ian56789/status/1272844272769867777</a></span>,
  <span class=reftitle>Not used early</span>, <span class=refdate>6/16</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="germany" href="#cite_germany">Germany</a><span class='refstatus refmixed'> - mixed use of early treatment with HCQ</span></div>
<div class=refcountryc>
We found several reports of early treatment early in the outbreak, confirmed by Sermo, later reports of trials paused post WHO/Lancet, current status of early treatment is unclear.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Col Pavan Nair</span>,
  <span class=refurl><a href="https://twitter.com/pavannair/status/1289884254365655043">https://twitter.com/pavannair/status/1289884254365655043</a></span>,
  <span class=reftitle>Used early in the outbreak</span>, <span class=refdate>8/2</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Munchensenton</span>,
  <span class=refurl><a href="https://twitter.com/Munchensenton/status/1286659832741867520">https://twitter.com/Munchensenton/status/1286659832741867520</a></span>,
  <span class=reftitle>Started using early</span>, <span class=refdate>7/24</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Christopher Kidwell</span>,
  <span class=refurl><a href="https://twitter.com/Lerianis1/status/1288039709218922496">https://twitter.com/Lerianis1/status/1288039709218922496</a></span>,
  <span class=reftitle>Early treatment used</span>, <span class=refdate>7/28</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Reuters</span>,
  <span class=refurl><a href="https://www.reuters.com/article/us-health-coronavirus-hydroxychloroquine/germany-pauses-anti-malaria-drug-study-for-covid-19-spiegel-idUSKBN2343AL">https://www.reuters.com/artic..ovid-19-spiegel-idUSKBN2343AL</a></span>,
  <span class=reftitle>Germany pauses anti-malaria drug study for COVID-19: Spiegel</span>, <span class=refcomment>two week pause in trial</span>, <span class=refdate>5/28</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="greece" href="#cite_greece">Greece</a><span class='refstatus refyes'> - widespread early treatment for high-risk patients for most of the outbreak</span></div>
<div class=refcountryc>
Approved for use April 15, they disregarded WHO's recommendation to stop.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Medical Xpress</span>,
  <span class=refurl><a href="https://medicalxpress.com/news/2020-06-global-controversy-greece-chloroquine.html">https://medicalxpress.com/new..versy-greece-chloroquine.html</a></span>,
  <span class=reftitle>Amid global controversy, Greece moves forward with chloroquine</span>, <span class=refcomment>greek epidemiologists consider chloroquine effective, especially in the early stages of COVID-19</span>, <span class=refdate>6/10</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Barron's</span>,
  <span class=refurl><a href="https://www.barrons.com/news/amid-global-controversy-greece-moves-forward-with-chloroquine-01591781707">https://www.barrons.com/news/..-with-chloroquine-01591781707</a></span>,
  <span class=reftitle>Amid Global Controversy, Greece Moves Forward With Chloroquine</span>, <span class=refcomment>the ongoing debate over the drugs has had little impact in Greece, where epidemiologists consider chloroquine effective, especially in the early stages of COVID-19</span>, <span class=refdate>6/10</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Afrik.com</span>,
  <span class=refurl><a href="https://www.afrik.com/edouard-philippe-emporte-par-le-covid-didier-raoult-l-hydroxychloroquine-et-le-remdesivir">https://www.afrik.com/edouard..ychloroquine-et-le-remdesivir</a></span>,
  <span class=reftitle>Edouard Philippe emporté par le Covid, Didier Raoult, l’hydroxychloroquine et le… remdésivir</span>, <span class=refcomment>Follows the Raoult protocol</span>, <span class=refdate>7/6</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="india" href="#cite_india">India</a><span class='refstatus refyes'> - widespread early treatment for high-risk patients for most of the outbreak</span></div>
<div class=refcountryc>
Widespread early use. Prophylaxis for healthcare workers and household contacts of confirmed cases.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Rathi et al. Lancet Infect. Dis. doi:10.1016/S1473-3099(20)30313-3</span>,
  <span class=refurl><a href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30313-3/fulltext">https://www.thelancet.com/jou..1473-3099(20)30313-3/fulltext</a></span>,
  <span class=reftitle>Hydroxychloroquine prophylaxis for COVID-19 contacts in India</span>, <span class=refcomment>ICMR recommends chemoprophylaxis with HCQ for asymptomatic health-care workers and asymptomatic household contacts of confirmed cases</span>, <span class=refdate>4/17</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Atikh Rashid</span>,
  <span class=refurl><a href="https://indianexpress.com/article/cities/pune/maharashtra-expands-use-of-hydroxychloroquine-as-preventive-measure-6376275/lite/?__twitter_impression=true">https://indianexpress.com/art..te/?__twitter_impression=true</a></span>,
  <span class=reftitle>Maharashtra expands use of hydroxychloroquine as preventive measure</span>, <span class=refdate>4/23</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Ministry of Health and Family Welfare</span>,
  <span class=refurl><a href="https://twitter.com/Billtheicon/status/1262508966321496066">https://twitter.com/Billtheicon/status/1262508966321496066</a></span>,
  <span class=reftitle>Advised all front line health care workers to take HCQ prophylactically</span>, <span class=refdate>3/28</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Oneindia</span>,
  <span class=refurl><a href="https://www.oneindia.com/india/no-covid-19-death-in-manipur-mizoram-nagaland-sikkim-so-far-health-ministry-3111048.html">https://www.oneindia.com/indi..-health-ministry-3111048.html</a></span>,
  <span class=reftitle>No COVID-19 death in Manipur, Mizoram, Nagaland, Sikkim so far: Govt</span>, <span class=refcomment>HCQ widely distributed</span>, <span class=refdate>6/26</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>AFP</span>,
  <span class=refurl><a href="https://www.msn.com/en-ph/news/world/india-backs-hydroxychloroquine-for-virus-prevention/ar-BB14EloP?ocid=st2">https://www.msn.com/en-ph/new..evention/ar-BB14EloP?ocid=st2</a></span>,
  <span class=reftitle>India backs hydroxychloroquine for virus prevention</span>, <span class=refdate>5/27</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>AAPS</span>,
  <span class=refurl><a href="https://aapsonline.org/hcq-90-percent-chance/">https://aapsonline.org/hcq-90-percent-chance/</a></span>,
  <span class=reftitle>Hydroxychloroquine Has about 90 Percent Chance of Helping COVID-19 Patients</span>, <span class=refcomment>many nations, including Turkey and India,  are protecting medical workers and contacts of infected persons prophylactically</span>, <span class=refdate>4/28</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>The Indian Express</span>,
  <span class=refurl><a href="https://indianexpress.com/article/india/vadodara-administration-drive-hcq-helping-in-containing-covid-19-cases-say-docs-as-analysis-begins-6486049/">https://indianexpress.com/art..s-as-analysis-begins-6486049/</a></span>,
  <span class=reftitle>Vadodara administration drive: HCQ helping in containing Covid-19 cases, say docs as analysis begins</span>, <span class=refcomment>used prophylactically in Vadora with positive results</span>, <span class=refdate>7/2</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Barron's</span>,
  <span class=refurl><a href="https://www.barrons.com/news/hydroxychloroquine-a-drug-dividing-the-world-01591006809">https://www.barrons.com/news/..ividing-the-world-01591006809</a></span>,
  <span class=reftitle>Hydroxychloroquine: A Drug Dividing The World</span>, <span class=refcomment>used as preventative measure</span>, <span class=refdate>6/1</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Government of India</span>,
  <span class=refurl><a href="https://www.mohfw.gov.in/pdf/RevisedHomeIsolationGuidelines.pdf">https://www.mohfw.gov.in/pdf/..edHomeIsolationGuidelines.pdf</a></span>,
  <span class=reftitle>The caregiver and all close contacts of such cases should take HCQ prophylaxis</span>, <span class=refdate>7/2</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>The Australian</span>,
  <span class=refurl><a href="https://www.theaustralian.com.au/world/coronavirus-india-and-indonesia-stand-by-antimalarials/news-story/d7856d1371697fe69e4fcc39d7f1f97c">https://www.theaustralian.com..56d1371697fe69e4fcc39d7f1f97c</a></span>,
  <span class=reftitle>India and Indonesia stand by antimalarials</span>, <span class=refdate>5/29</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="indonesia" href="#cite_indonesia">Indonesia</a><span class='refstatus refyes'> - widespread early treatment for high-risk patients for most of the outbreak</span></div>
<div class=refcountryc>
Used early. Disregarded WHO request to stop using HCQ.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Reuters</span>,
  <span class=refurl><a href="https://www.reuters.com/article/us-health-coronavirus-indonesia-chloroqu/exclusive-indonesia-major-advocate-of-hydroxychloroquine-told-by-who-to-stop-using-it-idUSKBN23227L">https://www.reuters.com/artic..o-stop-using-it-idUSKBN23227L</a></span>,
  <span class=reftitle>Exclusive: Indonesia, major advocate of hydroxychloroquine, told by WHO to stop using it</span>, <span class=refcomment>Indonesia told doctors to use HCQ to treat all COVID-19 patients with symptoms from mild to severe</span>, <span class=refdate>5/26</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>The Australian</span>,
  <span class=refurl><a href="https://www.theaustralian.com.au/world/coronavirus-india-and-indonesia-stand-by-antimalarials/news-story/d7856d1371697fe69e4fcc39d7f1f97c">https://www.theaustralian.com..56d1371697fe69e4fcc39d7f1f97c</a></span>,
  <span class=reftitle>India and Indonesia stand by antimalarials</span>, <span class=refdate>5/29</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Sag Leyos</span>,
  <span class=refurl><a href="https://twitter.com/sagleyos/status/1274856392902533120">https://twitter.com/sagleyos/status/1274856392902533120</a></span>,
  <span class=reftitle>Used early</span>, <span class=refdate>6/21</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Sag Leyos</span>,
  <span class=refurl><a href="https://twitter.com/sagleyos/status/1274992969549037569">https://twitter.com/sagleyos/status/1274992969549037569</a></span>,
  <span class=reftitle>Treatment given early, do not need to wait for test results</span>, <span class=refdate>6/22</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Sag Leyos</span>,
  <span class=refurl><a href="https://twitter.com/sagleyos/status/1274505486180782080">https://twitter.com/sagleyos/status/1274505486180782080</a></span>,
  <span class=reftitle>Used early</span>, <span class=refdate>6/20</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="ireland" href="#cite_ireland">Ireland</a><span class='refstatus refno'> - limited early treatment with HCQ</span></div>
<div class=refcountryc>
No early treatment.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Robert Nugent</span>,
  <span class=refurl><a href="https://twitter.com/RobertANugent1/status/1268877953825419264">https://twitter.com/RobertANu..t1/status/1268877953825419264</a></span>,
  <span class=reftitle>Nobody treated early with HCQ in Italy</span>, <span class=refdate>6/5</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Covid19Crusher</span>,
  <span class=refurl><a href="https://twitter.com/Covid19Crusher/status/1255194379255504897">https://twitter.com/Covid19Cr..er/status/1255194379255504897</a></span>,
  <span class=reftitle>Ireland waits for clinical trials</span>, <span class=refdate>4/28</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="israel" href="#cite_israel">Israel</a><span class='refstatus refyes'> - widespread early treatment for high-risk patients for most of the outbreak</span></div>
<div class=refcountryc>
We have received a report that Israel's use for early treatment may not be as widespread as believed. We would appreciate any confirmation of use or lack of use in early treatment of high-risk patients throughout the outbreak.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Covid19Crusher</span>,
  <span class=refurl><a href="https://twitter.com/Covid19Crusher/status/1256949969036214275">https://twitter.com/Covid19Cr..er/status/1256949969036214275</a></span>,
  <span class=reftitle>Received 2 million doses from Teva mid April</span>, <span class=refdate>5/3</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Association of American Physicians and Surgeons</span>,
  <span class=refurl><a href="https://www.prnewswire.com/news-releases/more-evidence-presented-for-why-hydroxychloroquine-should-be-made-available-in-a-new-court-filing-by-the-association-of-american-physicians--surgeons-aaps-301098030.html">https://www.prnewswire.com/ne..-surgeons-aaps-301098030.html</a></span>,
  <span class=reftitle>More Evidence Presented for Why Hydroxychloroquine Should be Made Available, in a New Court Filing by the Association of American Physicians & Surgeons (AAPS)</span>, <span class=refcomment>greater access to HCQ</span>, <span class=refdate>7/22</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Xinhua</span>,
  <span class=refurl><a href="http://www.xinhuanet.com/english/2020-04/09/c_138961933.htm">http://www.xinhuanet.com/english/2020-04/09/c_138961933.htm</a></span>,
  <span class=reftitle>Israel brings anti-malarial drug from India to fight COVID-19</span>, <span class=refdate>4/9</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Luke Mor</span>,
  <span class=refurl><a href="https://twitter.com/LukeMor19529310/status/1271442135720615938">https://twitter.com/LukeMor19..10/status/1271442135720615938</a></span>,
  <span class=reftitle>Used early</span>, <span class=refdate>6/12</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="italy" href="#cite_italy">Italy</a><span class='refstatus reflate'> - early HCQ treatment was adopted relatively late</span></div>
<div class=refcountryc>
Banned post WHO/Lancet. Some early treatment started late in Italy's outbreak.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Reuters</span>,
  <span class=refurl><a href="https://www.reuters.com/article/health-coronavirus-hydroxychloroquine-fr/eu-governments-ban-malaria-drug-for-covid-19-trial-paused-as-safety-fears-grow-idUSKBN2340A6">https://www.reuters.com/artic..fety-fears-grow-idUSKBN2340A6</a></span>,
  <span class=reftitle>EU governments ban malaria drug for COVID-19, trial paused as safety fears grow</span>, <span class=refcomment>banned May 27</span>, <span class=refdate>5/27</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Talking Points Memo</span>,
  <span class=refurl><a href="https://talkingpointsmemo.com/news/italian-pharmacological-agency-warns-against-the-use-of-hydroxychloroquine">https://talkingpointsmemo.com..the-use-of-hydroxychloroquine</a></span>,
  <span class=reftitle>Italian Pharmacological Agency Warns Against The Use Of Hydroxychloroquine</span>, <span class=refdate>5/22</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Trustnodes</span>,
  <span class=refurl><a href="https://www.trustnodes.com/2020/03/29/italy-finally-starts-mass-treatment-with-hydroxychloroquine">https://www.trustnodes.com/20..tment-with-hydroxychloroquine</a></span>,
  <span class=reftitle>Italy Finally Starts Mass Treatment with Hydroxychloroquine</span>, <span class=refcomment>early treatment starts in some areas</span>, <span class=refdate>3/29</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Barron's</span>,
  <span class=refurl><a href="https://www.barrons.com/news/hydroxychloroquine-a-drug-dividing-the-world-01591006809">https://www.barrons.com/news/..ividing-the-world-01591006809</a></span>,
  <span class=reftitle>Hydroxychloroquine: A Drug Dividing The World</span>, <span class=refcomment>banned except clinical trials</span>, <span class=refdate>6/1</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>CBC</span>,
  <span class=refurl><a href="https://www.cbc.ca/news/world/france-italy-belgium-act-to-stop-use-of-hydroxychloroquine-for-covid-19-over-safety-fears-1.5586220">https://www.cbc.ca/news/world..9-over-safety-fears-1.5586220</a></span>,
  <span class=reftitle>France, Italy, Belgium act to stop use of hydroxychloroquine for COVID-19 over safety fears</span>, <span class=refdate>5/27</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="kazakhstan" href="#cite_kazakhstan">Kazakhstan</a><span class='refstatus refyes'> - widespread early treatment for high-risk patients for most of the outbreak</span></div>
<div class=refcountryc>
Continues to use post WHO/Lancet.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Tengrinews</span>,
  <span class=refurl><a href="https://tengrinews.kz/news/effektivnosti-gidroksihlorohina-remdesivira-lechenii-covid-401386/">https://tengrinews.kz/news/ef..sivira-lechenii-covid-401386/</a></span>,
  <span class=reftitle>Об эффективности гидроксихлорохина и ремдесивира в лечении COVID-19 высказались в МЗ</span>, <span class=refdate>3/6</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Kazinform</span>,
  <span class=refurl><a href="https://www.inform.kz/en/why-kazakhstan-continues-to-use-hydroxychloroquine-to-treat-covid-19-patients_a3664897">https://www.inform.kz/en/why-..at-covid-19-patients_a3664897</a></span>,
  <span class=reftitle>Why Kazakhstan continues to use hydroxychloroquine to treat COVID-19 patients</span>, <span class=refcomment>continues to use HCQ</span>, <span class=refdate>6/23</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="malaysia" href="#cite_malaysia">Malaysia</a><span class='refstatus refmixed'> - mixed use of early treatment with HCQ</span></div>
<div class=refcountryc>
Used early since January until about 6/22.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Reuters</span>,
  <span class=refurl><a href="https://www.reuters.com/article/us-health-coronavirus-india-malaysia-exc/exclusive-india-agrees-to-sell-hydroxychloroquine-to-malaysia-to-help-fight-covid-19-idUSKCN21X0YQ">https://www.reuters.com/artic..-fight-covid-19-idUSKCN21X0YQ</a></span>,
  <span class=reftitle>Exclusive: India agrees to sell hydroxychloroquine to Malaysia to help fight COVID-19</span>, <span class=refcomment>Malaysia has been using hydroxychloroquine for mild to severe COVID-19 cases along with other drugs, according to its treatment protocol seen by Reuters</span>, <span class=refdate>4/15</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>CNA</span>,
  <span class=refurl><a href="https://www.channelnewsasia.com/news/asia/covid-19-malaysia-hydroxychloroquine-still-using-treatment-12771770">https://www.channelnewsasia.c..till-using-treatment-12771770</a></span>,
  <span class=reftitle>Malaysia still using hydroxychloroquine to treat COVID-19 patients; health ministry monitoring side effects</span>, <span class=refcomment>did not halt based on WHO recommendation</span>, <span class=refdate>5/26</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>CodeBlue</span>,
  <span class=refurl><a href="https://codeblue.galencentre.org/2020/06/09/malaysia-finds-hydroxychloroquine-can-slow-covid-19-progress/">https://codeblue.galencentre...e-can-slow-covid-19-progress/</a></span>,
  <span class=reftitle>Malaysia Finds Hydroxychloroquine Can Slow Covid-19 Progress</span>, <span class=refdate>6/9</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Malay Mail</span>,
  <span class=refurl><a href="https://www.malaymail.com/news/malaysia/2020/03/29/chloroquine-used-to-treat-covid-19-patients-since-first-wave-says-health-d/1851457">https://www.malaymail.com/new..st-wave-says-health-d/1851457</a></span>,
  <span class=reftitle>‘Chloroquine’ used to treat Covid-19 patients since first wave, says Health D-G</span>, <span class=refdate>3/29</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>CodeBlue</span>,
  <span class=refurl><a href="https://codeblue.galencentre.org/2020/06/22/malaysia-drops-hydroxychloroquine-from-covid-19-treatment/">https://codeblue.galencentre...uine-from-covid-19-treatment/</a></span>,
  <span class=reftitle>Malaysia Drops Hydroxychloroquine From Covid-19 Treatment</span>, <span class=refcomment>stopped using based on study with stage 2/3 patients, not clear if stopped for early use</span>, <span class=refdate>6/22</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>New Straits Times</span>,
  <span class=refurl><a href="https://www.nst.com.my/news/nation/2020/06/602538/dr-noor-hisham-malaysia-drops-use-hydroxychloroquine-covid-19">https://www.nst.com.my/news/n..e-hydroxychloroquine-covid-19</a></span>,
  <span class=reftitle>Dr Noor Hisham: Malaysia drops use of hydroxychloroquine for Covid-19</span>, <span class=refdate>6/22</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Hydroxychloroquine News</span>,
  <span class=refurl><a href="https://twitter.com/niro60487270/status/1261701176665337857">https://twitter.com/niro60487270/status/1261701176665337857</a></span>,
  <span class=reftitle>Used since the start</span>, <span class=refdate>5/16</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="mexico" href="#cite_mexico">Mexico</a><span class='refstatus refno'> - limited early treatment with HCQ</span></div>
<div class=refcountryc>
Not authorized outside of clinical trials. Doctors outside hospitals not allowed to prescribe. Some limited exceptions.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Mark F. McCarty</span>,
  <span class=refurl><a href="https://twitter.com/markfmccarty/status/1270421880697044993">https://twitter.com/markfmccarty/status/1270421880697044993</a></span>,
  <span class=reftitle>Doctors outside hospitals not allowed to prescribe</span>, <span class=refdate>6/9</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>El subsecretario de Prevención y Promoción</span>,
  <span class=refurl><a href="https://jalisco.quadratin.com.mx/Nacional/desmiente-lopez-gatell-autorizacion-para-uso-de-hidroxicloroquina/">https://jalisco.quadratin.com..ara-uso-de-hidroxicloroquina/</a></span>,
  <span class=reftitle>Not authorized for COVID-19 outside of clinical trials</span>, <span class=refdate>5/27</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Covid19Crusher</span>,
  <span class=refurl><a href="https://twitter.com/Covid19Crusher/status/1281912523470643200">https://twitter.com/Covid19Cr..er/status/1281912523470643200</a></span>,
  <span class=reftitle>Mexico is anti-HCQ</span>, <span class=refdate>7/11</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>The World</span>,
  <span class=refurl><a href="https://www.pri.org/file/2020-03-27/mexico-runs-out-malaria-drugs-over-unfounded-covid-19-link">https://www.pri.org/file/2020..-over-unfounded-covid-19-link</a></span>,
  <span class=reftitle>Mexico runs out of malaria drugs over unfounded COVID-19 link</span>, <span class=refdate>5/27</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="morocco" href="#cite_morocco">Morocco</a><span class='refstatus refyes'> - widespread early treatment for high-risk patients for most of the outbreak</span></div>
<div class=refcountryc>
All patients treated on first symptoms.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Le Nouvel Afrik</span>,
  <span class=refurl><a href="https://www.afrik.com/covid-19-pourquoi-les-marocains-decedent-plus-en-europe-qu-au-maroc">https://www.afrik.com/covid-1..nt-plus-en-europe-qu-au-maroc</a></span>,
  <span class=reftitle>Covid-19 : pourquoi les Marocains décèdent plus en Europe qu’au Maroc</span>, <span class=refcomment>All COVID patients treated with HCQ as soon as the first symptoms appear. Moroccans more likely to die in Europe than Morocco</span>, <span class=refdate>5/5</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>The Africa Report</span>,
  <span class=refurl><a href="https://www.theafricareport.com/26264/coronavirus-didier-raoult-the-african-and-chloroquine-from-dakar-to-brazzaville/">https://www.theafricareport.c..ne-from-dakar-to-brazzaville/</a></span>,
  <span class=reftitle>Coronavirus: Didier Raoult the African and chloroquine, from Dakar to Brazzaville</span>, <span class=refdate>4/15</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Afrik.com</span>,
  <span class=refurl><a href="https://www.afrik.com/edouard-philippe-emporte-par-le-covid-didier-raoult-l-hydroxychloroquine-et-le-remdesivir">https://www.afrik.com/edouard..ychloroquine-et-le-remdesivir</a></span>,
  <span class=reftitle>Edouard Philippe emporté par le Covid, Didier Raoult, l’hydroxychloroquine et le… remdésivir</span>, <span class=refcomment>Follows the Raoult protocol</span>, <span class=refdate>7/6</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Morocco World News</span>,
  <span class=refurl><a href="https://www.moroccoworldnews.com/2020/06/306587/moroccan-scientist-moroccos-chloroquine-success-reveals-european-failures/">https://www.moroccoworldnews...ss-reveals-european-failures/</a></span>,
  <span class=reftitle>Moroccan Scientist: Morocco’s Chloroquine Success Reveals European Failures</span>, <span class=refcomment>Zemmouri believes approximately 78% of Europe’s coronavirus-related deaths “could have been avoided” if European countries had applied the “same chloroquine strategy as Morocco.”</span>, <span class=refdate>6/22</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Challenge</span>,
  <span class=refurl><a href="https://www.challenge.ma/coronavirus-ce-que-le-maroc-a-reussi-144484/">https://www.challenge.ma/coro..que-le-maroc-a-reussi-144484/</a></span>,
  <span class=reftitle>Coronavirus : ce que le Maroc a réussi</span>, <span class=refcomment>Ignored WHO recommendation</span>, <span class=refdate>6/13</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Barron's</span>,
  <span class=refurl><a href="https://www.barrons.com/news/hydroxychloroquine-a-drug-dividing-the-world-01591006809">https://www.barrons.com/news/..ividing-the-world-01591006809</a></span>,
  <span class=reftitle>Hydroxychloroquine: A Drug Dividing The World</span>, <span class=refcomment>continue to promote</span>, <span class=refdate>6/1</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Franceinfo</span>,
  <span class=refurl><a href="https://www.francetvinfo.fr/monde/afrique/senegal/ces-pays-africains-qui-ont-decide-de-continuer-a-soigner-le-covid-19-avec-l-hydroxychloroquine_3983239.html">https://www.francetvinfo.fr/m..droxychloroquine_3983239.html</a></span>,
  <span class=reftitle>Ces pays africains qui ont décidé de continuer à soigner le Covid-19 avec l'hydroxychloroquine</span>, <span class=refcomment>continue to use after WHO warning, positive results</span>, <span class=refdate>5/28</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Marie94167358</span>,
  <span class=refurl><a href="https://twitter.com/Marie94167358/status/1260661671816835082">https://twitter.com/Marie94167358/status/1260661671816835082</a></span>,
  <span class=reftitle>Fully on HCQ since February</span>, <span class=refdate>5/13</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="netherlands" href="#cite_netherlands">Netherlands</a><span class='refstatus refno'> - limited early treatment with HCQ</span></div>
<div class=refcountryc>
Doctors will be fined if prescribing HCQ for COVID-19. Used for hospitalized patients.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>De Limburger</span>,
  <span class=refurl><a href="https://www.limburger.nl/cnt/dmf20200408_00155572/inspectie-huisarts-moet-stoppen-met-experimentele-behandeling-coronapatienten">https://www.limburger.nl/cnt/..e-behandeling-coronapatienten</a></span>,
  <span class=reftitle>Inspectie: Meijelse huisarts moet stoppen met experimentele behandeling coronapatiënten</span>, <span class=refcomment>doctors will be fined if prescribing HCQ for COVID</span>, <span class=refdate>4/8</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>AD - Nieuws</span>,
  <span class=refurl><a href="https://www.ad.nl/binnenland/ziekenhuizen-gaven-massaal-omstreden-malariamedicijn-aan-coronapatient~a0ddaabbd/">https://www.ad.nl/binnenland/..-aan-coronapatient~a0ddaabbd/</a></span>,
  <span class=reftitle>Ziekenhuizen gaven massaal omstreden malariamedicijn aan coronapatient</span>, <span class=refcomment>used for hospitalized patients</span>, <span class=refdate>5/20</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="pakistan" href="#cite_pakistan">Pakistan</a><span class='refstatus refmixed'> - mixed use of early treatment with HCQ</span></div>
<div class=refcountryc>
Obtained from India, later banned.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Government of Pakistan</span>,
  <span class=refurl><a href="http://covid.gov.pk/new_guidelines/04July2020_20200704_Clinical_Management_Guidelines_for_COVID-19_infections_1203.pdf">http://covid.gov.pk/new_guide.._COVID-19_infections_1203.pdf</a></span>,
  <span class=reftitle>Clinical Management Guidelines for COVID-19 Infections</span>, <span class=refcomment>HCQ not recommended for early or late treatment</span>, <span class=refdate>7/2</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>pIndia</span>,
  <span class=refurl><a href="https://www.opindia.com/2020/04/pakistan-hydroxychloroquine-india-coronavirus/">https://www.opindia.com/2020/..hloroquine-india-coronavirus/</a></span>,
  <span class=reftitle>Pakistan seeks Hydroxychloroquine from India to curb the Coronavirus pandemic</span>, <span class=refdate>4/15</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>The News</span>,
  <span class=refurl><a href="https://www.thenews.com.pk/print/667009-hcq-tablets-proving-effective-in-treatment-of-covid-19-patients-claims-top-medicine-expert">https://www.thenews.com.pk/pr..ts-claims-top-medicine-expert</a></span>,
  <span class=reftitle>HCQ tablets proving effective in treatment of COVID-19 patients, claims top medicine expert</span>, <span class=refcomment>trials suspended but some use continues</span>, <span class=refdate>6/3</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>ARY News</span>,
  <span class=refurl><a href="https://arynews.tv/en/corona-expert-panel-dexamethasone-actemra/">https://arynews.tv/en/corona-..-panel-dexamethasone-actemra/</a></span>,
  <span class=reftitle>Experts rule against plasma, Dexamethasone, Actemra as viable COVID-19 cures</span>, <span class=refcomment>all licenses related to stocking and selling of Hydroxychloroquine in Pakistan have been revoked and all human trials to verify its potency have been stopped</span>, <span class=refdate>6/22</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="portugal" href="#cite_portugal">Portugal</a><span class='refstatus refmixed'> - mixed use of early treatment with HCQ</span></div>
<div class=refcountryc>
Banned post WHO/Lancet.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Portual Resident</span>,
  <span class=refurl><a href="https://www.portugalresident.com/covid-19-portugal-becomes-4th-country-to-suspend-use-of-hydroxychloroquine/">https://www.portugalresident...nd-use-of-hydroxychloroquine/</a></span>,
  <span class=reftitle>Covid-19: Portugal becomes 4th country to suspend use of hydroxychloroquine</span>, <span class=refcomment>suspended post WHO/Lancet</span>, <span class=refdate>5/29</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Barron's</span>,
  <span class=refurl><a href="https://www.barrons.com/news/hydroxychloroquine-a-drug-dividing-the-world-01591006809">https://www.barrons.com/news/..ividing-the-world-01591006809</a></span>,
  <span class=reftitle>Hydroxychloroquine: A Drug Dividing The World</span>, <span class=refcomment>continue to promote</span>, <span class=refdate>6/1</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Covid19Crusher</span>,
  <span class=refurl><a href="https://twitter.com/Covid19Crusher/status/1258408833640267776">https://twitter.com/Covid19Cr..er/status/1258408833640267776</a></span>,
  <span class=reftitle>Portugal has less than half the ICU beds per capita of France or Spain and treatment at home quickly became the only option. With HCQ, the death rate was minimized</span>, <span class=refdate>5/7</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="russia" href="#cite_russia">Russia</a><span class='refstatus refyes'> - widespread early treatment for high-risk patients for most of the outbreak</span></div>
<div class=refcountryc>
Approved for use April 15, they disregarded WHO's recommendation to stop.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>The Moscow Times</span>,
  <span class=refurl><a href="https://www.themoscowtimes.com/2020/04/17/russia-approves-unproven-malaria-drug-to-treat-coronavirus-a70025">https://www.themoscowtimes.co..g-to-treat-coronavirus-a70025</a></span>,
  <span class=reftitle>Russia Approves Unproven Malaria Drug to Treat Coronavirus</span>, <span class=refdate>4/17</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Russian Government</span>,
  <span class=refurl><a href="http://publication.pravo.gov.ru/Document/View/0001202004160037#print">http://publication.pravo.gov...t/View/0001202004160037#print</a></span>,
  <span class=reftitle>Распоряжение Правительства Российской Федерации от 16.04.2020 № 1030-р</span>, <span class=refdate>4/16</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>The Moscow Times</span>,
  <span class=refurl><a href="https://www.themoscowtimes.com/2020/04/06/moscow-doctors-forced-to-self-test-risky-malaria-drug-for-coronavirus-bbc-a69877">https://www.themoscowtimes.co..ug-for-coronavirus-bbc-a69877</a></span>,
  <span class=reftitle>Moscow Doctors Forced to Self-Test Risky Malaria Drug for Coronavirus – BBC</span>, <span class=refdate>4/6</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Gummi Bear</span>,
  <span class=refurl><a href="https://twitter.com/gummibear737/status/1279874373046939649">https://twitter.com/gummibear737/status/1279874373046939649</a></span>,
  <span class=reftitle>Russian treatment protocol showing HCQ used early</span>, <span class=refdate>7/5</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Barron's</span>,
  <span class=refurl><a href="https://www.barrons.com/news/hydroxychloroquine-a-drug-dividing-the-world-01591006809">https://www.barrons.com/news/..ividing-the-world-01591006809</a></span>,
  <span class=reftitle>Hydroxychloroquine: A Drug Dividing The World</span>, <span class=refcomment>use not suspended post WHO/Lancet</span>, <span class=refdate>6/1</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>The BL</span>,
  <span class=refurl><a href="https://thebl.com/world-news/russia-supports-hydroxychloroquine-drug-ccp-virus-trump.html">https://thebl.com/world-news/..ine-drug-ccp-virus-trump.html</a></span>,
  <span class=reftitle>Russia supports the use of hydroxychloroquine, the drug to treat the CCP Virus suggested by Trump</span>, <span class=refcomment>will not follow WHO recommendation</span>, <span class=refdate>5/28</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="senegal" href="#cite_senegal">Senegal</a><span class='refstatus refyes'> - widespread early treatment for high-risk patients for most of the outbreak</span></div>
<div class=refcountryc>
Used early. Prof. Raoult was born in Senegal.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>NPR News</span>,
  <span class=refurl><a href="https://wfuv.org/content/senegal-pledges-bed-every-coronavirus-patient-%E2%80%94-and-their-contacts-too">https://wfuv.org/content/sene..%80%94-and-their-contacts-too</a></span>,
  <span class=reftitle>Senegal pledges a bed for every coronavirus patient</span>, <span class=refcomment>country's treatment plan uses HCQ despite warning from WHO</span>, <span class=refdate>5/17</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Teller Report</span>,
  <span class=refurl><a href="http://www.tellerreport.com/news/2020-05-02-coronavirus--a-study-in-senegal-confirms-the-effectiveness-of-hydroxychloroquine.BJeet4Kst8.html">http://www.tellerreport.com/n..xychloroquine.BJeet4Kst8.html</a></span>,
  <span class=reftitle>Coronavirus: a study in Senegal confirms the effectiveness of hydroxychloroquine</span>, <span class=refdate>5/2</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Africanews</span>,
  <span class=refurl><a href="https://www.africanews.com/2020/04/06/coronavirus-patients-on-chloroquine-heal-faster-senegalese-medic/">https://www.africanews.com/20..heal-faster-senegalese-medic/</a></span>,
  <span class=reftitle>Coronavirus patients on chloroquine heal faster - Senegalese medic</span>, <span class=refdate>6/4</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Medical Xpress</span>,
  <span class=refurl><a href="https://medicalxpress.com/news/2020-04-senegal-hydroxychloroquine-virus-treatment.html">https://medicalxpress.com/new..oroquine-virus-treatment.html</a></span>,
  <span class=reftitle>Senegal says hydroxychloroquine virus treatment is promising</span>, <span class=refdate>4/2</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Afrik.com</span>,
  <span class=refurl><a href="https://www.afrik.com/edouard-philippe-emporte-par-le-covid-didier-raoult-l-hydroxychloroquine-et-le-remdesivir">https://www.afrik.com/edouard..ychloroquine-et-le-remdesivir</a></span>,
  <span class=reftitle>Edouard Philippe emporté par le Covid, Didier Raoult, l’hydroxychloroquine et le… remdésivir</span>, <span class=refcomment>Follows the Raoult protocol</span>, <span class=refdate>7/6</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>The Africa Report</span>,
  <span class=refurl><a href="https://www.theafricareport.com/26264/coronavirus-didier-raoult-the-african-and-chloroquine-from-dakar-to-brazzaville/">https://www.theafricareport.c..ne-from-dakar-to-brazzaville/</a></span>,
  <span class=reftitle>Coronavirus: Didier Raoult the African and chloroquine, from Dakar to Brazzaville</span>, <span class=refdate>4/15</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Barron's</span>,
  <span class=refurl><a href="https://www.barrons.com/news/hydroxychloroquine-a-drug-dividing-the-world-01591006809">https://www.barrons.com/news/..ividing-the-world-01591006809</a></span>,
  <span class=reftitle>Hydroxychloroquine: A Drug Dividing The World</span>, <span class=refcomment>continue to promote</span>, <span class=refdate>6/1</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Franceinfo</span>,
  <span class=refurl><a href="https://www.francetvinfo.fr/monde/afrique/senegal/ces-pays-africains-qui-ont-decide-de-continuer-a-soigner-le-covid-19-avec-l-hydroxychloroquine_3983239.html">https://www.francetvinfo.fr/m..droxychloroquine_3983239.html</a></span>,
  <span class=reftitle>Ces pays africains qui ont décidé de continuer à soigner le Covid-19 avec l'hydroxychloroquine</span>, <span class=refcomment>continue to use after WHO warning, positive results</span>, <span class=refdate>5/28</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Hydroxychloroquine News</span>,
  <span class=refurl><a href="https://twitter.com/niro60487270/status/1256675338853072896">https://twitter.com/niro60487270/status/1256675338853072896</a></span>,
  <span class=reftitle>Used early</span>, <span class=refdate>5/2</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="south_korea" href="#cite_south_korea">South Korea</a><span class='refstatus refyes'> - widespread early treatment for high-risk patients for most of the outbreak</span></div>
<div class=refcountryc>
Promoted and prophylaxis for health care workers.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Hydroxychloroquine News</span>,
  <span class=refurl><a href="https://twitter.com/niro60487270/status/1256675338853072896">https://twitter.com/niro60487270/status/1256675338853072896</a></span>,
  <span class=reftitle>Used early</span>, <span class=refdate>5/2</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Luke Mor</span>,
  <span class=refurl><a href="https://twitter.com/LukeMor19529310/status/1271442135720615938">https://twitter.com/LukeMor19..10/status/1271442135720615938</a></span>,
  <span class=reftitle>Used early</span>, <span class=refdate>6/12</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>American RN</span>,
  <span class=refurl><a href="https://twitter.com/rn_american/status/1272812657142349826">https://twitter.com/rn_american/status/1272812657142349826</a></span>,
  <span class=reftitle>Prohpylactic use</span>, <span class=refdate>6/16</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>ChloroquineGuerilla</span>,
  <span class=refurl><a href="https://twitter.com/ProlongingCovid/status/1279874993153662977">https://twitter.com/Prolongin..id/status/1279874993153662977</a></span>,
  <span class=reftitle>Standard of care from the beginning</span>, <span class=refdate>7/5</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Businessriz</span>,
  <span class=refurl><a href="https://twitter.com/businessriz/status/1261092622312955904">https://twitter.com/businessriz/status/1261092622312955904</a></span>,
  <span class=reftitle>Promoted since January and used for prophylaxis with healthcare workers</span>, <span class=refdate>5/14</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="sweden" href="#cite_sweden">Sweden</a><span class='refstatus refno'> - limited early treatment with HCQ</span></div>
<div class=refcountryc>
Doctors instructed not to use.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Breaking News Today</span>,
  <span class=refurl><a href="https://www.breakingnewstoday.co.uk/trumps-miracle-drug-chloroquine-no-longer-being-used-in-swedish-hospitals/">https://www.breakingnewstoday..ng-used-in-swedish-hospitals/</a></span>,
  <span class=reftitle>Trump’s “Miracle Drug” Chloroquine No Longer Being Used in Swedish Hospitals</span>, <span class=refcomment>trials canceled</span>, <span class=refdate>4/8</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>AJMC</span>,
  <span class=refurl><a href="https://www.ajmc.com/newsroom/caution-strongly-recommended-when-using-chloroquine-hydroxychloroquine-in-patients-with-cardiovascular-disease-covid19">https://www.ajmc.com/newsroom..ardiovascular-disease-covid19</a></span>,
  <span class=reftitle>Caution Strongly Recommended When Using Chloroquine, Hydroxychloroquine in Patients With Cardiovascular Disease, COVID-19</span>, <span class=refcomment>clinicians instructed not to use [H]CQ for COVID outside of trials</span>, <span class=refdate>4/17</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Barron's</span>,
  <span class=refurl><a href="https://www.barrons.com/news/hydroxychloroquine-a-drug-dividing-the-world-01591006809">https://www.barrons.com/news/..ividing-the-world-01591006809</a></span>,
  <span class=reftitle>Hydroxychloroquine: A Drug Dividing The World</span>, <span class=refcomment>banned, used in the early phases of the pandemic for patients with severe symptoms, but halted in April after the European Medicines Agency recommended it only be used in clinical trials</span>, <span class=refdate>6/1</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Ian56</span>,
  <span class=refurl><a href="https://twitter.com/Ian56789/status/1272844272769867777">https://twitter.com/Ian56789/status/1272844272769867777</a></span>,
  <span class=reftitle>Not used early</span>, <span class=refdate>6/16</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Henrik Wallen</span>,
  <span class=refurl><a href="https://twitter.com/henrikwallin3/status/1280439318109184000?s=21">https://twitter.com/henrikwal..atus/1280439318109184000?s=21</a></span>,
  <span class=reftitle>Generally no treatment at all outside hospitals</span>, <span class=refdate>7/7</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="switzerland" href="#cite_switzerland">Switzerland</a><span class='refstatus reflate'> - early HCQ treatment was adopted relatively late</span></div>
<div class=refcountryc>
Started using May 1.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>É Mo Scél</span>,
  <span class=refurl><a href="https://twitter.com/e_scel/status/1262737713725239298">https://twitter.com/e_scel/status/1262737713725239298</a></span>,
  <span class=reftitle>Using since May 1</span>, <span class=refdate>5/19</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="tunisia" href="#cite_tunisia">Tunisia</a><span class='refstatus refmixed'> - mixed use of early treatment with HCQ</span></div>
<div class=refcountryc>
Was using but banned post WHO/Lancet.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Barron's</span>,
  <span class=refurl><a href="https://www.barrons.com/news/hydroxychloroquine-a-drug-dividing-the-world-01591006809">https://www.barrons.com/news/..ividing-the-world-01591006809</a></span>,
  <span class=reftitle>Hydroxychloroquine: A Drug Dividing The World</span>, <span class=refcomment>banned</span>, <span class=refdate>6/1</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>France 24</span>,
  <span class=refurl><a href="https://www.france24.com/en/eye-on-africa/20200410-coronavirus-pandemic-tunisia-begins-manufacturing-hydroxychloroquine">https://www.france24.com/en/e..ufacturing-hydroxychloroquine</a></span>,
  <span class=reftitle>Coronavirus pandemic: Tunisia begins manufacturing hydroxychloroquine</span>, <span class=refdate>4/10</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="turkey" href="#cite_turkey">Turkey</a><span class='refstatus refyes'> - widespread early treatment for high-risk patients for most of the outbreak</span></div>
<div class=refcountryc>
Science board suggested beneficial in early stages. Reported everyone testing positive receives HCQ. Gradual adoption at the beginning.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Middle East Eye</span>,
  <span class=refurl><a href="https://www.middleeasteye.net/news/coronavirus-turkey-hydroxychloroquine-malaria-treatment-progress">https://www.middleeasteye.net..ne-malaria-treatment-progress</a></span>,
  <span class=reftitle>Coronavirus: Turkey says hydroxychloroquine dramatically reduces pneumonia cases</span>, <span class=refcomment>used early - "our science board suggested that the drug is really beneficial in the early stages to prevent the spread of the virus in the body"</span>, <span class=refdate>4/8</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>BBC</span>,
  <span class=refurl><a href="https://www.bbc.com/news/world-europe-52831017">https://www.bbc.com/news/world-europe-52831017</a></span>,
  <span class=reftitle>Coronavirus: How Turkey took control of Covid-19 emergency</span>, <span class=refcomment>"controversially that includes the anti-malarial drug, hydroxychloroquine, as standard"</span>, <span class=refdate>5/29</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>David Stringer</span>,
  <span class=refurl><a href="https://twitter.com/davidstringer11/status/1264995116785246210">https://twitter.com/davidstri..11/status/1264995116785246210</a></span>,
  <span class=reftitle>Everyone testing positive gets HCQ</span>, <span class=refdate>5/25</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>The Palmer Foundation</span>,
  <span class=refurl><a href="https://www.palmerfoundation.com.au/turkey-highest-covid-19-cases-and-lowest-fatalities-in-middle-east-broad-use-hydrochloroquine-ministry-of-health/">https://www.palmerfoundation...loroquine-ministry-of-health/</a></span>,
  <span class=reftitle>Turkey: Highest COVID-19 cases and lowest fatalities in middle east, broad use hydrochloroquine – Ministry of Health</span>, <span class=refcomment>“Doctors prescribe hydroxychloroquine to everyone who is tested positive for coronavirus” Dr. Sema Turan, a member of the Turkish government’s coronavirus advisory board</span>, <span class=refdate>5/2</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Hydroxychloroquine News</span>,
  <span class=refurl><a href="https://twitter.com/niro60487270/status/1256675338853072896">https://twitter.com/niro60487270/status/1256675338853072896</a></span>,
  <span class=reftitle>Treating early with HCQ</span>, <span class=refdate>5/2</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>CBS News</span>,
  <span class=refurl><a href="https://www.msn.com/en-au/news/world/turkey-claims-success-treating-virus-with-drug-touted-by-trump/ar-BB13oMXS">https://www.msn.com/en-au/new..g-touted-by-trump/ar-BB13oMXS</a></span>,
  <span class=reftitle>Turkey claims success treating virus with drug touted by Trump</span>, <span class=refdate>4/30</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>AAPS</span>,
  <span class=refurl><a href="https://aapsonline.org/hcq-90-percent-chance/">https://aapsonline.org/hcq-90-percent-chance/</a></span>,
  <span class=reftitle>Hydroxychloroquine Has about 90 Percent Chance of Helping COVID-19 Patients</span>, <span class=refcomment>many nations, including Turkey and India, are protecting medical workers and contacts of infected persons prophylactically</span>, <span class=refdate>4/28</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Barron's</span>,
  <span class=refurl><a href="https://www.barrons.com/news/hydroxychloroquine-a-drug-dividing-the-world-01591006809">https://www.barrons.com/news/..ividing-the-world-01591006809</a></span>,
  <span class=reftitle>Hydroxychloroquine: A Drug Dividing The World</span>, <span class=refcomment>continue to promote</span>, <span class=refdate>6/1</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Covid19Crusher</span>,
  <span class=refurl><a href="https://twitter.com/Covid19Crusher/status/1257921469914517505">https://twitter.com/Covid19Cr..er/status/1257921469914517505</a></span>,
  <span class=reftitle>Turkey has adopted early HCQ use</span>, <span class=refdate>5/5</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Covid19Crusher</span>,
  <span class=refurl><a href="https://twitter.com/Covid19Crusher/status/1255516638033608710">https://twitter.com/Covid19Cr..er/status/1255516638033608710</a></span>,
  <span class=reftitle>Gradually adopted early HCQ</span>, <span class=refdate>4/29</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Association of American Physicians and Surgeons</span>,
  <span class=refurl><a href="https://www.prnewswire.com/news-releases/more-evidence-presented-for-why-hydroxychloroquine-should-be-made-available-in-a-new-court-filing-by-the-association-of-american-physicians--surgeons-aaps-301098030.html">https://www.prnewswire.com/ne..-surgeons-aaps-301098030.html</a></span>,
  <span class=reftitle>More Evidence Presented for Why Hydroxychloroquine Should be Made Available, in a New Court Filing by the Association of American Physicians & Surgeons (AAPS)</span>, <span class=refcomment>greater access to HCQ</span>, <span class=refdate>7/22</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Luke Mor</span>,
  <span class=refurl><a href="https://twitter.com/LukeMor19529310/status/1271442135720615938">https://twitter.com/LukeMor19..10/status/1271442135720615938</a></span>,
  <span class=reftitle>Turkey advocates early use</span>, <span class=refdate>6/12</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="ukraine" href="#cite_ukraine">Ukraine</a><span class='refstatus refyes'> - widespread early treatment for high-risk patients for most of the outbreak</span></div>
<div class=refcountryc>
Government treatment protocol shows early use.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Ukrinform</span>,
  <span class=refurl><a href="https://www.ukrinform.net/rubric-economy/3019049-uber-eats-to-close-down-in-ukraine-on-june-3.html">https://www.ukrinform.net/rub..own-in-ukraine-on-june-3.html</a></span>,
  <span class=reftitle>Ukraine receives batch of hydroxychloroquine tablets from India</span>, <span class=refcomment>received additional shipment</span>, <span class=refdate>5/5</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Ukraine Ministry of Health Care</span>,
  <span class=refurl><a href="https://www.dec.gov.ua/wp-content/uploads/2020/04/2020_762_protokol_covid19-f.pdf">https://www.dec.gov.ua/wp-con..20_762_protokol_covid19-f.pdf</a></span>,
  <span class=reftitle>ПРОТОКОЛ «НАДАННЯ МЕДИЧНОЇ ДОПОМОГИ ДЛЯ ЛІКУВАННЯ КОРОНАВІРУСНОЇ ХВОРОБИ (COVID-19)» </span>, <span class=refcomment>government treatment protocol showing early use</span>, <span class=refdate>4/2</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Ministry of Health of Ukraine</span>,
  <span class=refurl><a href="https://twitter.com/MoH_Ukraine/status/1248268122332766208">https://twitter.com/MoH_Ukraine/status/1248268122332766208</a></span>,
  <span class=reftitle>Ukraine will receive an additional 320 thousand tablets with the active substance Hydroxychloroquine for symptomatic treatment of patients with #COVIDー19</span>, <span class=refdate>4/9</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="united_kingdom" href="#cite_united_kingdom">United Kingdom</a><span class='refstatus refno'> - limited early treatment with HCQ</span></div>
<div class=refcountryc>
Use is banned outside of clinical trials. Media very negative.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>U.K. Government</span>,
  <span class=refurl><a href="https://www.gov.uk/government/news/chloroquine-and-hydroxychloroquine-not-licensed-for-coronavirus-covid-19-treatment">https://www.gov.uk/government..oronavirus-covid-19-treatment</a></span>,
  <span class=reftitle>Chloroquine and Hydroxychloroquine not licensed for coronavirus (COVID-19) treatment</span>, <span class=refcomment>use is banned outside of clinical trials</span>, <span class=refdate>3/25</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Daily Mail</span>,
  <span class=refurl><a href="https://www.dailymail.co.uk/news/article-8167241/UK-regulators-blocked-use-antimalarials-treat-coronavirus-despite-doctors-using-it.html">https://www.dailymail.co.uk/n..despite-doctors-using-it.html</a></span>,
  <span class=reftitle>US health regulator approves two malaria drugs as a last resort for coronavirus patients in hospital - but the UK will only let doctors use the promising medications in trials</span>, <span class=refdate>3/30</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Ian56</span>,
  <span class=refurl><a href="https://twitter.com/Ian56789/status/1272844272769867777">https://twitter.com/Ian56789/status/1272844272769867777</a></span>,
  <span class=reftitle>Not used early</span>, <span class=refcomment>blocked almost completely</span>, <span class=refdate>6/16</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="united_states" href="#cite_united_states">United States</a><span class='refstatus refno'> - limited early treatment with HCQ</span></div>
<div class=refcountryc>
FDA has warned against use, several states prohibit early use. Doctors may risk censure and their license for prescribing. Media very negative. Usage in late treatment in hospitals. Relatively minimal usage for early treatment.
</div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>FDA</span>,
  <span class=refurl><a href="https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or">https://www.fda.gov/drugs/dru..9-outside-hospital-setting-or</a></span>,
  <span class=reftitle>FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems</span>, <span class=refdate>4/24</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>The Washington Post</span>,
  <span class=refurl><a href="https://www.washingtonpost.com/health/2020/04/24/fda-warns-about-hydroxychloroquine-dangers-citing-serious-heart-issues-including-death/">https://www.washingtonpost.co..heart-issues-including-death/</a></span>,
  <span class=reftitle>FDA warns about hydroxychloroquine dangers, citing serious heart issues, including death</span>, <span class=refdate>4/24</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>National Academy for State Health Policy</span>,
  <span class=refurl><a href="https://www.nashp.org/wp-content/uploads/2020/03/State-covid-drug-chart-3-27-2020.pdf">https://www.nashp.org/wp-cont..ovid-drug-chart-3-27-2020.pdf</a></span>,
  <span class=reftitle>State Rules and Recommendations Regarding Chloroquine, Hydroxychloroquine and Other Drugs Related to COVID-19</span>, <span class=refdate>3/27</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Association of American Physicians and Surgeons</span>,
  <span class=refurl><a href="https://www.prnewswire.com/news-releases/more-evidence-presented-for-why-hydroxychloroquine-should-be-made-available-in-a-new-court-filing-by-the-association-of-american-physicians--surgeons-aaps-301098030.html">https://www.prnewswire.com/ne..-surgeons-aaps-301098030.html</a></span>,
  <span class=reftitle>More Evidence Presented for Why Hydroxychloroquine Should be Made Available, in a New Court Filing by the Association of American Physicians & Surgeons (AAPS)</span>, <span class=refcomment>pharmacists may be prevented from filling HCQ prescriptions, most Americans are unable to obtain HCQ for early treatment, and virtually no Americans are able to access it as preventive medicine</span>, <span class=refdate>7/22</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Texas Scorecard</span>,
  <span class=refurl><a href="https://texasscorecard.com/state/physician-says-texas-pharmacy-board-limited-coronavirus-medicine/">https://texasscorecard.com/st..limited-coronavirus-medicine/</a></span>,
  <span class=reftitle>Physician Says Texas Pharmacy Board Limited Coronavirus Medicine</span>, <span class=refdate>5/12</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Harvey Risch, MD, PhD</span>,
  <span class=refurl><a href="https://www.newsweek.com/key-defeating-covid-19-already-exists-we-need-start-using-it-opinion-1519535">https://www.newsweek.com/key-..tart-using-it-opinion-1519535</a></span>,
  <span class=reftitle>The Key to Defeating COVID-19 Already Exists. We Need to Start Using It</span>, <span class=refcomment>doctors have been threatened by medical boards with the chance of losing their license for prescribing HCQ</span>, <span class=refdate>7/23</span>.
</span></div>

<!-- ---------- -->



<div class=refspace></div>
<div class=refsum>
<div class=refcountry><a class=ct id="venezuela" href="#cite_venezuela">Venezuela</a><span class='refstatus refyes'> - widespread early treatment for high-risk patients for most of the outbreak</span></div>
</div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Efecto Cocuyo</span>,
  <span class=refurl><a href="https://efectococuyo.com/coronavirus/venezuela-empieza-a-usar-la-cloroquina-para-tratar-covid-19-anuncia-jorge-rodriguez/">https://efectococuyo.com/coro..d-19-anuncia-jorge-rodriguez/</a></span>,
  <span class=reftitle>Venezuela empieza a usar la cloroquina para tratar COVID-19, anuncia Jorge Rodríguez</span>, <span class=refcomment>used prophylactically</span>, <span class=refdate>3/23</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Association of American Physicians and Surgeons</span>,
  <span class=refurl><a href="https://www.prnewswire.com/news-releases/more-evidence-presented-for-why-hydroxychloroquine-should-be-made-available-in-a-new-court-filing-by-the-association-of-american-physicians--surgeons-aaps-301098030.html">https://www.prnewswire.com/ne..-surgeons-aaps-301098030.html</a></span>,
  <span class=reftitle>More Evidence Presented for Why Hydroxychloroquine Should be Made Available, in a New Court Filing by the Association of American Physicians & Surgeons (AAPS)</span>, <span class=refcomment>available OTC</span>, <span class=refdate>7/22</span>.
</span></div>

<!-- ---------- -->

<div class=ref><span class=refsrc>Barron's</span>,
  <span class=refurl><a href="https://www.barrons.com/news/hydroxychloroquine-a-drug-dividing-the-world-01591006809">https://www.barrons.com/news/..ividing-the-world-01591006809</a></span>,
  <span class=reftitle>Hydroxychloroquine: A Drug Dividing The World</span>, <span class=refcomment>used as preventative measure</span>, <span class=refdate>6/1</span>.
</span></div>

<!-- ---------- -->

</div>




<div id=toc class=toc><div class=toc2>
<div class=desktop>Go&nbsp;to:&nbsp;&nbsp;</div><a href='#top'>Top</a>&nbsp;&nbsp;<a href='#setup'>Trial</a>&nbsp;&nbsp;<a href='#results'>Results</a>&nbsp;&nbsp;<a href='#confounding'>Confounding</a>&nbsp;&nbsp;<a href='#literature'>Literature</a>&nbsp;&nbsp;<a href='#discussion'>Discussion</a>&nbsp;&nbsp;<a href='#references'>References</a>&nbsp;&nbsp;<a href='#appendix_countrystats'>Appendices</a>&nbsp;&nbsp;</div>
</div>


<div class=subblock>
<div class=underu><a href="/faq.html">Frequently Asked Questions</a></div><br>

<div>Please send us corrections, updates, or comments:</div>
<div class=subdiv>
<textarea id=feedback class=subtext rows='2' data-min-rows='2' placeholder='Feedback'></textarea>
</div>
<a class=subbtn onclick="OnSubmit()">Submit</a>&nbsp;&nbsp;&nbsp;&nbsp;<span class=subresp id=subresp></span>
</div>

<!------------------------------------------------------------------------------------>

<br>

<div class=footer>
<div class=fdiv><a target="_blank" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fhcqtrial.com%2F"><img class=socialimg src='fb.svg'></a>&nbsp;</div>
<div class=fdiv><span class=underu><a target="_blank" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fhcqtrial.com%2F">Share</a></span>&nbsp;&nbsp;</div>
<div class=fdiv><a href="https://twitter.com/intent/tweet?text=Early%20treatment%20with%20hydroxychloroquine%3A%20a%20country-randomized%20controlled%20trial&url=https%3A%2F%2Fhcqtrial.com%2F&hashtags=hcqtrial&via=CovidAnalysis"><img class=socialimg src='twitter.svg'></a></div>
<div class=fdiv><span class=underu><a href="https://twitter.com/intent/tweet?text=Early%20treatment%20with%20hydroxychloroquine%3A%20a%20country-randomized%20controlled%20trial&url=https%3A%2F%2Fhcqtrial.com%2F&hashtags=hcqtrial&via=CovidAnalysis">Tweet</a></span>&nbsp;&nbsp;</div>
<div class=fdiv><span class=underu><a href="https://twitter.com/CovidAnalysis">@CovidAnalysis</a></span>&nbsp;&nbsp;</div>
</div>

</div>

<!------------------------------------------------------------------------------------->

<script>
function el(s) {
 return document.getElementById(s);
}
var textarea = document.querySelector('textarea');
textarea.addEventListener('keydown', autosize);
textarea.addEventListener('focus', autosize);
function autosize() {
  var el = this;
  setTimeout(function() {
    el.style.height='auto';
    el.style.height=(el.scrollHeight + 2)+'px';
    // el.style.cssText = 'height:auto;padding:30px;';  // color:#000
    // el.style.cssText = 'height:' + (el.scrollHeight + 2) + 'px;padding:30px;';
    // for box-sizing other than "content-box" use: el.style.cssText = '-moz-box-sizing:content-box';
    // if (el.value.startsWith('Enter your')) { el.value = ''; el.style.color = '#000000'; }
  }, 0);
}
// document.getElementById('feedback').focus();
var ajax = {};
ajax.x = function() {
  if (typeof XMLHttpRequest !== 'undefined') {
    return new XMLHttpRequest();
  }
  var versions = [ "MSXML2.XmlHttp.6.0","MSXML2.XmlHttp.5.0","MSXML2.XmlHttp.4.0",
    "MSXML2.XmlHttp.3.0","MSXML2.XmlHttp.2.0","Microsoft.XmlHttp" ];
  var xhr;
  for (var i = 0; i < versions.length; i++) {
    try {
      xhr = new ActiveXObject(versions[i]);
      break;
    } catch (e) {
    }
  }
  return xhr;
};
ajax.send = function(url, callback, method, data, async) {
  if (async === undefined) {
    async = true;
  }
  var x = ajax.x();
  x.open(method, url, async);
  x.onreadystatechange = function() {
    if (x.readyState == 4) {
      callback(x.status, x.responseText)
    }
  };
  if (method == 'POST') {
    x.setRequestHeader('Content-type', 'application/x-www-form-urlencoded');
  }
  x.send(data)
};
ajax.get = function(url, data, callback, async) {
  var query = [];
  for (var key in data) {
    query.push(encodeURIComponent(key) + '=' + encodeURIComponent(data[key]));
  }
  ajax.send(url + (query.length ? '?' + query.join('&') : ''), callback, 'GET', null, async)
};
ajax.post = function(url, data, callback, async) {
  var query = [];
  for (var key in data) {
    query.push(encodeURIComponent(key) + '=' + encodeURIComponent(data[key]));
  }
  ajax.send(url, callback, 'POST', query.join('&'), async)
};
function OnSubmit() {
  comment = el("feedback").value;
  if (comment.length > 0) {
    comment += ' [rct]';
    el('subresp').innerHTML = "Submitting..";
    ajax.post('/sub', {"comment": comment}, function(code, s) {
      // console.log(code);
      // console.log(s);
      if (code == 200) {
        el('subresp').innerHTML = "Submitted, thanks!"
        // <br><br>You submitted:<br><br>" + comment;
        el("feedback").value = '';
      } else {
        el('subresp').innerHTML = "Error, please try later.<br>";
      }
    });
  } else {
    el('subresp').innerHTML = "Enter some feedback first."
  }
}
function download(id,t) {
  var e = document.getElementById('dl'+id);
  e.style.top = t+'px';
  e.style.display = 'block';
}
function download2(id) {
  var e = document.getElementById('dl'+id);
  e.style.display = 'none';
}
function update() {
  // --dtd--
  var t = 1596610800.0;
  var d2d = 700539.0;
  var delta = 5772.428571428572;
  // --dtd--
  var seconds = new Date() / 1000;
  var current = d2d + (seconds - t) * (delta / 86400.0);
  p = [ [ 'psave', 65.52994278838395 ], [ 'p100', 100 ] ];
  for (i = 0; i < p.length; i++) {
    d = Math.floor(p[i][1] / 100.0 * current);
    // var ds = d.toLocaleString(undefined);
    var ds = String(d);
    var e = document.getElementById(p[i][0]);
    if (e) {
      var prev = e.innerHTML;
      e.innerHTML = ds;
      // e.classList.remove('change');
      if (ds != prev) {
        // e.classList.add('change');
      }
    }
  }
  setTimeout(update, 500);
}
/*! odometer 0.4.6 */
(function(){var a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G=[].slice;q='<span class="odometer-value"></span>',n='<span class="odometer-ribbon"><span class="odometer-ribbon-inner">'+q+"</span></span>",d='<span class="odometer-digit"><span class="odometer-digit-spacer">8</span><span class="odometer-digit-inner">'+n+"</span></span>",g='<span class="odometer-formatting-mark"></span>',c="(,ddd).dd",h=/^\(?([^)]*)\)?(?:(.)(d+))?$/,i=30,f=2e3,a=20,j=2,e=.5,k=1e3/i,b=1e3/a,o="transitionend webkitTransitionEnd oTransitionEnd otransitionend MSTransitionEnd",y=document.createElement("div").style,p=null!=y.transition||null!=y.webkitTransition||null!=y.mozTransition||null!=y.oTransition,w=window.requestAnimationFrame||window.mozRequestAnimationFrame||window.webkitRequestAnimationFrame||window.msRequestAnimationFrame,l=window.MutationObserver||window.WebKitMutationObserver||window.MozMutationObserver,s=function(a){var b;return b=document.createElement("div"),b.innerHTML=a,b.children[0]},v=function(a,b){return a.className=a.className.replace(new RegExp("(^| )"+b.split(" ").join("|")+"( |$)","gi")," ")},r=function(a,b){return v(a,b),a.className+=" "+b},z=function(a,b){var c;return null!=document.createEvent?(c=document.createEvent("HTMLEvents"),c.initEvent(b,!0,!0),a.dispatchEvent(c)):void 0},u=function(){var a,b;return null!=(a=null!=(b=window.performance)?"function"==typeof b.now?b.now():void 0:void 0)?a:+new Date},x=function(a,b){return null==b&&(b=0),b?(a*=Math.pow(10,b),a+=.5,a=Math.floor(a),a/=Math.pow(10,b)):Math.round(a)},A=function(a){return 0>a?Math.ceil(a):Math.floor(a)},t=function(a){return a-x(a)},C=!1,(B=function(){var a,b,c,d,e;if(!C&&null!=window.jQuery){for(C=!0,d=["html","text"],e=[],b=0,c=d.length;c>b;b++)a=d[b],e.push(function(a){var b;return b=window.jQuery.fn[a],window.jQuery.fn[a]=function(a){var c;return null==a||null==(null!=(c=this[0])?c.odometer:void 0)?b.apply(this,arguments):this[0].odometer.update(a)}}(a));return e}})(),setTimeout(B,0),m=function(){function a(b){var c,d,e,g,h,i,l,m,n,o,p=this;if(this.options=b,this.el=this.options.el,null!=this.el.odometer)return this.el.odometer;this.el.odometer=this,m=a.options;for(d in m)g=m[d],null==this.options[d]&&(this.options[d]=g);null==(h=this.options).duration&&(h.duration=f),this.MAX_VALUES=this.options.duration/k/j|0,this.resetFormat(),this.value=this.cleanValue(null!=(n=this.options.value)?n:""),this.renderInside(),this.render();try{for(o=["innerHTML","innerText","textContent"],i=0,l=o.length;l>i;i++)e=o[i],null!=this.el[e]&&!function(a){return Object.defineProperty(p.el,a,{get:function(){var b;return"innerHTML"===a?p.inside.outerHTML:null!=(b=p.inside.innerText)?b:p.inside.textContent},set:function(a){return p.update(a)}})}(e)}catch(q){c=q,this.watchForMutations()}}return a.prototype.renderInside=function(){return this.inside=document.createElement("div"),this.inside.className="odometer-inside",this.el.innerHTML="",this.el.appendChild(this.inside)},a.prototype.watchForMutations=function(){var a,b=this;if(null!=l)try{return null==this.observer&&(this.observer=new l(function(){var a;return a=b.el.innerText,b.renderInside(),b.render(b.value),b.update(a)})),this.watchMutations=!0,this.startWatchingMutations()}catch(c){a=c}},a.prototype.startWatchingMutations=function(){return this.watchMutations?this.observer.observe(this.el,{childList:!0}):void 0},a.prototype.stopWatchingMutations=function(){var a;return null!=(a=this.observer)?a.disconnect():void 0},a.prototype.cleanValue=function(a){var b;return"string"==typeof a&&(a=a.replace(null!=(b=this.format.radix)?b:".","<radix>"),a=a.replace(/[.,]/g,""),a=a.replace("<radix>","."),a=parseFloat(a,10)||0),x(a,this.format.precision)},a.prototype.bindTransitionEnd=function(){var a,b,c,d,e,f,g=this;if(!this.transitionEndBound){for(this.transitionEndBound=!0,b=!1,e=o.split(" "),f=[],c=0,d=e.length;d>c;c++)a=e[c],f.push(this.el.addEventListener(a,function(){return b?!0:(b=!0,setTimeout(function(){return g.render(),b=!1,z(g.el,"odometerdone")},0),!0)},!1));return f}},a.prototype.resetFormat=function(){var a,b,d,e,f,g,i,j;if(a=null!=(i=this.options.format)?i:c,a||(a="d"),d=h.exec(a),!d)throw new Error("Odometer: Unparsable digit format");return j=d.slice(1,4),g=j[0],f=j[1],b=j[2],e=(null!=b?b.length:void 0)||0,this.format={repeating:g,radix:f,precision:e}},a.prototype.render=function(a){var b,c,d,e,f,g,h,i,j,k,l,m;for(null==a&&(a=this.value),this.stopWatchingMutations(),this.resetFormat(),this.inside.innerHTML="",g=this.options.theme,b=this.el.className.split(" "),f=[],i=0,k=b.length;k>i;i++)c=b[i],c.length&&((e=/^odometer-theme-(.+)$/.exec(c))?g=e[1]:/^odometer(-|$)/.test(c)||f.push(c));for(f.push("odometer"),p||f.push("odometer-no-transitions"),f.push(g?"odometer-theme-"+g:"odometer-auto-theme"),this.el.className=f.join(" "),this.ribbons={},this.digits=[],h=!this.format.precision||!t(a)||!1,m=a.toString().split("").reverse(),j=0,l=m.length;l>j;j++)d=m[j],"."===d&&(h=!0),this.addDigit(d,h);return this.startWatchingMutations()},a.prototype.update=function(a){var b,c=this;return a=this.cleanValue(a),(b=a-this.value)?(v(this.el,"odometer-animating-up odometer-animating-down odometer-animating"),b>0?r(this.el,"odometer-animating-up"):r(this.el,"odometer-animating-down"),this.stopWatchingMutations(),this.animate(a),this.startWatchingMutations(),setTimeout(function(){return c.el.offsetHeight,r(c.el,"odometer-animating")},0),this.value=a):void 0},a.prototype.renderDigit=function(){return s(d)},a.prototype.insertDigit=function(a,b){return null!=b?this.inside.insertBefore(a,b):this.inside.children.length?this.inside.insertBefore(a,this.inside.children[0]):this.inside.appendChild(a)},a.prototype.addSpacer=function(a,b,c){var d;return d=s(g),d.innerHTML=a,c&&r(d,c),this.insertDigit(d,b)},a.prototype.addDigit=function(a,b){var c,d,e,f;if(null==b&&(b=!0),"-"===a)return this.addSpacer(a,null,"odometer-negation-mark");if("."===a)return this.addSpacer(null!=(f=this.format.radix)?f:".",null,"odometer-radix-mark");if(b)for(e=!1;;){if(!this.format.repeating.length){if(e)throw new Error("Bad odometer format without digits");this.resetFormat(),e=!0}if(c=this.format.repeating[this.format.repeating.length-1],this.format.repeating=this.format.repeating.substring(0,this.format.repeating.length-1),"d"===c)break;this.addSpacer(c)}return d=this.renderDigit(),d.querySelector(".odometer-value").innerHTML=a,this.digits.push(d),this.insertDigit(d)},a.prototype.animate=function(a){return p&&"count"!==this.options.animation?this.animateSlide(a):this.animateCount(a)},a.prototype.animateCount=function(a){var c,d,e,f,g,h=this;if(d=+a-this.value)return f=e=u(),c=this.value,(g=function(){var i,j,k;return u()-f>h.options.duration?(h.value=a,h.render(),void z(h.el,"odometerdone")):(i=u()-e,i>b&&(e=u(),k=i/h.options.duration,j=d*k,c+=j,h.render(Math.round(c))),null!=w?w(g):setTimeout(g,b))})()},a.prototype.getDigitCount=function(){var a,b,c,d,e,f;for(d=1<=arguments.length?G.call(arguments,0):[],a=e=0,f=d.length;f>e;a=++e)c=d[a],d[a]=Math.abs(c);return b=Math.max.apply(Math,d),Math.ceil(Math.log(b+1)/Math.log(10))},a.prototype.getFractionalDigitCount=function(){var a,b,c,d,e,f,g;for(e=1<=arguments.length?G.call(arguments,0):[],b=/^\-?\d*\.(\d*?)0*$/,a=f=0,g=e.length;g>f;a=++f)d=e[a],e[a]=d.toString(),c=b.exec(e[a]),e[a]=null==c?0:c[1].length;return Math.max.apply(Math,e)},a.prototype.resetDigits=function(){return this.digits=[],this.ribbons=[],this.inside.innerHTML="",this.resetFormat()},a.prototype.animateSlide=function(a){var b,c,d,f,g,h,i,j,k,l,m,n,o,p,q,s,t,u,v,w,x,y,z,B,C,D,E;if(s=this.value,j=this.getFractionalDigitCount(s,a),j&&(a*=Math.pow(10,j),s*=Math.pow(10,j)),d=a-s){for(this.bindTransitionEnd(),f=this.getDigitCount(s,a),g=[],b=0,m=v=0;f>=0?f>v:v>f;m=f>=0?++v:--v){if(t=A(s/Math.pow(10,f-m-1)),i=A(a/Math.pow(10,f-m-1)),h=i-t,Math.abs(h)>this.MAX_VALUES){for(l=[],n=h/(this.MAX_VALUES+this.MAX_VALUES*b*e),c=t;h>0&&i>c||0>h&&c>i;)l.push(Math.round(c)),c+=n;l[l.length-1]!==i&&l.push(i),b++}else l=function(){E=[];for(var a=t;i>=t?i>=a:a>=i;i>=t?a++:a--)E.push(a);return E}.apply(this);for(m=w=0,y=l.length;y>w;m=++w)k=l[m],l[m]=Math.abs(k%10);g.push(l)}for(this.resetDigits(),D=g.reverse(),m=x=0,z=D.length;z>x;m=++x)for(l=D[m],this.digits[m]||this.addDigit(" ",m>=j),null==(u=this.ribbons)[m]&&(u[m]=this.digits[m].querySelector(".odometer-ribbon-inner")),this.ribbons[m].innerHTML="",0>d&&(l=l.reverse()),o=C=0,B=l.length;B>C;o=++C)k=l[o],q=document.createElement("div"),q.className="odometer-value",q.innerHTML=k,this.ribbons[m].appendChild(q),o===l.length-1&&r(q,"odometer-last-value"),0===o&&r(q,"odometer-first-value");return 0>t&&this.addDigit("-"),p=this.inside.querySelector(".odometer-radix-mark"),null!=p&&p.parent.removeChild(p),j?this.addSpacer(this.format.radix,this.digits[j-1],"odometer-radix-mark"):void 0}},a}(),m.options=null!=(E=window.odometerOptions)?E:{},setTimeout(function(){var a,b,c,d,e;if(window.odometerOptions){d=window.odometerOptions,e=[];for(a in d)b=d[a],e.push(null!=(c=m.options)[a]?(c=m.options)[a]:c[a]=b);return e}},0),m.init=function(){var a,b,c,d,e,f;if(null!=document.querySelectorAll){for(b=document.querySelectorAll(m.options.selector||".odometer"),f=[],c=0,d=b.length;d>c;c++)a=b[c],f.push(a.odometer=new m({el:a,value:null!=(e=a.innerText)?e:a.textContent}));return f}},null!=(null!=(F=document.documentElement)?F.doScroll:void 0)&&null!=document.createEventObject?(D=document.onreadystatechange,document.onreadystatechange=function(){return"complete"===document.readyState&&m.options.auto!==!1&&m.init(),null!=D?D.apply(this,arguments):void 0}):document.addEventListener("DOMContentLoaded",function(){return m.options.auto!==!1?m.init():void 0},!1),"function"==typeof define&&define.amd?define(["jquery"],function(){return m}):typeof exports===!1?module.exports=m:window.Odometer=m}).call(this);
// update();
</script>
</body>
</html>
